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Background 
Milk and derived dairy products are essential sources of food for the majority of the world 
population. The per capita consumption of milk and dairy products is higher in developed 
countries, but the gap with many developing countries is narrowing. The growing demand 
offers a good opportunity for producers in high-potential, peri urban areas to enhance their 
livelihoods through increased production (FAO, 2015). In 2014, the EU member states were 
delivering 40% of the global milk production. Also in Belgium the total milk production has 
increased with almost 20% since 2006 (Annual Report BCZ, 2015). Within Belgium, Flemish 
dairy farms are responsible for this increase (Annual Report BCZ, 2015). On the other hand, 
there are substantial differences between the Flemish provinces, with the largest herds being 
located in the provinces of Antwerp and Limburg, and the smallest herds in Vlaams-Brabant 
and West-Vlaanderen. However, the largest milk deliveries originate from the province West-
Vlaanderen (Annual Report BCZ, 2015). In order to achieve this growth and to keep dairy 
farming profitable at the same time, the average milk yield (MY) per cow as well as the average 
herd size, has increased substantially in recent decades (Lucy, 2001). The higher MY has 
resulted from genetic selection as well as improved cow nutrition and management (Barkema 
et al., 2015). Also, while in the past heifer rearing was too often neglected on dairy farms, it 
has become a priority in modern intensive dairy systems. Huijps and Hogeveen (2007) 
illustrated that a heifer producing 8,000 kg of milk during the first lactation will have returned 
little more than the investment cost, provided it remains healthy during its first lactation, under 
Dutch (milk quota) circumstances. One of the diseases potentially threatening these 
challenges is mastitis. Besides well-studied mastitis pathogens such as Staphylococcus 
aureus, Escherichia coli and the Streptococcus uberis, emerging pathogens causing mastitis 
are diagnosed more often than before, e.g. Mycoplasma bovis (Fox et al., 2005). Still, the 
prevalence on Flemish dairy herds is yet unknown. Also, together with the intensification on 
dairy farms in the last decades, the quality and safety of dairy products have become an 
increasing issue of concern for both consumers and producers (Flores-Miyamoto et al., 2014). 
This phenomenon is at least partly attributable to incidents such as the dioxin contamination 
of animal feed in Belgium (Boor, 2001; Noordhuizen and Metz, 2005) and Germany (Velthuis 
and Van Asseldonk, 2011), melamine-contaminated powdered infant formula in China 
(Haenlein, 2002; WHO, 2008), and outbreaks of Escherichia coli O104:H4 infection in 16 
countries in Europe and North America (EFSA, 2010). Also, antimicrobial overuse and/or 
misuse in food animal production has the potential to increase antimicrobial resistance which 
might threat human health. The latter stresses the importance of the absence of residues in 
milk and even more the request for a more targeted use of antimicrobials in the dairy industry, 
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all the more so since approximately 80% of the antimicrobial residue violations in milk can be 
traced back to mastitis treatments (Leslie et al., 1997; Ruegg and Tabone, 2000). 
 
 Udder health 
Clinical and subclinical mastitis 
Mastitis is defined as an inflammatory reaction of the udder tissue, generally in response 
to a bacterial intramammary infection (IMI) (Bradley, 2002). It is still one of the most costly 
diseases for the dairy industry as it affects a high proportion of dairy cows throughout the world. 
A recent study estimated the costs of mastitis at 140 euro per cow per year (Halasa et. al., 
2009).  
The disease is a 2-faceted health problem including subclinical and clinical mastitis (CM) 
(Barnouin et al., 2005). Clinical mastitis is readily apparent and easy to detect by the milker - 
less so by an automated milking system (AMS) - as it results in alterations in milk appearance 
(clots, flakes, watery secretion,...) and a decreased milk production, often accompanied with 
elevated body temperature, and swelling, redness, pain or heat of the infected udder 
quarter(s). Subclinical mastitis, which is the most prevalent form of mastitis, reduces the milk 
production and milk quality without visible signs. The most common method to detect cases of 
subclinical mastitis is by measuring the milk somatic cell count (SCC). An elevated SCC is a 
sign of inflammation and a useful indicator for the presence of IMI (Schukken et al., 2003). The 
bulk milk somatic cell count (BMSCC) is, besides being a proxy for the prevalence of cows 
suffering from subclinical mastitis in a herd, also a key milk quality parameter in national and 
international regulatory systems. 
Mastitis causing pathogens 
Various pathogens, typically bacteria, are capable of invading the mammary gland, to multiply, 
and to induce an inflammatory response. Over 200 different organisms have been recorded in 
scientific literature as potential causes of bovine mastitis (Blowey and Edmondson, 2010). 
Mastitis-causing pathogens can be classified as either environmental or contagious in nature, 
reflecting their epidemiological behaviour (Table 1). So-called environmental pathogens are 
particularly adapted to survive in the bovine environment and can be considered opportunistic 
invaders of the mammary gland. The most frequently isolated environmental pathogens are 
streptococci other than Streptococcus agalactiae, commonly referred to as environmental 
streptococci, and Gram-negative bacteria such as E. coli and Klebsiella spp. (Bramley and 
Dodd, 1984; Smith et al., 1985). So-called contagious mastitis pathogens are adapted to 
survive within the mammary gland and are spread from cow to cow primarily during the milking 
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process. Examples are: S. aureus, Strep. agalactiae, Mycoplasma species, and 
Corynebacterium bovis (Smith, 1983; Bramley and Dodd, 1984). However, this classification 
is not as clear-cut as accepted before as strains within species can act differently (Zadoks and 
Schukken, 2006). Classifying mastitis causing pathogens as purely environmental or 
contagious is, however, a simplified representation of the reality. Evidence has been provided 
for both environmental S. aureus as well as contagious Strep. uberis mastitis-causing strains 
(Zadoks et al., 2001, 2002a). Therefore, the epidemiology of mastitis-causing pathogens is 
more and more represented by a sliding scale, where the balance of contagious and 
environmental transmission shifts gradually, instead of a species-based dichotomy (Zadoks, 
2002b). The sources and transmission routes of the coagulase-negative staphylococci (CNS) 
are currently still largely unknown. In a recent study, they appeared to be more environmental 
as group than contagious (Sampimon et al., 2009), yet differences between species have been 
reveald (De Visscher et al., 2014; Vanderhaeghen et al., 2015).  
Table 1. Overview of the most prevalent mastitis pathogens, classified as environmental or contagious.  
Contagious pathogens Environmental pathogens 
Staphylococcus aureus Streptocococcus uberis 
Streptococcus agalactiae Coliforms (E. coli, Citrobacter spp., Enterobacter 
spp., Klebsiella spp.) 
 Bacillus cereus, Bacillus licheniformis 
Streptococcus dysgalactiae Pasteurella spp. 
Pseudomonas aeruginosa 
Corynebacterium bovis Streptococcus faecalis 
Mycoplasma spp. Fungi, Yeasts 
Recently, mastitis caused by Mycoplasma spp. have been receiving more attention. The 
premise that Mycoplasma mastitis has an emerging presence is reflected in reports from 
Canada (Francoz et al., 2012), Greece (Fillioussis et al., 2007), Iran (Ghazaei, 2006), and 
Mexico (Miranda-Morales et al., 2008) and the multifold increase in herds with apparent 
Mycoplasma mastitis over time in the Pacific Northwest of the USA (Fox et al, 2003). 
Mycoplasma bovis is clearly the most prevalent Mycoplasma spp. that causes mastitis and it 
is estimated that more than 90% of the Mycoplasma mastitis cases are due to Mycoplasma 
bovis (Boonyayatra et al., 2012). Other Mycoplasma spp. that cause mastitis include: 
Mycoplasma californicum, Mycoplasma bovigenitalium, Mycoplasma arginini, Mycoplasma 
bovirhinis, Mycoplasma canadense, and Mycoplasma alkalescens (Gonzalez and Wilson, 
2003). One of the explanations for the emerging nature of Mycoplasma mastitis might be found 
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in the increasing herd size.  There is a significant correlation between herd size and the risk of 
Mycoplasma mastitis (Thomas et al., 1981; Fox et al., 2003). Presumably, this is because 
larger herds are more likely to import new cattle. It is assumed that the increased risk is a result 
of the inclusion of cattle that are infected with novel strains of Mycoplasma spp., where such 
infection might be symptomatically or asymptomatically expressed (Fox, 2012). However, the 
results reported by Wilson et al. (2007) indicate that an outbreak of Mycoplasma-associated 
disease could also occur spontaneously in a closed herd. Risk factors other than novel 
introduction of the agent might thus exist as well. Until now, no information is available on the 
prevalence of Mycoplasma mastitis on Flemish dairy herds.  
Prevention and control 
Mastitis prevention and control programs were developed in the sixties of the last century 
and have ever since been adopted with considerable success in reducing the prevalence and 
incidence of subclinical and clinical mastitis in every dairy herd where it has been applied 
(Hillerton et al., 1995; Bradley, 2002). The first standard mastitis control program comprised 5 
points: appropriate treatment of clinical mastitis, culling of chronically infected cows, post-
milking teat disinfection, correct maintenance and use of the milking equipment, and 
application of blanket dry cow therapy (Neave et al., 1969). Those measures mainly focused 
on how to reduce the transmission of contagious mastitis pathogens, and thus were less 
effective against environmental pathogens. Studies have shown that as the prevalence of 
contagious mastitis pathogens is reduced, the proportion of mastitis cases caused by 
environmental pathogens increases (Oliver et al., 1997; Jayarao et al., 1999). It was therefore 
realised that with these shifting distributions of pathogens, new approaches were needed. This 
eventually resulted in the extension of the 5-point plan into the 10-point prevention and control 
program of the National Mastitis Council (2014). The first points of the program still focus on 
the prevention and control of contagious mastitis pathogens. The added points stress the 
importance of a comfortable, hygienic and well-ventilated housing to prevent and control 
mastitis caused by environmental pathogens, besides some other aspects related to goal 
setting and regular monitoring. However, the shift in the distribution of mastitis pathogens is 
still continuing and has in many countries resulted in a substantial increase of CNS IMI over 
the last 10 years (Myllys et al. 1998; Makovec and Ruegg, 2003; Pitkäla et al., 2004), also in 
Flanders (Piepers et al., 2007). 
Interestingly, most measures included in the 10-point standard mastitis prevention and 
control program are derived from studies that focused on subclinical mastitis and not on CM. 
In that respect, it is surprising to see only a few peer-reviewed publications report on risk 
factors for CM (Peeler et al., 2000; Barnouin et al. 2005; Verbeke et al., 2014). Some studies 
suggested that low BMSCC was associated with a high incidence rate of CM (IRCM) (Elbers 
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et al., 1998; Beaudeau et al., 2002; Green et al., 2004) whereas other work did not reveal any 
interrelationship (Barkema et al., 1998; Beaudeau et al., 1998). In general, there is a lack of 
information on success factors for herds combining a low incidence rate of clinical mastitis 
(IRCM) with a low BMSCC, also in our part of the world.  
The increase in average herd size has required an increase in the number of replacement 
heifers, prioritizing optimal dairy heifer rearing in modern intensive dairy systems. A heifer has 
returned little more than the investment cost after completion of the first lactation, provided it 
has remained healthy. One of the diseases threatening its health is mastitis. It is currently well-
known that a high proportion of heifers freshens with IMI in one or more quarters (De Vliegher 
et al., 2012). Mastitis in dairy heifers is recognised as a distinct problem from that in 
multiparous cows because of its different pattern of disease and unique factors that determine 
its occurrence. After all, primigravid animals have never been milked upon calving whereas 
the milking process is, as mentioned above, generally considered one of the principal risk 
factors of mastitis. Consequently, heifers are less exposed to contagious pathogens and their 
teats have not been challenged by the milking vacuum, undermining its role as first barrier 
against environmental pathogens. All in all, heifer mastitis is a costly disease. Typically, the 
cost of mastitis is ascribed to lost milk production, premature culling, additional labor, 
management changes, and veterinary needs, additional use of drugs and increased risk of 
residues, and production of nonsaleable milk (Huijps et al., 2009). Early lactation mastitis in 
heifers also results in lost future milk yield (Coffey et al., 1986; Rupp and Boichard, 2000; De 
Vliegher et al., 2005a). Additionally, heifer mastitis increases the risk of premature culling (De 
Vliegher et al., 2005b) and puts heifers at greater risk for CM (Coffey et al., 1986; Rupp and 
Boichard, 2000). More cases of CM in its turn is associated with an increased drug use, more 
discarded milk, and an increased risk of residues appearing in the milk supply. Several 
pathogens are involved in heifer mastitis, with coagulase-negative staphylococci (CNS) being 
the most prevalent (Fox, 2009; De Vliegher et al., 2012). Recent work suggests that CNS IMI 
in fresh heifers have a less pronounced effect on the heifers’ future performances compared 
with IMI caused by major pathogens, making the need for prevention of IMI with CNS, at least 
in early lactation heifers, not a priority, or even unwanted, as heifers with CNS IMI at calving 
produce more and have a lower IRCM during their first lactation compared with noninfected 
heifers (Piepers et al., 2010, 2013; Pearson et al., 2013). The high prevalence of IMI in fresh 
dairy heifers and the potentially compromising effects for future productivity have urged 
researchers to seek for risk factors specifically associated with mastitis in dairy heifers. Based 
on the findings of all heifer mastitis risk factor studies conducted in the last decades, a 10-point 
program specifically focusing on the prevention and control of heifer mastitis was recently 
proposed (De Vliegher et al., 2012), but did not distinguish between (subgroups of) mastitis 
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pathogens (Table 2). Still, studying pathogen group-specific risk factors for IMI in early lactating 
heifers is even more interesting as it allows for the development of pathogen group-specific 
prevention and control programs.  
 
Table 2. Ten-point program to prevent and control heifer mastitis (De Vliegher et al., 2012 and NMC, 
2014). 
 
1. Improve general udder health management at the farm level to decrease the pressure of infection 
with udder pathogens from older cows to heifers 
2. Control for cross-suckling in calves and young stock 
3. Implement an effective and efficient fly control system 
4. Keep young and primigravid heifers in a clean and hygienic environment and separate from 
multiparous animals—provide as much attention to this group of animals related to hygiene and 
cleanliness as is spent on lactating animals 
5. Avoid any nutritional deficiency—monitor vitamin E and selenium levels when any doubt exists, 
especially in relation to CM; zinc, copper, and vitamin A play a role as well and could be checked 
6. Minimize the risk of negative energy balance before and after calving through appropriate transition 
feeding systems 
7. Reduce the incidence of udder edema through optimized peripartum management 
8. Minimize stress around calving (e.g., by not moving heifers to the calving pen when already in 
labor) and minimize incidence of dystocia and peripartum disease 
9. Consider use of internal teat sealants prepartum where a high risk of environmental mastitis exists 
in the peripartum period 
10. Use prepartum antibiotic treatment in heifers under certain conditions only: 
a.under the supervision of the herd veterinarian, within the context of a valid 
veterinary/client/patient relationship 
b.after quantification of the problem and identification of major pathogens (not CNS) as 
the cause through culturing 
c.choice of the antibiotics should be based on antimicrobial susceptibility testing 
d.testing for residues before every milk delivery 
e.upgrading of management at the same time—discontinue treatment as soon as new 
management strategies become effective 
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Milk quality and milk safety 
Microbiological contamination of milk is an important issue because pathogens can affect 
food safety, and spoilage microorganisms can limit shelf life and affect quality or yield of dairy 
products. Bacterial milk quality can be determined using several parameters including bacterial 
count (BC), preliminary incubation counts, laboratory pasteurization counts, and coliform 
counts (CC; Murphy, 1997). Among these, BC is the most commonly used one in regulatory 
programs (Murphy and Boor, 2000). Besides penalties for not meeting the legal milk quality 
standards, the majority of milk processors in Flanders (Belgium) pays incentives to farmers 
that meet higher quality requirements. The combination of a system combining both penalties 
and premiums has shown to provide a strong incentive for improvement of milk quality 
(Nightingale et al., 2008) and is also a strong motivator to implement management changes 
on dairy farms. In Flanders (Belgium), the official mandatory milk quality regulations follow 
European legislation and require a geometric mean BMSCC over the last three months (based 
on 4 recordings per month) < 400 x 10³ cells/mL, a geometric mean BC, expressed as 
individual bacterial count (IBC) over the last two months (based on two recordings per month 
) < 100 x 10³ IBC/mL milk, a geometric mean of the freezing point over the last two months 
(based on all deliveries) > -510 m°C, no visible impurities (filtration test done once a month) 
and absence of antibiotic residues in any milk delivery. In 2014, 2.75% of the herds received 
one or more penalties because of not meeting the legal standards (Annual Report MCC 
Vlaanderen, 2015). In contrast, testing of CC is nonobligatory for milk quality in Flanders, yet 
implemented as part of the aforementioned incentive program. However, there is a lack of 
information on factors related to (not) achieving milk quality premiums, also in Flanders. With 
a low milk price and marginal profits, it is important to provide farmers with tools to produce 
high quality milk in the most efficient way. Until now, most studies have identified factors 
holding information on milking and equipment hygiene, sanitizing procedures (Elmoslemany 
et al., 2009; Pantoja et al., 2011), and milk storage conditions (Murphy and Boor, 2000), 
explaining variability in TBC and CC. Apart from 2 studies (van Schaik et al., 2005 and 
Elmoslemany et al., 2010), factors related to either herd health management, transition and 
feeding management, or housing, which are known to affect udder health, have not been 
studied as potential factors related to milk quality. Also, little information is available on which 
management practices predispose a farm to the loss of premiums due to inferior milk quality.  
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A shift from curative towards preventive veterinary medicine 
With regard to the herd size and management of dairy farms over the past few decades, 
some trends have become visible. Dairy farms have been coping with increased (feed) costs 
and had to improve productivity for that reason or changed their business model towards e.g. 
organic farming. Apart from having more cows, cows have also been genetically selected to 
produce more milk (Noordhuizen and Wentink, 2001). This intensification led to more cows per 
producer and more production-related problems such as subfertility and subclinical disease 
(Shanks et al., 1978). The focus of dairy management has therefore changed from curative to 
preventive (Cannas da Silva et al., 2006; LeBlanc et al., 2006). Yet, even though modern dairy 
producers are nowadays more aware of the costs of animal diseases than some decades ago 
and are therefore more eager to prevent them, they often experience difficulties with their 
detection and with finding a solution for them (Cannas da Silva et al., 2006). Both scientific 
evidence and personal experiences from the field teach that farmers therefore often keep 
returning their old habits and keep reaching for antimicrobials in case of (udder/infectious) 
health problems rather than changing their herd management in a way that disease can be 
prevented in the future (McDougall et al., 2009). Still, in order to safeguard the effectiveness 
of existing and novel antimicrobials, there is an increasing global pressure to develop 
strategies in both human and veterinary medicine to slow down the emerging resistance in 
bacteria by selection pressure (Morley et al., 2005). This implies a shift to a more preventive 
rather than curative veterinary medicine and a more responsible use of drugs when 
antimicrobials are needed.  
Prevention and treatment of mastitis accounts for 60% of the antimicrobial use on a dairy 
farm of which approximately 50% is applied for (blanket) dry cow therapy (Stevens et al., 2016). 
Treatment of all cows with long-acting antimicrobials at dry-off (so-called blanket dry cow 
therapy) has been applied since the 1960 (Neave et al., 1969) and is still a cornerstone of the 
10-point mastitis prevention and control program (NMC, 2009). In the early 1990ies, prepartum 
antimicrobial treatment of end-term heifers was also suggested in the control of heifer mastitis. 
In general, prepartum treatment of heifers with lactating or dry cow products results in higher 
bacteriological cure rates of infected quarters (Nickerson et al., 2009). Studies investigating 
the effects of systemic treatment are, however, rare (Kreiger et al., 2007; Parker et al., 2008), 
although systemic over local antibiotic treatment has the advantages of a decreased risk of  
teat contamination (i.e. iatrogenic infection) during the application, is more convenient and 
safer to administer, and allows to treat four quarters at a time with a single administration. 
Logically, a widespread distribution of the systemically administered antimicrobial drug in the 
dry udder is a prerequisite for being successfull. Positive long-term effects of prepartum 
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antibiotic treatment such as lower SCC and higher MY over the first lactation were seen in 
some studies (e.g. Sampimon et al., 2009) but not in others (Borm et al., 2006). The latter 
indicates that some yet not identified herd-specific factors (e.g. prevalence of major pathogens, 
milk production, …) might play a role. Also, the added value of treatment over the 
implementation of other prevention and control measures, in particular on farms that do not 
specifically suffer from a true heifer mastitis problem, is yet not known. Finding an answer on 
the latter question has even become more relevant over the last few years as the use of 
antimicrobials in farming animals is increasingly subjected to criticism (Kaesbohrer et al., 
2012).  
Monitoring and managing herd health, such as udder health, has become an important and 
challenging issue on dairy farms. To cope with these challenges, veterinary herd health 
management programs (VHHM) were set up. They are defined as a combination of (advice 
on) animal health, milk production, and disease prevention, placed in a framework of farm 
economics, welfare, food safety, and environment (Brand et al., 1996). Given their knowledge 
on epidemiology, farm management, and physiology and pathology of dairy cows, veterinary 
practitioners have always been an important partner for dairy farmers regarding animal health 
and herd profitability. This started in the 1960ies with mastitis control (Bramley and Dodd, 
1984), followed by herd fertility schemes (Bramley and Dodd, 1984; Esslemont et al., 1985; 
Esslemont et al., 2001), disease prevention (de Kruif and Opsomer, 2004) and, finally, quality 
control programs (Esslemont et al., 1985; Noordhuizen and Wentink, 2001; de Kruif and 
Opsomer, 2004). Veterinary herd health management programs ideally follow a fixed structure 
of goal setting, advice, action, and evaluation (Brand et al., 1996) as shown in Figure 1. 
Defining short- and long-term goals and getting a better understanding of the motivation and 
mindset of each individual farmer is a first step in such a VHHM program. Some farmers 
perceive the extra stress and labour as the most annoying aspects of mastitis while other 
farmers are more worried by the lost revenues. Also, the level at which mastitis is perceived 
as a problem and thus the goals will differ between farmers (Huijps et al., 2008). Of course, in 
the light of a more prudent use of antimicrobials, it would be good if dairy farmers became 
aware of potential problems with infectious disease and are open for possible improvements 
before serious problems occur (Lam et al. 2011). A more pro-active rather than reactive role 
on the part of the veterinarian in supporting the dairy farmer could of course be very helpful. 
Also, while defining the farmer-specific goals, the interests of both the milk buyers and the 
society should not be forgotten. In a second step, data should be collected, recorded and 
analysed. In a third step, herd-specific advices should be formulated and a farmer-tailored 
(udder) health management plan should be implemented.  And last but not least, results should 
be regularly evaluated and the formulated management plan should be adapted accordingly.  
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Still, to be succesfull, more insights are needed in the potential challenges and bottlenecks 
that one might encounter in setting-up and executing such a VHHM program, also when 
focussing on udder health and milk quality, under the current Flemish conditions, but which 
might, in turn, offer opportunities for both the vets and farmers (Fig. 1).  
 
Conclusions 
The dairy industry in the developed world has undergone profound changes over the 
recent decades (Barkema et al., 2014). Also in Flanders the average herd size has 
continuously increased with labour becoming more and more a limiting factor on the family-
owned farms. Since the abolition of the quota system in Europe, the price producers receive 
for there milk is market-driven and highly volatile at times. At the same time consumers and 
citizens have long-standing interests in the safety and quality of milk products (Drake, 2007) 
and in the welfare of the cows that produce milk and its associated products (von Keiserlingk 
et al., 2009). Since livestock can be reservoirs of resistance genes (Fey et al., 2000), 
antimicrobial resistance in bacteria has become an important public hazard (Prescott, 2014).  
Flemish dairy farmers and their veterinarians must learn how to deal with these 
challenges in the near future, if they want to retain their position in the global dairy industry. 
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The general aim of this thesis was to study (new) challenges related to udder health and milk 
quality (i.e. prudent use of antimicrobials, safeguarding milk quality and safety, excellent 
animal welfare, emerging pathogens, volatile milk prices, pressure to grow) that Flemish dairy 
farmers and their veterinarians are currently facing or will be facing in the (near) future. More 
specifically, this thesis aimed at giving better insights in if and how the udder health and milk 
quality on the Flemish dairy herds can be further improved in order to better respond to the 
public concerns related to antimicrobial usage, animal welfare, and milk quality and safety, 
and to at least partly counteract the volatile and often low milk prices. It also examines if 
mycoplasma mastitis is emerging on Flemish dairy farms as well, and which (additional) 
actions should be taken to further safeguard the udder health of their fresh dairy heifers.  
 
In this regard, the specific aims of this thesis were: 
 
 To develop a picture of the udder health and milk quality on Flemish dairy herds, using 
a number of parameters, i.e.: 
 The incidence of clinical mastitis and summary of the bulk milk somatic cell 
count (Chapter 3.1), 
 The total bacterial count and coliform count in unpasteurized bulk milk 
(Chapter 4.1), 
 Achieving milk quality premiums (Chapter 4.2), 
 The between-herd prevalence of Mycoplasma bovis (Chapter 3.2). 
 
 To evaluate to what extent differences in management practices explain between-herd 
differences in those parameters, i.e.: 
 The incidence of clinical mastitis and the bulk milk somatic cell count (Chapter 
3.1), 
 The total bacterial and coliform count in unpasteurized bulk milk (Chapter 4.1), 
 Achieving milk quality premiums (Chapter 4.2). 
 
 To evaluate the added value of systemically treating heifers prepartum with 
antimicrobials by: 
 Assessing the distribution of penicillin G in mammary tissue and secretions of 
heifers (Chapter 5.1), 
 Assessing the short-term and long-term effects on udder health, milk yield, and 
culling (Chapter 5.2), 
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 Identifying pathogen-group specific risk factors for intramammary infection in 
treated and untreated dairy heifers (Chapter 5.3). 
 
The results of this thesis give insights in which bottlenecks need to be tackled first in order to 
turn the abovementioned challenges into opportunities. Based on the results of the different 
studies, practical guidelines and recommendations for farmers, veterinarians and the industry 
are generated by implementing fixes for veterinarian and his clients through veterinary herd 
health management programs.      
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Abstract 
 
Associations between dairy herd management practices and characteristics, collected 
through a web-based questionnaire from 242 dairy herds in Flanders (Belgium), and their 
udder health status were studied. Herds were classified into four groups based on their bulk 
milk somatic cell count (BMSCC) and the estimated incidence of clinical mastitis (EICM). Four 
separate binary logistic regression models with the likelihood of being a good udder health 
herd (BMSCC ≤ 250,000 cells/mL and EICM ≤ 3%/month), a high clinical mastitis herd (CM 
herd) (BMSCC ≤ 250,000 cells/mL and EICM >3%/month),a high subclinical mastitis herd 
(SCM herd) (BMSCC > 250,000 cells/mL and EICM ≤ 3%/month), and a mixed herd (BMSCC 
> 250,000 cells/mL and EICM > 3%/month) as dependent variables were fit.    
Only one-third (35.1%) of the participating herds had low BMSCC (≤ 250,000 cells/mL) 
and a low EICM (≤3%/month) and were considered as good udder health herds. Thirty (12.4%) 
herds were classified as SCM herds, whereas 74 (30.6%) were defined as CM herds. Mixed 
herds counted for 21.9 % (n = 53) of the participating herds. No strong correlation was found 
between BMSCC and EICM in this study. Several management practices and characteristics 
were associated with the likelihood of being a good udder health herd, of being a CM herd, a 
SCM herd and a mixed herd. Participation in a veterinary herd health monitoring program 
increased the probability of having a good udder health and decreased the probability of 
having CM problems. Different management practices were associated with the likelihood of 
being a CM or SCM herd, suggesting that herds that suffer from SCM require a different 
approach than the ones that suffer from CM.  
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Introduction 
 Despite the fact that much research and effort have been dedicated to mastitis control, it 
remains a persistent problem and is still the most expensive disease in dairy cows (Schepers 
and Dijkhuizen, 1991; Lam et al., 2013). The disease can have two very distinctive 
presentations: subclinical or clinical, depending on both the pathogen involved and the 
immune response of the cow (Barnouin et al., 2005). Some studies suggested that a low 
BMSCC is associated with a high incidence rate of clinical mastitis (IRCM) (Elbers et al., 1998; 
Beaudeau et al., 2002; Green et al., 2004; Riekerink et al., 2008) whereas other work did not 
reveal any relationship (Barkema et al., 1998a; Beaudeau et al., 1998) between both types of 
mastitis. 
Throughout the world, the importance of udder health programs has increased in the last 
30 years. In Europe, the European economic community (EEC) directive 92/46 in April 1992 
stated that bulk milk with a SCC over 400,000 cells/mL may not be used for fluid milk and from 
1998 on not for milk products intended for human consumption  such as cheese. However, as 
shown by Schukken et al. (1990), annual mean BMSCC should be lower than 250,000 
cells/mL to minimize both the risk of exceeding the penalty limit of 400,000 cells/mL in any 
given bulk tank evaluation and milk production losses due to subclinical mastitis. In Flanders, 
Belgium, the BMSCC decreased from above 300,000 cells/mL in 1991 to 196,000 cells/mL in 
1999. Since that time, however, the geometric mean BMSCC increased again to 214,200 
cells/mL in 2014 (Annual Report 2014, Milk Control Centre Flanders, Lier, Belgium).   
Increased awareness of consumer and dairy organizations with regard to animal welfare 
issues is another aspect linked to udder health. Clinical mastitis may be a severe and painful 
disease that causes distress to the animal. Based on several studies across Europe (Barkema 
et al, 1998a; Barnouin et al., 2005; Bradley et al., 2007; Wolf et al., 2012) the average IRCM 
can be expected to be approximately 2.8% cases per month. Recently, Verbeke et al. (2014) 
estimated the mean IRCM in Flemish dairy herds at 2.4% cases per month and showed a high 
between-herd variation (range: 0 - 21.3 quarter cases per 10,000 cow-days at risk).   
 Human health concerns regarding milk consumption represents a third issue related to 
mastitis. The risk of antibiotic residues in milk, transfer of antibiotic resistance from animal to 
human, and transfer of pathogens or pathogen products through milk or milk products are of 
concern to the dairy consuming public. While antibiotic residues in milk are rare in developed 
industries, approximately 80% of antibiotic residues in milk can be traced back to mastitis 
treatments, either during lactation of during dry period (Leslie et al., 1997; Ruegg et al., 2000).  
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Along with the introduction of penalty limits for the BMSCC, the development and 
widespread acceptance of mastitis prevention and national dairy herd control programs 
(Neave et al., 1969; National Mastitis Council, 2006) has led to a substantial progress in 
controlling subclinical mastitis world-wide. Management practices potentially associated with 
a lower BMSCC have been extensively studied in Belgium (Piepers et al., 2010) and other 
countries (Neave et al., 1969; Goodger et al., 1993; Barkema et al., 1998a). However, only a 
few groups have published peer-reviewed research on risk factors for CM (Peeler et al., 2000; 
Barnouin et al., 2005; Verbeke et al., 2014).  
The main objective of the present epidemiological study was to identify, from a large list of 
potentially relevant variables, dairy herd management practices and characteristics 
associated with the udder health status on Flemish dairy farms. The udder health status was 
defined based on a combination of clinical and subclinical mastitis data. 
Materials and Methods 
Herd Selection and Data Collection 
A web-based questionnaire was conducted between January 2010 and July 2010. The 
questionnaire was pre-tested and refined in close cooperation with 4 dairy farmers prior to the 
start of the study. The questionnaire was emailed to approximately 1000 farmers based on a 
list (subscribers on the weekly newsletter) from the largest farmer’s organization (Boerenbond) 
in Flanders and an incentive (USB-stick) for a completed questionnaire was provided.  
In total, 242 farmers (almost 25% of those solicited and representing approximately 4% of 
Flemish farmers) completed the online questionnaire that consisted of 43 questions 
concerning general management (n = 8), herd health management (n = 9), milking (n = 11), 
calving and dry cow management  (n = 9) and nutrition (n = 6), in place on farm during 2009 
(Table 1).  The survey tool (in Dutch) is available from the corresponding author. 
From all farms that completed the online questionnaire, the BMSCC records measured 
between January 2009 and January 2010, were retrieved from the Milk Control Centre 
Flanders that executes the regulatory farm screening program in Flanders. All analyses were 
conducted on unpasteurized bulk milk samples collected in 30 mL sterile screw-cap tubes by 
trained milk haulers. The samples were kept cool (± 4°C) until arrival at the laboratory.   
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Table 1. Overview of all herd management practices collected via a web-based questionnaire on 242 
dairy herds in Belgium. 
General management 
 Type of livestock farming, expected time the farm will still exist, herd size, number of lactating 
cows, milk quota size, duration of access to pasture during summer, barn type, cleaning 
frequency of the housing  
Herd health management 
 Registration of animal diseases, herd health monitoring by veterinarian, participation in udder 
health monitoring, monthly estimated incidence of clinical mastitis, antimicrobial treatment 
during lactation of subclinical mastitis, treatment of prepartum heifers with antimicrobials, 
treatment based on vet advice or culture results, treatment duration of mild clinical mastitis, 
use of self-prepared off-label udder infusions  
Milking management 
 Milking machine type, milking parlor type, cows kept in headlock after milking, use of 
automatic cluster removal, providing a preparation lag-time of 60 s, teat preparation method, 
application of premilking teat disinfection, application of postmilking teat disinfection, type of 
machine unit liner, rinsing of machine unit liners, replacement of machine unit liners  
Calving management 
 Calving on pasture, presence of calving pen, use of calving pen for sick cows  
Nutrition management 
 Concentrate provided during milking, concentrate provided on top of forage, concentrate 
provided via total mixed ration, concentrate provided via automatic feeder, forage provided, 
type of forage feeding system  
Dry cow management 
 Drying-off procedure, use of long-acting antimicrobials, adapted diet provided, 
mineral/vitamin mix provided, use of external teat sealer, use of internal teat sealer  
 
Laboratory Analyses 
The bulk milk somatic cell count was determined within 24h after pick-up at the farm. The 
milk samples were vortexed prior to the start of the analyses. Milk SCC was quantified by 
electronic counting using a Fossomatic 5000 (Foss Electric, Hillerød, Denmark) at the Milk 
Control Centre Flanders (Lier, Belgium). A monthly geometric mean BMSCC was calculated 
based on the recordings (4 recordings per month) of the last 2 months. 
Definitions  
Estimated incidence of clinical mastitis (EICM). Clinical mastitis data were collected via 
the questionnaire. Clinical mastitis was defined as the presence of visual signs such as clots 
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in the milk, with or without redness, swelling of the udder quarter, or systemic signs (Lam et 
al., 2009). Farmers were asked to fill in the average number of CM cases per month. The 
EICM was calculated as the number of average CM cases per month divided by the average 
number of lactating cows in the herd during 2009 and expressed as a percentage. The 
threshold for defining an elevated EICM was set at 3% which was based on the average 
percentage of CM reported accross several European studies (Barkema et al., 1998a; 
Barnouin et al., 2005; Bradley et al., 2007; Wolff et al., 2012, and Verbeke et al., 2014).  
Bulk milk somatic cell count. Per herd, the average of the monthly geometric mean of 
four measurements per month was calculated. Based on the latter BMSCC value, the herds 
were classified into two groups using the threshold proposed by Schukken et al. (1990) and 
others (Erskine and Eberhart, 1991; Barkema et al., 1998a, Rodrigues et al., 2005). Herds 
with a BMSCC ≥ 250,000 cells/ml were considered as high BMSCC herds while herds with a 
BMSCC < 250,000 cells/ml were considered as low BMSCC herds.   
Udder health status. Herds having a good udder health were defined as those herds 
where the average monthly EICM was ≤ 3% and the average BMSCC was ≤ 250,000 cells/mL. 
Herds  with an average monthly EICM >3% and an average BMSCC ≤ 250,000 cells/mL were 
defined as high clinical mastitis herds (further referred as CM herds) . Herds with an average 
BMSCC > 250,000 cells/mL and an average monthly EICM ≤ 3% were defined as high 
subclinical mastitis herds ( further referred as SCM herds). High subclinical and clinical 
mastitis herds (further referred as mixed herds) were defined as herds with an average 
BMSCC > 250,000 cells/mL and an average monthly EICM > 3%.   
Statistical Analyses 
All data were entered in an electronic spreadsheet program (Excel 2010, Microsoft 
Corporation) and were checked for unlikely values. Bulk milk somatic cell count and (n = 2616) 
and EICM were available for 242 farms that fully completed the questionnaire. A natural 
logarithmic transformation of the BMSCC data was performed in order to obtain a normal 
distribution (LnBMSCC). Pearson correlation coefficient between EICM and the LnBMSCC 
was assessed by using SPSS 20.0 (SPSS Inc., Chicago, Illinois, USA).  
The regression model-building process to identify management practices potentially 
associated with the likelihood of being a good udder health herd, a CM herd, a SCM herd, and 
a mixed herd involved several steps as described previously (De Vliegher et al., 2004). Four 
separate binary logistic regression models with four different binary dependent variables (good 
udder health herds versus the other herds; CM herds versus good udder health herds; SCM 
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herds versus good udder health herds; mixed herds versus good udder health herds) were fit 
using SPSS 20.0 (SPSS Inc., Chicago, Illinois, USA).  
Initially, unconditional associations were tested between the three different dependent 
herd-level variables and all management practices (n = 41, Table 1). Statistical significance in 
this step was assessed at P < 0.15. Some of the categorical variables were recoded for 
biological plausibility reasons or because of low frequencies in one or more categories in this 
step. For example, the five categories describing frequency (never, rarely, sometimes, usually 
and always) were combined in two categories. Second, Pearson and Spearman’s rank 
correlation coefficients were calculated among the significant independent variables to avoid 
multicollinearity in the next steps. If two independent variables had a correlation coefficient ≥ 
0.6, only the one with the highest statistical significance or the most biologically relevant 
variable was selected for further analysis. In the third step, multivariable models were built 
with the remaining management practices as independent variables, and with good udder 
health, CM herd, SCM herd and mixed herd, respectively, as dependent variables (Table 1). 
Non-significant variables were removed using backwards elimination at P ≤ 0.05. In all models, 
all first order interactions between the remaining variables in the multivariable model were 
tested and removed when non-significant (Wald’s tests, P > 0.05).   
 
Figure 1.  Average bulk milk somatic cell count and estimated incidence of clinical mastitis per month 
(% clinical mastitis per month) in Flemish dairy herds in 2009. 
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Results 
Descriptive Results 
In total, 242 farmers completed the questionnaire. The average herd size of the 218 
remaining herds included in the study was 65.8 [interquartile range (IQR) from 45 to 80] 
lactating cows per herd with an average milk quota size of 552,188 kg of milk (IQR from 
375,750 to 676,500) per year. The average of the BMSCC was 202,000 cells/mL (IQR from 
155,000 to 239,800 cells/mL) and the median was 224,083 cells/mL. The average monthly 
EICM was 3.9% (IQR from 2.1% to 4.7%) and the median was 3.1%.  
Of the 242 herds, 94.6% (n = 229) used a conventional milking system, whereas 5.4% (n 
= 13) was milking their cows with an AMS. Eighty percent of the farms (n = 194) housed their 
cows in a freestall with slatted floor. In almost 60% of the herds (n = 138), some herd health 
aspects such as fertility, and (or) udder health, and (or) heifer rearing, and (or) claw health 
were monitored by a veterinarian on a regular basis. Disease recording was systematically 
done on approximately half of the herds. More than 80% (n = 198) of the farmers expected 
that their farm would still exist for more than 10 years.  
The distribution of BMSCC and EICM in the participating herds in 2009 is shown in Figure 
1. One-third (n = 85) of the herds were classified as having a good udder health, whereas 
12.4% and 30.6% were classified as SCM herds (n=30) and CM herds (n=74), respectively. 
Forty-nine herds (21.9%) were classified as mixed herds. The Pearson correlation coefficient 
between the LnBMSCC and EICM was 0.23 (P ≤ 0.01). 
Unconditional Associations 
Risk factors associated (P ≤ 0.15) with achieving good udder health are listed in Table 2. 
Risk factors associated (P ≤ 0.15) with the likelihood of being a CM herd are listed in Table 3. 
In this model, a strong correlation was found between participation in a veterinary herd health 
monitoring (VHHM) program and participation in an udder health monitoring program. The 
latter variable had the highest statistical significance and was therefore selected for further 
analysis. Table 4 gives an overview of the risk factors associated (P ≤ 0.15) with the likelihood 
of being a SCM herd. In this model, a strong correlation was found between the type of milking 
machine and automated milking system (AMS). The latter variable had the highest statistical 
significance and was therefore selected for further analysis. Table 5 presents the risk factors 
associated (P ≤ 0.15) with the likelihood of being a mixed herd. A strong correlation was again 
found between participation in a VHHM program and participation in an udder health 
monitoring program and between the type of milking machine  and AMS.  
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Based on the statistical significance, participation in an udder health monitoring program and 
type of milking machine were selected for further analysis. 
Final Multivariable Models 
The final multivariable models are presented in Tables 6, 7, 8 and 9. In none of the 
multivariable models, any of the tested interaction terms was significant (P < 0.05).  
Risk factors associated with achieving good udder health (Table 6). The final model 
revealed that herds where all cows are fixed in the headlocks after milking, the likelihood of 
having good udder health was 2.4 times higher than on farms where cows were not fixed in 
the headlocks (P = 0.007). The culling rate was positively associated with the likelihood of 
achieving a good udder health (P = 0.003). On herds that participated in a VHHM program 
that focused on other herd health items than udder health (e.g. reproduction), the likelihood of 
achieving a good udder health was 3.5 times higher than on herds that didn’t participate in 
any udder health monitoring (P = 0.009).  
Risk factors associated with CM herds (Table 7). Herds that did not participate in a 
VHHM program were significantly more likely to be classified as a CM herd (P = 0.004). The 
likelihood of having a high CM increased with an increasing culling rate (P = 0.015). Also, 
herds where the treatment decisions were usually or always based on the advice of the 
veterinarian or based on culture results, were significantly more likely to be classified as a CM 
herd (P = 0.012). When all cows are dried off with an internal teat sealer, the likelihood of 
being a CM herd was 3.1 times higher than when no internal teat sealers were used (P = 
0.007). 
Risk factors associated with SCM herds (Table 8). Postmilking teat disinfection (PMTD) 
(P = 0.018) and feeding dry cow minerals significantly decreased the odds of being classified 
as a SCM herd (P = 0.030). Also, herds with no access to pasture in summer (P = 0.027) and 
herds where cows were not calving at pasture were more likely to be associated with a SCM 
herds (P = 0.010). Keeping cows in the headlocks after milking (P = 0.020) and intermittent 
milking before dry-off cows (P = 0.009), were decreasing the odds for being classified as a 
SCM herd. On the contrary, milking cows with an AMS (P = 0.019) and selective dry cow 
therapy with long-acting antimicrobials (P = 0.037), were significantly increasing the odds for 
being a SCM herd.      
Risk factors associated with mixed herds (Table 9). Application of postmilking teat 
disinfection (PMTD) (P = 0.019) and providing a mineral/vitamin mix significantly decreased 
the odds of being classified as a mixed herd (P = 0.025). Also, herds with a high line milking 
machine (P = 0.005) and herds where cows did not calve at pasture were more likely to suffer 
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from both SCM and CM  (P = 0.047). The likelihood of being a mixed herd increased with an 
increasing culling rate (P = 0.021). The use of self-prepared off-label udder infusions (P = 
0.042) and keeping cows in the headlocks after milking (P = 0.037), significantly decreased 
the odds of being a mixed herd. Providing a lag preparation time of 60s increased  the 
likelihood of being a mixed herd almost 4 times (P = 0.013) compared to herds where no lag 
time of 60 s was provided.  
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Discussion 
This is the first study that focused on the identification of risk factors for udder health on 
Flemish dairy herds in which the udder health status was defined based on BMSCC data 
combined with CM data, two primary parameters for udder health (Barkema et al., 2013). To 
determine which management factors were associated with CM and BMSCC in Flanders, a 
web-based questionnaire was used. The latter way of working allowed, for a relatively easy, 
efficient and cost-effective data collection. The response rate was around 24%, which 
represented 4% of the dairy farmers in Flanders in 2009 (Annual Report 2009, Belgian Dairy 
Confederation, Leuven, Belgium). The average herd and quota size (65.8 lactating cows and 
552,188 kg of milk per year) of the selected farms were higher than the Flemish average, 
being 44 lactating cows and 310,650 kg of milk per herd, respectively (Annual Report 2009, 
Belgian Dairy Confederation, Leuven, Belgium). Herd size and the need to have internet 
access, might have selected the input of more contemporary farmers potentially diminishing 
the external validity of the data (Dohoo et al., 2009). Still, the high variation in BMSCC between 
the respondents suggests a wide diversity of management styles (Barkema et al., 1998a). The 
average BMSCC (202,000 cells/mL) of the selected herds was lower than the average 
BMSCC for the whole of Flanders being 230,000 cells/mL in 2009 (Annual Report 2009, Milk 
Control Center Flanders, Lier, Belgium). The average EICM was higher than the IRCM found 
by Verbeke et al. (2014) and other studies from the Netherlands, Sweden and France 
(Barkema et al., 1998a; Wolff et al., 2012, Barnouin et al., 2005), but lower than the averages 
found in England and Wales (Bradley et al., 2007).  Because of differences in methodology 
and selection criteria between studies, caution is required in comparing results between CM 
studies (Olde Riekerink et al., 2008). In our study, the majority of the farmers admitted they 
were not keeping accurate disease records whereas in the study of Verbeke et al. (2014) 
farmers agreed to record every CM case and collect a milk sample before treatment. The 
discrepancy between the results obtained in the latter study and ours contrasts the findings of 
Peeler et al. (2000) who found that farmers that kept records of CM reported a significantly 
higher level of mastitis compared with those not keeping records. Also, even if all farmers 
received the same instructions on the definition of a case of CM, several factors can cause 
differences in the identification of the cases of CM among farmers including the motivation of 
the farmer, the skills of the farmer to recognize a clinical case, and differences in management 
practices (i.e. stripping the foremilk).  
Since esculin-positive cocci are the most commonly isolated organisms in both subclinical 
and clinical mastitis cases in Flanders (Annual Report 2009, Milk Control Centre Flanders, 
Lier, Belgium), a strong association between EICM and BMSCC was expected, but was not 
Management Practices associated with Clincal Mastitis and Bulk Milk Somatic Cell Count 
57 
 
observed in this study. The lack of a strong relationship between BMSCC and EICM is 
consistent with the results of some previous research (Beaudeau et al., 1998; Barkema et al., 
1998a, Olde Riekerink et al., 2008), but not with the findings of others who reported a strong 
association between both parameters (Erskine et al., 1988; Elbers et al., 1998; Beaudeau et 
al., 2002; Green et al., 2004). Since no milk samples for bacteriological culturing were 
collected in this study, a potential association between BMSCC and the pathogen-specific 
IRCM as observed by Barkema et al. (1999) and Olde Riekerink et al. (2008) could not be 
further elaborated. We should also bear in mind that BMSCC is determined on the milk of all 
lactating cows whose milk is not discarded, making non-saleable milk (e.g. milk from treated 
cows, milk from cows with a high SCC) an unknown component in the analysis.   
Although statistically significant associations were found between management practices 
and the four types of herds (good udder health, SCM herds, CM herds and mixed herds), 
those management practices were not necessarily causally related. The only way to determine 
whether a variable that has a significant association really has a causal relationship is to 
perform a prospective intervention study as has been done for postmilking teat disinfection 
(Lam et al., 1997). Also, several factors presented very little variation in the dataset, and failure 
to observe relationships under these circumstances does not necessarily imply that there is 
no association between the studied management practices and the outcome variable(s). 
Some of the management practices were highly adopted in our population of herds. 
Postmilking teat disinfection and replacing the machine unit liners according to the 
recommended schedule were for example done by more than 90% and less than 10% of the 
herds, respectively, making it difficult to demonstrate statistical significance in the multivariable 
analyses. Shewe et al. (2015) showed that ensuring strict compliance with milking protocols 
was negatively associated with BMSCC in farms with nonfamily employees. Based on our 
study design and the type of questions, we were obviously not able to measure compliance of 
management practices, making us more cautious in interpreting our findings. Jansen et al. 
(2009) showed that the farmer’s attitudes towards mastitis was significantly associated with 
increased BMSCC and incidence of CM. Since we used the average BMSCC and EICM on a 
year-base, we could not examine the seasonal effect of some possible management practices. 
Barkema et al. (1998a) found conflicting significant associations from one season to another 
for herds keeping their cows standing after milking.  
Herds where cows calved at pasture were less likely to be categorized as mixed herds. As 
almost 50% of the dairy herds in Flanders use their calving pen for both sick and periparturient 
cows (De Vliegher et al., 2004), we hypothesize that a prolonged stay in a more infectious 
environment at least partly explains this finding. Herds where cows calved in the barn were 
Chapter 3.1 
58 
 
more likely to be SCM herds. The latter was in contrast with the findings of Wenz et al., (2007), 
who reported that herds without an outside area for peripartum cows were more likely to have 
a low BMSCC. Access to pasture in summer decreased the likelihood of being categorized as 
a SCM herd compared to zero-grazing.  However, limited access to pasture lowered the odds 
of being a SCM herd compared to having access more than 12 hours/day. The difference 
between the two risks factors is probably more reflecting the farmers’ attitude concerning cow 
comfort and nutrition than the difference in infection pressure between inside housing and 
pasture. 
The finding that postmilking teat disinfection and providing a mineral/vitamin mix 
significantly decreased the odds of being classified as a SCM and mixed herd, was not 
surprising, despite the fact that very few herds were not applying postmilking teat disinfection. 
Several research groups have shown that postmilking teat disinfection was associated with a 
low BMSCC (Erksine et al., 1987; Erskine and Ebelhart, 1991; Hutton et al., 1991; Barkema 
et al., 1998a; Bareille et al., 1998 and Khaitsa et al., 2000). A similar association was found 
for providing a mineral/vitamin mix to dry cows and low BMSCC (Erskine et al. (1987); Weiss 
et al., (1990) and Barkema et al., 1998a).  
Herds where the treatment decision for mastitis is usually or always based on the advice 
of a veterinarian or on culture results are significantly more likely to be classified as a CM herd. 
Also, herds where all cows were dried off with an internal teat sealer were more likely to suffer 
from CM. A cause-effect reversal is suspected. Both risk factors are most likely the 
consequence of dealing with CM, instead of a cause. The same reasoning can be assumed 
for the findings that self-prepared off-label udder infusions and providing a preparation lag 
time of 60 s were more often applied on a herd that suffered from both SCM and CM than on 
a herd classified as having a good udder health. However, the high percentage (66%) of herds 
that is using self-prepared off-label udder infusions to treat CM is worrying, especially in the 
light of prudent drug use and antimicrobial resistance. The use of an internal teat sealer was 
positively associated with the likelihood of being a CM herd. This finding is probably also a 
cause-effect reversal, since Verbeke et al. (2014) found that a majority of CM cases was found 
in the beginning of lactation and Bradley et al. (2004) also showed that 60% of those cases 
originated from the dry period. Finding these cause-effect reversals, could also be interpreted 
as farmers only change their management practices when problems occur. This latter shows 
opporturnities to a more proactive approach of udder health management. 
The fact that milking cows with an AMS is increasing the odds of being a SCM herd 
corresponds well with the findings from other studies (reviewed by Hovinen and Pyörälä, 
2011). Still, this finding stresses the importance of implementing a pro-active mastitis 
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prevention and control plan on AMS herds. On the other hand, manufacturers of AMS should 
also be aware of the fact that most of the AMS are less effective in cleaning teats (Knappstein 
et al., 2004; Bade et al., 2008) and are not able to distinguish and separate abnormal milk 
(Hovinen et al., 2009). 
A higher culling rate increased the likelihood of being a CM herd. This is consistent with 
the studies done by Peeler et al. (2000) and Barnouin et al. (2005) in low somatic cell count 
herds, where a higher culling rate was also associated with a higher IRCM. Also, herds with a 
higher culling rate were significantly less likely to have good udder health and more likely to 
be classified as a mixed herd.   A high culling rate is generally an indication of poor fertility 
management, which might also result in high levels of mastitis, because farmers are not able 
to cull cows for other reasons than fertility (e.g. high cell count) to achieve their production 
goals. In addition, introducing new cows into an established herd may itself be a risk for 
mastitis (Peeler et al., 2000).  
Herds that did not participate in a VHHM program were significantly more likely to be 
classified as a CM herd. Regular visits of the herd veterinarian in the barn could possibly help 
to confront farmers with known risk factors for CM which can easily be evaluated during the 
visit (e.g. hygiene, housing, nutrition).  
Also, herds that participated in a monitoring program that focused on other herd health 
items than udder health (e.g. reproduction), had more chance to be classified as having good 
udder health. First, farmers that chose to monitor reproduction in their farms, will possibly have 
a different attitude and have a more intrinsic motivation compared with those that do not, which 
might be extrapolated to the compliance of their daily (udder health) management. Also, 
following VHHM programs probably will help farmers to keep better records (e.g. expected 
calving date) and making the dry period better manageable since for example dry period 
lengths will have less variations. Fourth, on those herds, veterinarians might have advised the 
farmers to get rid of their sick or problematic cows (e.g. high cell count cows); they might have 
recommended to cull some cows where farmers would otherwise maybe have waited, as 
shown by Derks et al. (2014). We should, however, be cautious in drawing conclusions as the 
reasons for culling are not known in our study. Still, literature shows that subfertility is generally 
the most common reason for culling on dairy herds (Bascom et al., 1998 and Ahlman et al., 
2010).  
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Conclusions 
Only one-third of the herds in Flanders have low BMSCC (≤ 250,000 cells/mL) and a low 
EICM (≤ 3%). No strong association between BMSCC and EICM could be found in this study. 
The latter along with the fact that different management practices were associated with the 
likelihood of being a SCM or CM herd suggests that both types of herds require a different 
approach. Several factors are found to be associated with good udder health, CM herds, SCM 
herds and SCM+CM herds. Participation in a VHHM program seems to have an added value 
in prevention of udder health problems on Flemish dairy herds. 
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Abstract 
Mycoplasma bovis is a highly infectious pathogen of cattle causing pneumonia, 
polyarthritis, otitis, and less frequently, subcutaneous abscesses, abortions and meningitis. 
Ineffective drugs treatments, culling of infected cows and loss of milk production can lead to 
significant economic loss on dairy farms. The early detection of cows excreting M. bovis 
bacteria to prevent mastitis outbreaks is warranted. Reports suggest that the risk of M. bovis 
mastitis is higher in larger dairy herds. The objective of this study is to estimate the herd-level 
prevalence of M. bovis in Flanders, Belgium by culturing bulk tank milk samples taken from 
dairy farms. Three bulk tank milk samples per dairy herd were taken over four weeks, with 
collection intervals of two weeks. Culturing was done after pre-incubation using modified 
Hayflicks media to increase the chances of recovery of bacteria. For the identification of M. 
bovis, tDNA intergenic spacer PCR was used. In three herds (1.5%) of the 200 herds sampled, 
M. bovis was isolated from one of the three consecutive bulk tank milk samples. We conclude 
that in Flanders in 2009 at least 1.5% of the dairy herds had one or more cows excreting M. 
bovis in the milk. The frequent monitoring of bulk tank milk to detect the presence of M. bovis, 
especially in expanding herds on farms that often purchase replacement animals, should be 
encouraged in order to detect the presence of M. bovis and to monitor the success of control 
procedures following an outbreak of mycoplasmal mastitis in the herd. 
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Introduction 
Mycoplasma bovis is a highly infectious pathogen of cattle, causing pneumonia, 
polyarthritis, otitis, and, less frequently, subcutaneous abscesses, abortions, and meningitis 
(Nicholas and Ayling, 2003). In addition, it is the most important agent of outbreaks of 
mycoplasmal mastitis in dairy cows (Gonzalez, 2003). Mycoplasma spp. lacks a typical cell 
wall, and so are not affected by many of the commercially available antimicrobial drugs, which 
act by interfering with cell wall synthesis (Bushnell, 1984). Over the last decade, M. bovis 
isolates have developed an acquired resistance to a wide range of commonly used antibiotics 
such as macrolides and tetracyclines (Nicholas et al., 2008). Intramammary infections with M. 
bovis are difficult to treat successfully even if the antimicrobials used show good in vitro activity 
against the agent (Ayling et al., 2000). Unsuccessful therapy, culling of infected cows and loss 
of milk production can lead to significant economic loss on a dairy farm (Nicholas and Ayling, 
2003). The early detection of cows excreting M.bovis to prevent mastitis outbreaks is 
warranted. Recently, several cases of clinical and subclinical mastitis caused by Mycoplasma 
spp. in Belgian dairy herds have been reported (personal communication, Milk Control Centre 
Flanders, Lier, Belgium). Also, the number of milk samples submitted to the central milk quality 
laboratory (Milk Control Centre Flanders, Lier, Belgium) for bacteriological culturing for M. 
bovis increased from zero in 2007 to 553 in 2008, (a combination of bulk milk samples and 
individual cow milk samples). Nearly 9% (n=48) of all samples were culture-positive (Annual 
Report 2008, Milk Control Centre Flanders, Lier, Belgium). No information is available on the 
between-herd prevalence of cows excreting M. bovis bacteria in Flanders, Belgium. The 
culture of bulk tank milk samples is a valuable procedure for screening and surveillance of 
mastitis-causing pathogens at the herd level, in particular for the detection of cows excreting 
Streptococcus agalactiae and M. bovis (Jasper, 1979; Bushnell, 1984; Gonzalez, 1986; 
Gonzalez, 1992; Jayarao, 2003). The objective of this study was to estimate the herd-level 
prevalence of M. bovis in Flanders, Belgium, by means of culturing of bulk tank milk samples.  
 
Materials and Methods 
The sample size required to estimate the prevalence of Mycoplasma spp.-infected herds 
accurately was calculated using Win Episcope 2.0 (Thrushfield et al., 2001). The target 
population was 6,287 Flemish dairy producers with an expected prevalence of M. bovis of 5% 
(± 3%), and a 95% confidence interval. Based on this calculation, the suggested adjusted 
sample size was 197 herds. In the 2009 year, 201 herds were selected randomly in Flanders 
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in proportion to the total number of dairy farmers in each of the five Provinces for this study 
(Table 1). Bulk milk samples were collected through routine sampling as currently performed 
when milk is collected as part of the legal requirements for milk quality control procedures by 
the Milk Control Centre Flanders, Lier, Belgium. The milk samples were immediately stored at 
4°C and transported under cooled conditions (at 4°C) to the laboratory for bacteriological 
analysis the next day. Three bulk milk samples per herd were collected and analysed over 
four weeks, with collection intervals of two weeks. Culturing was performed as described by 
the National Mastitis Council after pre-incubation using modified Hayflicks media to increase 
the recovery rates of the bacteria (Hogan et al., 1999). For identification of M. bovis, tDNA 
intergenic spacer PCR was used (Stakenborg et al., 2005). 
 
Table 1. Bulk tank milk samples required and numbers tested during a survey for Mycoplasma bovis, 
to detect a between-herd prevalence of 5% (with 95% confidence), proportionally to the total number of 
dairy herds per province. 
Province 
Recorded no. dairy 
herds in Flanders 
No. dairy herds 
required 
No. dairy herds 
included 
Antwerpen 1189 37 38 
Limburg 594 19 19 
Oost-Vlaanderen 1752 55 56 
Vlaams Brabant 407 13 13 
West-Vlaanderen 2346 74 75 
Total 6287 197 200α 
α one farm stopped delivering milk, was only sampled once, and omitted from the results  
 
Results & Discussion 
One of the 201 selected farms stopped delivering milk during the study and was sampled 
only once (with a negative culture result). In the remaining 200 herds, M. bovis was isolated 
from one of the three consecutive bulk tank milk samples taken from 3 herds (1.5%). All 
culture-positive samples were positive at the first reading (three days after the commencement 
of incubation). The between-herd prevalence of M. bovis in bulk milk ranges between 1% and 
8% in the USA (Fox et al., 2003); is 5.4% in Greece (Filiousis et al., 2007), and is nil in New 
Zealand (McDonald et al., 2009). False-negatives may occur, suggesting the between-herd 
prevalence in Flanders, Belgium may be higher than the 1.5% prevalence found in this study. 
Infected cows may excrete the organisms in low numbers (Gonzalez, 1986) or intermittently, 
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and so may not be isolated on culture (Jasper, 1979; Bushnell, 1984; Biddle, 2003). 
Additionally, milk from M. bovis infected cows in large herds will be diluted in the total herd 
milk. Dairy producers also often withhold abnormal milk from the milk tank (Jasper, 1979; 
Thomas, 1981; Gonzalez, 1992). Reports suggest that the risk of mastitis caused by 
Mycoplasma spp. is higher in large herds, presumably because cows and heifers are 
purchased more frequently either to maintain or expand the existing herd. (Thomas et al., 
1981, Fox et al., 2003).  During the last 20 years, the size of the dairy herd increased in 
Flanders, Belgium as illustrated by the increasing average volume of milk quota per farm 
(Annual Report 2010, Confederation of the Belgian Dairy Industry, Belgium). This increase in 
herd size is mainly driven by the acquisition of cows and heifers from other herds, a key risk 
factor for the introduction of M. bovis into a dairy herd (Jasper, 1979; Gonzalez and Wilson, 
2003). As well, the average BMSCC in Flanders has increased since 1999, indicating that 
more attention to udder health management by farmers is required. Both of these observations 
indicate that the risk of M. bovis infection in a dairy herd has increased.  
 
Conclusion 
Our conclusion from the study is that in Flanders, Belgium in 2009, at least 1.5% of dairy 
herds had one or more cows excreting M. bovis in the milk. Frequent monitoring of bulk tank 
milk (especially on farms that purchase replacement animals) should be encouraged in order 
to screen for and detect the presence of M. bovis and to monitor the success of control 
procedures on the farm following an outbreak of mycoplasmal mastitis.  
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Abstract 
Associations between herd management practices and both bacterial counts (BC) and 
coliform counts (CC) from 254 and 242 dairy herds in Flanders (Belgium), respectively, were 
studied. Data were analyzed using multivariable, multilevel linear regression analysis, allowing 
variance components’ analyses. Both BC and CC fluctuated throughout the year, although the 
milk quality parameters followed an opposite pattern. Bacterial count values decreased with 
each increase of the cleaning frequency of the cubicles (once a week, once a day, twice a 
day, more than twice a day) between January and March. Herds with a conventional milking 
parlor had substantially lower BC than herds where the cows were milked using an AMS. 
Lower BC were observed when the milking parlor was equipped with an automatic cluster 
removal system, when premilking teat desinfection was applied, when the dry cows were 
supplemented with a mix of minerals and vitamins, and when the teats were prepared either 
first wet and dried or via an AMS. Milking cows with a high-pipeline milking parlor set-up or 
with an AMS was associated with substantially higher CC values. Herds where prepartum 
heifers were often treated with antimicrobials before calving had a lower CC than farms where 
heifers were either not or only rarely treated. Most variation in BC and CC resided at the herd 
level rather than at the observation level, indicating that management is important in the 
control of both BC and CC. Still, only a small proportion of the total variance was explained by 
factors capturing information related to the milking, herd health, and dry cow management, 
which suggests that the bacteriological milk quality and in particular CC is primarily driven by 
other factors than the ones included in this study.  
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Introduction 
High bacterial levels in milk, whether originating from the cow or the environment, 
substantially affect the quality, safety, and consumer acceptance of milk and dairy derived-
products. Some bacteria found in unpasteurized milk such as Staphylococcus aureus, 
Escherichia coli, Listeria monocytogenes, Campylobacter jejuni, Mycobacterium tuberculosis 
and Salmonella spp. pose a potential risk for human health (Gilmour and Rowe, 1990; Murphy 
and Boor, 2000). Bacteria that are not known to be pathogenic can cause flavor-changes, 
rancidity and thus reduced shelf life (Boor, 2001; Barbano et al., 2006). Bacterial quality of 
milk can be determined using a number of parameters including BC, preliminary incubation 
counts, laboratory pasteurization counts, and CC (Murphy, 1997). Among these, BC is the 
most commonly used one in regulatory programs (Murphy and Boor, 2000) and estimate the  
number of colony forming units (cfu) or individual bacteria counts (IBC) present in 
unpasteurized bulk tank milk. 
In Flanders (Belgium), the official mandatory milk quality regulations follow European 
legislation and require a geometric mean BC over the last two months (based on two 
recordings per month) < 100 x 103 IBC per mL milk. In contrast, testing of CC is non-obligatory 
for milk quality in Flanders yet implemented as part of an incentive program. Similar to other 
countries such as Ireland (Berry et al., 2006) and different regions in the US (Jayarao et al., 
2004), the majority of milk processors in Flanders pays incentives of up to 0.75 € per 100 L of 
milk to farmers that meet higher quality requirements, including geometric mean BC < 50 x 
103 IBC/mL and geometric mean CC < 50 cfu/mL over the last two months (4 recordings) in 
combination with a geometric mean SCC < 350 x 103 cells/mL, in the absence of antibiotic 
residues in any milk delivery; all to ensure the image of milk as a high quality and safe product. 
Although bulk tank BC and CC in Flanders decreased by 19.2% between 2005 and 2008, an 
increase of almost 10% was observed between 2008 and 2009 (Milk Control Centre, Lier, 
Belgium), warranting the need to understand the reasons behind this tendency.  
Most studies have identified factors holding information on milking and equipment hygiene, 
sanitizing procedures (Elmoslemany et al., 2009a; Elmoslemany et al., 2009b; Pantoja et al., 
2011) and milk storage conditions (Murphy and Boor, 2000) explaining variability in  BC and 
CC. Apart from two studies, of which one was conducted in Chile (van Schaik et al., 2005) and 
the other one in Canada (Elmoslemany et al., 2010), factors related to either herd health 
management, transition and feeding management or housing, that are known to affect udder 
health, have not been studied as potential risk factors. Still, mastitis-causing streptococci such 
as Streptococcus uberis and Streptococcus agalactiae can be important contributors to 
bacterial levels of the unpasteurized bulk tank milk (Zadoks et al., 2004). Given this 
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information, one could anticipate that the latter management practices are also relevant for 
milk quality and BC in particular, and could explain the increase in BC and CC in Flanders, 
coincident with the increase in the average bulk milk SCC during the same period. 
The main objective of this study was to evaluate to what extent differences in management 
practices different from those related to milking and equipment hygiene are associated with 
BC and CC in unpasteurized bulk milk on Flemish dairy herds. A secondary objective was to 
assess whether the variation in BC and CC resided mostly at the herd or at the observation 
level. 
Materials and Methods 
Herd Demographic Data 
In 2009, Flanders had 6,971 dairy herds with an average herd size and milk production of 
40.9 cows and 8,059 milk kg/cow per year. The average milk quota size was 310,708 kg. 
Herds included in this study were on average larger (65.8 cows/herd) in both size and milk 
production (8,503 kg milk/cow per year). The average of the geometric mean of BC and CC 
in Flanders were 11.3 x 103 IBC/mL and 10 cfu/mL, respectively. In 2009, 97% of the herds 
met the requirements for BC according to the European legislation (geometric mean BC < 100 
x 103 IBC/mL) whereas approximately 85% of the herds met the specific requirements for 
higher quality milk for CC (geometric mean CC < 50 cfu/mL).  The average of the geometric 
mean bulk milk SCC was 230,000 cells/mL. The milk quality of the herds included in this study 
was comparable.  
 
Herd Selection and Data Collection 
A written web-based questionnaire was conducted between January 2010 and July 2010. 
The questionnaire was pretested and fine-tuned in close cooperation with 4 dairy farmers prior 
to the start of the study.  
In total, 254 farmers completed the online questionnaire that consisted of 39 questions 
concerning general management (n = 8), herd health management (n = 5), milking 
management (n = 11), calving (n = 3) and dry cow management (n = 6), and nutrition (n = 6), 
in place on farm during 2009 (Table 1).  
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Table 1. Overview of all herd management practices collected via a web-based questionnaire on 254 
dairy herds in Belgium. 
General management 
 Type of livestock farming, expected time the farm will still exist, herd size, number of lactating 
cows, milk quota size, duration of access to pasture during summer, barn type, cleaning 
frequency of the housing 
Herd health management 
 Registration of animal diseases, herd health monitoring by veterinarian, monthly incidence of 
clinical mastitis, antimicrobial treatment during lactation of subclinical mastitis, treatment of 
prepartum heifers with antimicrobials 
Milking management 
 Milking machine type, milking parlor type, cows kept in headlock after milking, use of 
automatic cluster removal, providing a prep-lag time of 60 s, teat preparation method, 
application of premilking teat disinfection, application of postmilking teat disinfection, machine 
unit liner, rinsing of machine unit liners, replacement of machine unit liners  
Calving management 
 Calving on pasture, presence of calving pen, use of calving pen for sick cows 
Nutrition management 
 Concentrate provided during milking, concentrate provided on top of forage, concentrate 
provided via TMR, concentrate provided via automatic feeder, forage provided, type of 
forage feeding system  
Dry cow management 
 Drying off procedure, use of long-acting antimicrobials, adapted diet provided, 
mineral/vitamin mix provided, use of external teat sealer, use of internal teat sealer 
 
From all farms that completed the online questionnaire, the bulk tank milk BC and CC 
records measured at 2-weekly intervals from January 2009 to December 2010 were retrieved 
from the Milk Control Center Flanders that executes the (regulatory) farm screening program 
in Flanders. Bacterial counts and CC were examined on unpasteurized bulk milk samples 
collected in 30-mL sterile screw-cap tubes by trained milk haulers. The samples were kept 
cooled (± 4°C) until arrival at the laboratory.  
 
Total Bacterial and Coliform Counts 
All microbiological analyses were performed within 24h after pick-up at the farm. The milk 
samples were vortexed prior to the start of the analyses. For BC, undiluted milk samples were 
used and automatically analyzed by means of a BactoScanTM FC (Foss Electric, Hillerød, 
Denmark). Bacterial counts were expressed as the number of IBC/ml of milk. For CC, milk 
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samples were first diluted using trypton salt broth at 1:10. One mL of diluted milk was plated 
on 3MTM Petrifilm CC plates and incubated at 30°C for 24h. Colony-forming units were counted 
electronically using an automated colony counter (protoCOL, Synbiosis, Cambridge, UK). 
Coliform counts were expressed as the number of cfu/mL of milk. Per month, a geometric 
mean BC and CC was calculated based on the last 4 recordings (last 2 months). A log10-
transformation of the geometric mean BC and CC was performed to normalize the data before 
statistical analyses.  
 
 
 
aBacterial count, bColiform count, cAll univariable models were corrected for month of observation to 
take into account the longitudinal nature of the data, dInteraction between month of observation and 
one other variable. 
 
Figure 1. Flow chart of variable reduction through different steps in the statistical analysis.  
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Statistical Analysis 
All data were entered in an electronic spreadsheet program (Excel 2010, Microsoft 
Corporation) and were checked for unlikely values. Monthly geometric means for BC (n = 3046) 
and CC (n = 2895) were available for 254 and 242 of the farms, respectively. 
The regression-model building process to identify management practices associated with 
BC and CC involved several steps as described previously (De Vliegher et al., 2004) and is 
presented in a flow chart (Figure 1). Linear mixed regression models with BC and CC as 
dependent variables were fit using SPSS 17.0 (SPSS Inc., Chicago, Illinois, USA). In all 
models, herd was included as random effect to model the repeated measurements within herds 
using a first-order autoregressive correlation structure.  
Initially, unconditional associations were tested between the continuous dependent 
variables at the herd level, log10BC and log10CC, respectively, and all management practices 
(n = 39, Table 1) and month of observation as fixed effect, the latter to take into account the 
longitudinal nature of the data. Statistical significance at this step was assessed at P < 0.20 
(Maldonado and Greenland, 1993). Some of the categorical variables were recoded based on 
biological reasons because of low frequencies in one or more categories in this step. Second, 
Pearson and Spearman’s rank correlation coefficients were calculated among the significant 
independent variables to avoid multicollinearity in the next steps. If two management practices 
had a correlation coefficient > 0.6, only one was withheld for further analysis. In the third step, 
multivariable models were built with the remaining management variables as independent 
variables, and with log10BC and log10CC, respectively, as dependent variables (Tables 2, 3 
and 4). Non-significant variables were removed using backwards elimination at P ≤ 0.05. In 
both models, all first order interactions among month of observation and the remaining 
variables in the multivariable model were tested and removed when non-significant (Wald’s 
tests, P > 0.05). The adequacy of the final model was tested by examining normal probability 
plots of residuals and plots of residuals versus predicted values to check whether the 
assumptions of normality and homogeneity of variance had been fulfilled. No patterns 
indicating heteroscedasticity were revealed.  
To evaluate the proportion of variance occurring at the different levels of the data hierarchy, 
two-level null models (intercept and month of observation as fixed effect only, to take into 
account the longitudinal nature of the data), with herd as random effect were fit for both BC 
and CC.  
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Results 
Descriptive Statistics  
The average herd size of the 254 herds included in the study was 65.8 [interquartile range 
(IQR) from 45 to 80] lactating cows per herd with an average milk quota size of 551,937 kg 
milk (IQR from 375,750 to 676,500) per year. The average of the geometric mean BC was 9.1 
x 103 IBC/mL (IQR from 5 x 103 to 11 x 103 cfu/mL) and the average of the geometric mean 
CC was 21.3 cfu/mL (IQR from 2 to 16 cfu/mL). Approximately 94% of the herds met the 
specific requirements for higher quality milk in Belgium for BC (geometric mean BC < 50 x 103 
IBC/mL), whereas 98.4 % of the herds met the requirements according to the European 
legislation (geometric mean BC < 100 x 103 IBC/mL) for the whole year. However, 38.5 % of 
the herds exceeded at least once in the studied years the specific requirements for higher 
quality milk for CC (geometric mean CC < 50 cfu/mL). Average BMSCC was 223,621 cells/mL 
with an IQR from 173,000 to 271,000 cells/mL. Similar figures were obtained using the subset 
of 242 farms of which monthly geometric mean CC values were available for further analyses. 
Of the 254 herds, 60.2 % (n = 153) only housed dairy cows, 22.9 % (n = 58) also kept 
double-purpose or beef cows, and 16.9 % (n = 43) also farmed other animals such as pigs. On 
nearly 60 % of the herds (n = 146), some herd health aspects such as fertility, and/or udder 
health, and/or heifer rearing, and/or claw health were monitored by a veterinarian on a regular 
basis. Disease registration was systematically done on approximately half of the herds. Almost 
80 % of the farms (n = 202) housed their cows in a free stall with slatted floor.  
 
Unconditional Associations 
A first reduction based on unconditional associations and highly correlated variables, 
revealed 22 and 9 herd management practices to be associated with log10IBC and log10CC, 
respectively (Tables 2, 3 and 4). A strong correlation was found between the number of cows, 
the number of lactating cows, and the milk quota size. The number of lactating cows was 
selected for further analysis. 
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Table 5. Final multivariable, multilevel model for log10BC of 254 Flemish dairy farms. 
Independent variables βa SE b LSM c P-valuee 
 Intercept 1.20 0.079 … < 0.001 
 Month of observation    < 0.001 
  January Ref.d …. 10.0  
  February 0.100 0.049 11.6 0.04 
  March 0.016 0.065 11.3 0.80 
  April -0.148 0.075 10.2 0.05 
  May -0.197 0.082 9.2 0.02 
  June -0.280 0.087 7.6 0.01 
  July -0.367 0.090 6.8 < 0.001 
  August -0.274 0.093 7.3 0.01 
  September -0.216 0.094 7.4 0.02 
  October -0.227 0.096 7.3 0.02 
  November -0.200 0.097 7.8 0.04 
  December -0.105 0.064 8.9 0.29 
General management     
 Cleaning frequency of the housing    0.22 
  1 time per week Ref. … 10.1 … 
  1 time per day -0.114 0.094 8.2 0.22 
  2 times per day -0.212 0.074 8.5 0.01 
  > 2 times per day -0.312 0.078 7.9 0.01 
Milking management     
 Milking parlor type    < 0.001 
  Fishbone Ref. … 7.6 … 
  Tandem 0.056 0.022 8.6 0.01 
  Rotary 0.003 0.034 7.6 0.92 
  Side-by-side 0.063 0.059 8.7 0.28 
  Automatic milking system 0.179 0.045 11.4 < 0.001 
  Tie stall 0.048 0.041 8.4 0.24 
 Use of automatic cluster removal    < 0.001 
  No Ref. … 10.3 … 
  Yes -0.148 0.029 7.3  
 Teat preparation method    0.01 
  Wet and dry after / automatic Ref. … 7.9 … 
  Dry with paper towel 0.082 0.028 9.6 0.01 
  Disinfection towels 0.037 0.052 8.7 0.47 
  Dry with cloths 0.025 0.033 8.4 0.43 
 Application of premilking teat disinfection    0.01 
  Never / rarely / sometimes Ref. … 9.3 … 
  Always / usually -0.063 0.030 8.0 0.04 
Dry cow management     
 Mineral/vitamin mix provided    0.01 
  No Ref. … 9.2 … 
  Yes -0.057 0.021 8.1  
 
Month of observation × Cleaning frequency of  
barnf 
   0.01 
aEstimate, bStandard error, cBack-transformed least square means of log10 bacterial count 
(x103IBC/mL), dReference, eP-value of the fixed effects, fSee Figure 2 for more detailed information. 
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Table 6. Final multivariable, multilevel model for log10CC of 242 Flemish dairy farms. 
 
Independent variables βa SE b LSM c P-value 
 Intercept 0.694 0.039 … < 0.001 
 Month    < 0.001 
  January Ref.d … 4.9 … 
  February -0.020 0.028 4.7 0.47 
  March -0.043 0.036 4.5 0.01 
  April -0.007 0.042 4.9 0.24 
  May 0.026 0.045 5.3 0.86 
  June 0.073 0.047 5.9 0.11 
  July 0.232 0.048 8.4 < 0.001 
  August 0.309 0.049 10.1 < 0.001 
  September 0.260 0.050 9.0 < 0.001 
  October 0.213 0.051 8.1 < 0.001 
  November 0.201 0.051 7.9 < 0.001 
  December 0.137 0.051 6.8 0.01 
Milking management     
Milking machine type    < 0.001 
Low-line Ref. … 5.7 … 
High-line 0.171 0.076 9.6 0.03 
With glass jars -0.064 0.069 4.9 0.35 
          Automatic milking system 0.419 0.098 13.8 < 0.001 
Herd health management     
Treatment of prepartum heifers with antimicrobials    0.02 
Never / rarely / sometimes Ref. … 8.7 … 
Usually / always -0.261 0.115 4.9 … 
aEstimate, bStandard error, cBack-transformed least square means of log10 coliform count (cfu/mL) 
obtained from the final model, dReference.
 
Final multivariable, multilevel Models 
The final multivariable, multilevel models for log10BC and log10CC are presented in Tables 
5 and 6, respectively. Although the correlation coefficient between type of milking machine and 
type of milking parlor did not exceed the cut-off value of 0.6 (R = 0.27), a multivariable model 
for log10BC in which both variables were included did not reach convergence as all tie stall 
milking parlors were obviously equipped with a high-pipeline set-up (Table 7). Therefore, it was 
decided to exclude the variable type of milking machine from the multivariable model for 
log10BC. 
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Factors associated with Bacterial Counts. Individual bacteria count varied throughout 
the year with the highest values being observed from January to March and the lowest values 
from June until November (P < 0.001). Individual bacteria count values decreased with each 
increase of the cleaning frequency of the cubicles (once a week, once a day, twice a day, more 
than twice a day) between January and March (interaction between Month of observation × 
Cleaning frequency of cubicles, P < 0.05) (Figure 2).  When cows were milked using an AMS, 
BC were higher than on other herds using different systems (P < 0.001). A lower BC was 
observed when the milking parlor was equipped with an automatic cluster removal system as 
opposed to when the milking clusters were removed manually (P < 0.001). Lower BC was 
observed on herds where the teats were prepared either first wet and then dried or via an AMS 
(P < 0.05). Premilking teat disinfection via dipping or spraying as well as supplementation of 
dry cows with minerals were associated with lower BC as well (P < 0.05).  
 
 
Figure 2. Back-transformed least square means of log10 bacterial count (BC) (x 103 IBC/mL) throughout 
the year (- - - -) for herds were the cubicles were cleaned once per week (■), once per day (▲), two 
times per day (♦), or more than two times per day (○).  
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Factors associated with Coliform Counts. Coliform counts varied throughout the year (P 
< 0.001) (Figure 3). Herds with a high-line milking parlor set-up or AMS had substantially higher 
CC compared to herds using a low-line milking parlor set-up or reservoir (P < 0.001). Farms 
that treated prepartum heifers with antimicrobials before calving had lower CC than farms 
where heifers were either not or only rarely treated before calving (P < 0.05). 
 
 
Figure 3. Back-transformed least square means of log10 coliform count (CC) (cfu/mL) throughout the 
year. 
 
Variance Components 
When fitting null-models 93.6 % of the variation in BC occurred at the herd level and 6.4 % 
at the observation level, whereas for CC 68.1% and 31.9% of the variation occurred at the herd 
and observation level, respectively (Table 8). These proportions only changed slightly in the 
final multivariable models. Of the total variance in BC and CC, only 4.6% and 2.1% of the 
variation, respectively, was explained by the fixed effects in the final models.  
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Table 8. Variance components at each level of the null and final multivariable models for log10BC and 
log10CC, respectively.  
aModel containing only ''month of observation” as fixed effect to take the longitudinal nature of the 
dataset in to account, bModel containing all fixed effects as presented in Tables 5 and 6 , cStandard 
error of the variance estimate of the parameter, dVariance proportion explained at the level of the data 
hierarchy. 
 
Discussion 
A number of studies have identified risk factors associated with milk quality parameters 
such as BC and CC (Elmoslemany et al., 2009a; Elmoslemany et al. 2009b; Pantoja et al., 
2011). Apart from two studies of which one conducted in the 10th region of Chile (van Schaik 
et al., 2005) and another on Prince Edward Island in Canada (Elmoslemany et al., 2010), most 
studies focused on factors associated with milking equipment and cow hygiene rather than on 
factors related to herd health in general. In this study, a number of manageable risk factors 
associated with BC and CC that can be readily implemented by the Flemish dairy farmer in 
order to control BC and CC at acceptable levels were identified.  
Web-based questionnaires are commonly used tools as they allow for relatively easy and 
cheap data collection. This approach has allowed us to include data of farms that were 
distributed over the 5 different Flemish provinces. The need to have internet access, however, 
might have selected the input of more contemporary farmers that are also better managers, 
potentially diminishing the external validity of the data (Dohoo et al., 2009). However, the high 
variation in BMSCC between the respondents suggests a wide diversity of management styles 
(Barkema et al., 1998). Also, both the average BMSCC and BC of the selected herds 
approached the average BMSCC and BC in 2009 for the whole of  Flanders being 230,000 
cells/mL and 11,3 x 103 IBC/mL, respectively (Annual Report 2009, Milk Control Center, Lier, 
Belgium). Altogether, the results are believed to reflect the BC and CC status of typical dairy 
Data Hierarchy 
Null modela  Final modelb 
Estimate SE c % d  Estimate SE c % d 
Bacterial count (BC)        
 Herd level 0.798 0.010 93.6  0.767 0.011 94.3 
 Observation level 0.054 0.003 6.4  0.046 0.002 5.7 
 Total variance 0.852 … 100  0.813 … 100 
        
Coliform count (CC)        
 Herd level 0.719 0.012 68.1  0.709 0.013 68.6 
 Observation level 0.337 0.014 31.9  0.325 0.014 31.4 
 Total variance 1.056 … 100.0  1.034 … 100.0 
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herds in Flanders and are likely valid for the Flemish dairy situation and herds of other regions 
and countries with similar management conditions.  
The average BC in our study was slightly lower than the 11.4 x 103 IBC per mL found in 
the New York State (van Schaik et al., 2002). The average CC, on the other hand, was almost 
half of the average CC of 44 cfu/mL across a number of studies (e.g. Elmoslemany et al., 
2009b; Pantoja et al., 2011), suggesting better conditions on the Flemish dairy farms 
compared to the farms included in the other studies (Jayarao and Wolfgang, 2003). As was 
expected the average CC and BC strongly varied among herds which is comparable with other 
studies (Elmoslemany et al., 2009a; Elmoslemany et al., 2009b; Pantoja et al., 2011; Mallet et 
al., 2012).  
Several variables reflecting milking, herd health and dry cow management were 
significantly associated with either BC or CC, but explained only a small proportion of their 
total variance. The latter suggests that the bacteriological milk quality and then in particular 
the CC is primarily driven by other management practices than those studied, such as factors 
related to milking equipment and milk storage, although unknown factors should be suspected 
as well. Obviously, the fact that a number of associations were statistically significant in the 
analyses not necessarily indicates that a causal relation exists (Dohoo et al., 1997). Rather, 
some associations need confirmation, whereas others such as the association between 
prepartum antibiotic treatment in heifers and CC as well as the negative association between 
feeding diets supplemented with minerals to the dry cows and BC generate new hypotheses 
on controlling BC and CC that should be tested.  
Bacterial counts and CC changed over time. Bacterial counts were highest during the 
winter and spring months opposed whereas CC followed the opposite pattern. In other studies 
conducted in the Balearic Islands, Chile, and Prince Edward Islands, both BC and CC were 
highest in summer (Soler et al., 1995; van Schaik et al., 2002; Elmoslemany et al., 2010). The 
discrepancy between our results and those reported by others can yet not be fully explained, 
but might be related to the temperate maritime climate in Belgium including ample rainfall all 
year around. The fact that cows on Flemish dairy farms are in confined housing from October 
up to May might expose the udder and teats under the rather mild and humid weather 
conditions to high bacterial levels, increasing the risk for contamination of the udder and teats 
in the winter and spring months. The opposite pattern of CC compared to BC indicates that 
both are partly determined by other factors. Coliforms only start to grow and multiply when the 
ambient temperature exceeds 10°C (Naemura and Seidler, 1978). Accumulation of soil from 
the teats and udders somewhere in the milking equipment will therefore have a larger impact 
on CC in summer than in winter time. 
Manageable Risk Factors associated with Bacterial and Coliform Counts in Unpasteurized Bulk Milk 
101 
 
The dose-response relationship of frequency of cleaning of the housing on BC between 
January and March corresponded well with the data published by Kelly et al. (2009).  
Frequency of bedding change has been associated with the cleanliness of udder and teats 
and thus the exposure of teats to bacteria before (Ward et al., 2002). Also, dirty teats increase 
the risk of elevated BC (Elmoslemany et al., 2009a). Keeping in mind the confinement-housing 
and the mild and wet Belgian weather conditions in winter time, farmers should, in particular 
during those months, put more effort in keeping the housing of the lactating cows clean.  
The higher BC and CC levels on farms equipped with an AMS are complementary with the 
increasing bulk milk BC levels observed on farms switching from conventional to automatic 
milking (Rasmussen et al, 2002; de Koning et al., 2003). The increase in BC shortly after 
introduction of the AMS has been suggested to partly originate from contamination of milk 
from the teat surfaces and partly from the inappropriate cleaning of the milking equipment and 
cooling of the milk (Rasmussen et al., 2002). The CC was also affected by the type of milking 
machine. Higher CCs were observed in milking parlors with a high-pipeline set-up compared 
with those with a low-pipeline set-up or reservoir (Reineman et al., 2003). A common 
denominator among the studies that have yet been performed is the overriding importance of 
proper cleaning and sanitation of the milking system in producing high quality milk 
(Elmoslemany et al., 2009a; Pantoja et al., 2011). The cleaning and sanitation of the pipelines 
in stalls with a high-pipeline set-up are more often lacking than in other milking systems likely 
due to the higher risk for accumulation of milk fat and drying of milk in the high-pipeline set-up 
and in particular in the cool line at the high end of the system (Reineman et al., 2003).  
Individual bacteria count was affected by premilking teat cleaning practices which was not 
that unexpected as Elmoslemany et al. (2009a) reported that the risk of having high BC 
increased by 5.3 for each unit increase in the teat-end cleanliness before the milking unit was 
attached. In our study, a wet teat preparation followed by dry wiping was associated to lower 
BC than dry wiping with a paper towel alone, corresponding well with the results of Kelly et al. 
(2009). Still, in almost 25% of the cases the wet teat preparation consisted of premilking teat 
disinfection which was associated with lower BC as well which is obviously positive. The latter 
finding corresponds well to the numerous studies that showed a strong reducing effect of 
premilking teat disinfection on the teat microbial load (e.g. Galton et al., 1986; Magnusson et 
al., 2006; Gibson et al., 2008).   
A negative relationship was found between the presence of automatic removal and BC 
which is in accordance with the results reported by Kelly et al. (2009). This finding might be 
related to the increased risk for teat end callosity and hyperkeratosis in case of manual cluster 
removal. Teats with a highly calloused teat end have an increased load of environmental 
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pathogens (Paduch et al., 2012). Also, teats with a distinct callosity ring are most likely less 
effectively cleaned during premilking teat preparation, leaving more bacteria on the teat end 
when the milking cluster is attached (Hovinen et al., 2005). Although little peer-reviewed 
publications are available on the risk factors associated with teat-end callosity, it is reasonable 
to accept that manual cluster removal might more often lead to overmilking compared to 
automatic cluster removal, thereby compromising the teat-end quality (Rasmussen et al., 
1991; Gleeson et al., 2003).    
Conclusions 
Multivariable, multilevel regression analysis revealed a number of management practices 
associated with either BC or CC. Increasing the cleaning frequency of the housing during 
winter time under the Belgian weather conditions and implementing premilking teat 
disinfection by either dipping or spraying the teats before attaching the milking unit will likely 
result in lower BC values. The variation in both BC and CC seems to be mainly determined by 
differences in management between the herds as most variation in both parameters resided 
at the herd rather than at the observation level. As only a small proportion of the total variance 
was explained by the management practices included in our study, bacteriological milk quality 
seems to be primarily driven by other factors than the ones included in this study. 
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Abstract 
Associations between herd management practices, collected through a web-based 
questionnaire from 242 dairy herds in Flanders (Belgium), and achieving of milk quality 
premiums (MQP) were studied. Monthly geometric means for bulk milk somatic cell count 
(BMSCC), bacterial count (BC) and coliform count (CC) were available, as well as monthly 
test results of freezing point, residues and filtration. Data were analyzed using binary logistic 
regression. Only 52.9% (n = 128) of the herds achieved their milk quality premium in all (n = 
12) months in 2009. If the BMSCC threshold would have been 250 x 10³ rather than 350 x 10³ 
cells/mL in a hypothetical milk quality premium system (hMQP), only 23.5% (n = 57) would 
have achieved their milk quality premium every month of 2009. The main reason for not 
achieving the milk quality premiums in 2009 in the current system was CC, whereas this would 
have been BMSCC in the hMQP system. Lowering the threshold from 350 x 10³ to 250 x 10³ 
cells/mL in the latter system, would have most likely been accompanied with lower BC and 
CC values. The final model revealed that herds where premilking teat disinfection was applied 
and where dry cows received minerals were significantly more likely to achieve the MQP in 
2009. On the other hand, herds with a high estimated incidence of clinical mastitis (> 3%)  and 
equipped with an automatic milking system (AMS) were significantly less likely to achieve the 
MQP.   
 
 
 
 
 
 
  
Chapter 4.2 
110 
 
Introduction 
The production of high-quality milk begins at the farm. Milk quality is important with 
implications for human health, milk processing and on-farm profitability (More, 2009). It 
involves multiple factors related to cow health and udder hygiene, hygiene of the environment 
in which cows are housed and milked, herd health management, and nutrition. Elevated 
somatic cell count (SCC) lead to decreased raw milk quality and has been associated with 
decreased shelf life of dairy products and lower cheese yields (Klei et al., 1998; Barbano et 
al., 2006). Also, high bacterial levels in milk, whether originating from the cow or through 
contamination from the environment, substantially affect the quality, safety, and consumer 
acceptance of milk and dairy derived-products (Keefe and Elmoslemany, 2007; Flores-
Miyamoto et al., 2014). Poor milk hygiene also undermines the trust in milk as a healthy 
product and raises consumer concerns with regard to human health, bacterial contamination, 
and antimicrobial residues (Ruegg and Tabone, 2000; Saville et al., 2000; Jayarao and 
Henning, 2001; Hogan, 2005; Straley et al., 2006). Of these, SCC is the most important single 
indicator of milk quality, reflecting the health status of the mammary gland and the risk of non-
physiological changes to milk composition (Dohoo and Leslie, 1991). It is also the key 
component of national and international regulation programs for milk quality (van Schaik et al., 
2002).  
Payment schemes are an important incentive in controlling all bulk milk quality parameters 
(Veerkamp et al., 1998). Premium policies motivate farmers to produce high quality milk 
without providing a potential disruption to the milk supply. The combination of a penalty and a 
premium has been shown to provide a strong incentive for improvement of milk quality 
(Nightingale et al., 2008) and are also effective motivators to enhance management practices 
on dairy farm; for example, mastitis management (Valeeva et al., 2007) improved after 
changes in the penalty system related to exceeded levels of SCC (Schukken et al., 1992; 
Nightingale et al., 2008).  
In Flanders (Belgium), the official mandatory milk quality regulations follow European 
legislation and require a geometric mean BMSCC over the last three months (based on 4 
recordings per month) < 400 x 10³ cells/mL, a geometric mean bacterial count (BC), expressed 
as individual bacterial count per mL (IBC/mL) over the last two months (based on two 
recordings per month ) < 100 x 10³ IBC/mL milk, a geometric mean of the freezing point over 
the last two months (based on all deliveries) > -510 m°C, no visible impurities (filtration test 
done once a month) and absence of antibiotic residues in any milk delivery. Testing of the CC 
is non-obligatory for milk quality in Flanders yet implemented as part of an incentive program. 
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Similar to other countries such as Ireland (Berry et al., 2006) and different regions in the US 
(Jayarao et al., 2004), the majority of milk processors in Flanders pays incentives of up to €1 
per 100 L (which represents approximately 3% of the milk price) of milk to farmers that meet 
the higher quality requirements. Reaching all monthly standards for milk quality premiums and 
avoiding penalties obviously has potential to increase the farmer’s income but definite figures 
have not been published. Until now, there is also little information available on which 
management practices predispose a farm to the loss of premiums due to inferior milk quality.  
The aim of this study was to determine to what extent differences in management practices 
were associated with achieving milk quality premiums each month during the year 2009 on 
Flemish dairy herds. As a secondary objective, we examined what management practices 
were associated with achieving milk quality premiums if the BMSCC threshold was 250 x 10³ 
rather than 350 x 10³ cells/mL, leaving the other thresholds unchanged. 
Materials and Methods 
Herd Selection and Data Collection 
A web-based questionnaire was conducted between January 2010 and July 2010. The 
questionnaire was pre-tested and refined in close cooperation with 4 dairy farmers prior to the 
start of the study. An invitation to fill out the questionnaire was emailed to approximately 1000 
farmers based on a list from the largest farmer’s organization in Flanders and an incentive 
(USB-stick) for a completed questionnaire was provided. 
In total, 242 farmers (4% of Flemish farmers) completed the online questionnaire that 
consisted of 43 questions concerning general management (n = 8), herd health management 
(n = 9), milking practices (n = 11), calving and dry cow management (n = 9) and nutrition (n = 
6), in place on farm during 2009 (Table 1).  
From all farms that completed the online questionnaire, the BMSCC, BC and CC records 
measured between January 2009 and January 2010, as well as the results of the filtration test, 
the freezing point and residue test, were retrieved from the Milk Control Centre Flanders (Lier, 
Belgium) that executes the regulatory farm screening program in Flanders. All analyses were 
examined on unpasteurized bulk milk samples collected in 30 mL sterile screw-cap tubes by 
trained milk haulers. The samples were kept cooled (± 4°C) until arrival at the laboratory.  
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Laboratory Analyses 
All microbiological analyses were performed within 24h after pick-up at the farm. The milk 
samples were vortexed prior to the start of the analyses. Milk SCC was quantified by electronic 
counting using a Fossomatic 5000 (Foss Electric, Hillerød, Denmark) at the Milk Control 
Centre Flanders (Lier, Belgium). For BC, undiluted milk samples were used and automatically 
analyzed by means of a Bactoscan™ FC (Foss Electric, Hillerød, Denmark). Bacterial counts 
were expressed as the number of IBC/mL of milk. For CC, milk samples were first diluted 
using trypton salt broth at 1:10. One mL of diluted milk was plated on Petrifilm CC plates and 
incubated at 30°C for 24h. Colony-forming units were counted electronically using an 
automated colony counter (protoCOL, Synbiosis, Cambridge, UK). Coliform counts were 
expressed as the number of colony-forming units per milliliter of milk. For the freezing point, 
undiluted milk samples were used and automatically analyzed by means of a Milkoscan™ 
4000. Visible impurities were determined by a filtration test. Briefly, 40 mL of undiluted milk 
was drawn through the watt disk with a special device (Ledoux b.v., Dodewaard, The 
Netherlands). After filtration, the watt disk was dried for 1h by room temperature and was 
checked for visible impurities. All deliveries were checked for residues with a Delvo test (DSM 
Food Specialties, Delft, the Netherlands) before processing the milk (Angelidis et al., 1999). 
Per month, a geometric mean SCC, BC and CC was calculated based on the recordings of 
the last 2 months for BC and CC and the last 3 months for BMSCC.  
Definitions 
Current Milk Quality Premium (MQP). Several criteria were required to achieve the 
premium during the study period. The herds had to be part of the Dairy Quality Assurance 
program for all months of the year 2009. Additionally, the farm had to meet all legal standards 
regarding the filtration test, freezing point and residues. Regarding the BC and BMSCC levels, 
the premium was achieved if the geometric mean BC was < 50 x 10³ IBC/mL and the geometric 
mean CC was < 50 cfu/mL over the last two months (2 recordings per month) in combination 
with a geometric mean BMSCC < 350 x 10³ cells/mL (4 recordings per month) over the last 
three months.  
Hypothetical Milk Quality Premium (hMQP). A hypothetical premium would have been 
achieved if, based on the abovementioned standards, the level of BMSCC would have been 
lowered to a geometric mean BMSCC < 250 x 103 cells/mL rather than 350 x 103 cells/mL, 
with all other legal standards remaining unchanged, for all months of the year 2009. So, in this 
system we would not use CC as a standard.  
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Statistical Analyses 
All data were entered in an electronic spreadsheet program (Excel 2010, Microsoft 
Corporation) and were checked for unlikely values. Monthly geometric means for SCC (n = 
2904), BC (n = 2904) and CC (n = 2904) were available for 242 farms. As well, monthly test 
results of freezing point (n = 2904), residues (n = 2904) and filtration test (n = 2904) were 
available.  
 
Figure 1. Flow chart of variable reduction through different steps in the statistical analysis. 
 
The regression model-building process to identify management practices associated with 
achieving MQP involved several steps as described previously (De Vliegher et al., 2004) and 
is presented in a flowchart (Figure 1). A binary logistic regression model with MPQ as 
dependent variable was fit using SPSS 20.0 (SPSS Inc., Chicago, Illinois, USA).  
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Table 1. Overview of all herd management practices collected via a web-based questionnaire on 242 
dairy herds in Belgium. 
General management 
 Type of livestock farming, expected time the farm will still exist, herd size, number of lactating 
cows, milk quota size, duration of access to pasture during summer, barn type, cleaning 
frequency of the housing  
Herd health management 
 Registration of animal diseases, herd health monitoring by veterinarian, participation in udder 
health monitoring, monthly estimated incidence of clinical mastitis, antimicrobial treatment 
during lactation of subclinical mastitis, treatment of prepartum heifers with antimicrobials, 
treatment based on vet advice or culture results, treatment duration of mild clinical mastitis, 
use of self-prepared off-label udder infusions  
Milking management 
 Milking machine type, milking parlor type, cows kept in headlock after milking, use of 
automatic cluster removal, providing a preparation lag-time of 60 s, teat preparation method, 
application of premilking teat disinfection, application of postmilking teat disinfection, type of 
machine unit liner, rinsing of machine unit liners, replacement of machine unit liners  
Calving management 
 Calving on pasture, presence of calving pen, use of calving pen for sick cows  
Nutrition management 
 Concentrate provided during milking, concentrate provided on top of forage, concentrate 
provided via total mixed ration, concentrate provided via automatic feeder, forage provided, 
type of forage feeding system  
Dry cow management 
 Drying-off procedure, use of long-acting antimicrobials, adapted diet provided, 
mineral/vitamin mix provided, use of external teat sealer, use of internal teat sealer  
 
Initially, unconditional associations were tested between the binary dependent variable MQP 
at the herd level and all management practices (n = 41, Table 1). Statistical significance in this 
step was assessed at P < 0.15. Some of the categorical variables were recoded based on 
biological relatedness because of low frequencies in one or more categories in this step. 
Second, Pearson and Spearman’s rank correlation coefficients were calculated among the 
significant independent variables to avoid multicollinearity in the next steps. If two independent 
variables had a correlation coefficient ≥ |0.6|, only the one with the highest statistical 
significance or the most relevant variable was selected for further analysis. In the third step, a 
multivariable model was built with the remaining management variables as independent 
variables, and with MQP as dependent variable (Table 1). Non-significant variables were 
removed using backwards elimination at P ≤ 0.05. All first-order interactions between the 
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remaining variables in the multivariable model were tested and removed when non-significant 
(Wald’s tests, P > 0.05).  
Results 
Descriptive Results 
The average herd size of the 242 herds included in the study was 65.8 [interquartile range 
(IQR) from 45 to 80] lactating cows per herd, with an average milk quota size of 552,188 kg of 
milk (IQR from 375,750 to 676,500) per year. The average of the BMSCC was 202,000 
cells/mL (IQR from 155,000 to 239,800 cells/mL). The median of the BC and CC was 7.0 x 
103 IBC/mL (IQR from 5 x 103 to 11 x 103 IBC/mL) and 4.0 cfu/mL (IQR from 2 to 12 cfu/mL), 
respectively. Averages of the BC and CC were 8.9 x 103 IBC/mL and 13 cfu/mL, respectively. 
Of the 242 herds, 94.6% (n = 229) used a conventional milking system, whereas 5.4% 
(n=13) were milking their cows with an automated milking system (AMS). Eighty percent of 
the farms (n = 194) housed their cows in a freestall with slatted floor. In almost 60% of the 
herds (n = 138), some herd health aspects such as fertility, and (or) udder health, and (or) 
heifer rearing, and (or) claw health were monitored by a veterinarian on a regular basis. 
Disease registration was systematically done on approximately half of the herds. More than 
80% (n = 198) of the farmers claimed their farm would still exist for more than 10 years.  
 
 
 
Figure 2. Distribution of the herds (n = 242) that achieved the milk quality premium in 2009.    
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Only 52.9% (n = 128) of the herds achieved their milk quality premium for all 12 months in 
2009 (Figure 2). If the BMSCC threshold would have been 250 x 10³ cells/mL, only 23.5% (n 
= 57) would have achieved their milk quality premium in all months of 2009 (Figure 3).  
 
 
1 Bulk milk somatic cell count (BMSCC) level was set at 250,000 cells/mL and all other standards 
remained unchanged.   
Figure 3. Distribution of the herds (n = 242) that would have achieved a hypothetical milk quality 
premium1 in 2009. 
 
The main reasons for not achieving the milk quality premiums in 2009 are listed in Table 
2a. For 406 months, the MQP was not achieved, but in 47 cases, the MQP could not be 
achieved due to more than one reason, resulting in a combined total of 359 months that the 
MQP was not achieved.  In the current premium system, CC is the predominant reason (63.3% 
of the reasons for not achieving the premium) for not achieving the monthly milk quality 
premium, whereas this would be due to BMSCC (77.2% of the reasons for not achieving the 
premium) if the premium system would have been changed using a lower 250 x 10³ cells/mL 
BMSCC threshold (Table 2b). Also in the hMQP, for 1280 months the hMQP would not have 
been achieved, but in 175 cases a hMQP would not be achieved due to more than one reason, 
resulting in a combined total of 1105 months the hMQP would not be achieved. Average 
BMSCC, BC and CC of herds achieving and not achieving the MQP and hMQP are listed in 
Table 3a and Table 3b.  
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Table 2a. Reasons for not achieving the monthly milk quality premium in 2009.  
 Milk quality premium 
Reason Not achieved (months) Achieved (months) % not achieved 
Somatic cell count 114 2790 3.9 
Bacterial count  19 2885 0.7 
Coliform count  257 2647 8.8 
Filtration 0 2904 0.0 
Freezing point  4 2900 0.1 
Residu  12 2892 0.4 
Combined total 359 2545 12.36 
    
 
Table 2b. Reasons for not achieving the monthly hypothetical milk quality premium in 2009.  
 Hypothetical milk quality premium 
Reason Not achieved (months) Achieved (months) % not achieved 
Somatic cell count 988 1916 34.0 
Bacterial count  19 2885 0.7 
Coliform count  257 2647 8.8 
Filtration 0 2904 0.0 
Freezing point  4 2900 0.1 
Residu  12 2892 0.4 
Combined total 1105 1799 38.05 
    
 
 
 
Table 3a. Average bulk milk somatic cell count (BMSCC), bacterial count (BC) and coliform count 
(CC) of herds achieving and not achieving the monthly milk quality premium.  
 Milk quality premium 
Variable Achieved Not achieved 
BMSCC (cells/mL) 180,000 226,000 
BC (x103 IBC/mL)  7.5 10.3 
CC (cfu/mL)  7.24 19.4 
   
 
Table 3b. Average bulk milk somatic cell count (BMSCC), bacterial count (BC) and coliform count 
(CC) of herds achieving and not achieving the monthly hypothetical milk quality premium.  
 Hypothetical milk quality premium 
Variable Achieved Not achieved 
BMSCC (cells/mL) 151,000 217,000 
BC (x103 IBC/mL)  6.4 9.6 
CC (cfu/mL)  5.7 15.3 
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Unconditional Associations  
A first reduction based on unconditional associations and highly correlated variables 
revealed 18 herd management practices to be associated (P ≤ 0.15) with achieving MQP 
(Table 4). A strong correlation was present between the number of lactating cows and the 
quota size. The number of lactating cows was selected for further analysis because this 
variable is more precise to describe a farm, since some farmers were not using their quota 
size as a goal for milk production.  
 
Table 5. Final multivariable model for achieving milk quality premium (MQP) (P<0.05). 
 Milk quality premium 
Independent variables Beta SE1 OR2 P-value 
Premilking teat disinfection    0.049 
 no Ref. …   
 yes 1.002 0.555 2.981  
Dry cows received minerals    0.031 
 no Ref. …   
 yes 0.669 0.309 1.951  
Estimated incidence of clinical mastitis in 2009    0.007 
 ≤3% Ref. …   
                          >3% -0.756 0.278 0.470  
Automated milking system    0.003 
 no Ref. …   
 yes -3.132 1.064 0.044  
1 SE = Standard error, 2 OR = Odds ratio 
 
Final Multivariable Model 
The final multivariable model for achieving MQP is presented in Table 5. The final model 
revealed that herds of where application of premilking teat desinfection was done, were 
significantly more likely to achieve the MQP. Also, when dry cows received minerals, herds 
were more likely to achieve the MQP. On the other hand, herds with a high estimated incidence 
of clinical mastitis (>3%) and herds with an AMS were significantly less likely to achieve the 
MQP in 2009.   
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Discussion 
To determine what management factors were associated with achieving MQP in Flanders, 
a web-based questionnaire was used as this allowed for relatively easy, efficient and cheap 
data collection. The response rate was around 24%, which represented 4% of the dairy 
farmers in Flanders in 2009 (Annual Report 2009, Belgian Dairy Confederation, Leuven, 
Belgium). The average herd and quota size of the selected farms were slightly higher than the 
Flemish average, being 44 lactating cows and 310,650 kg of milk per herd, respectively 
(Annual Report 2009, Belgian Dairy Confederation, Leuven, Belgium). Herd size and the need 
to have internet access, might have selected the input of more contemporary farmers that are 
also better managers, potentially diminishing the external validity of the data (Dohoo et al., 
2009). Still, the high variation in BMSCC between the respondents suggests a wide diversity 
of management styles (Barkema et al., 1998). Also, both the average BMSCC and BC of the 
selected herds approached the average BMSCC and BC for the whole of Flanders being 
230,000 cells/mL and 11.3 x 103 IBC/mL, respectively, in 2009 (Annual Report 2009, Milk 
Control Center Flanders, Lier, Belgium). The average CC of the participating herds was even 
higher than the Flemish average of 10 cfu/mL in that period (Annual Report 2009, Milk Control 
Center Flanders, Lier, Belgium).  
The finding that only 52.9% of the herds achieved their MQP 12 months in 2009 was 
surprising, especially because of the fact that the thresholds for the legal standards and for 
achieving the premium are close together. On the other hand, premiums only represent 3% of 
the milk price, which is low compared to other premium systems in the EU. Most of the milk 
buyers in the EU pay a premium of 3-5% of the milk price below the premium threshold, a 
neutral price above that premium threshold and then introduce price reductions of 5-10% from 
a higher threshold on, often 250 x 10³ cells/mL up to the regulatory level (Hillerton and Berry, 
2004). However, as shown by Valeeva et al. (2007), with respect to monetary factors, farmers 
are expected to be more motivated by a quality penalty system design than by a quality 
premium system design, which could potentially explain at least partly why only half of the 
herds achieved their milk quality premium. 
Interestingly, CC was the main reason for not achieving the MQP in Flanders, but if the 
threshold for BMSCC would have been 250 x 10³ cells/mL then BMSCC (77.2%) would have 
been the main reason. However, the median and average CC in our study were much lower 
than the average CC of 44 cfu/mL across a number of studies (Elmoslemany et al., 2009; 
Pantoja et al., 2011), still suggesting better conditions concerning milk refrigeration, milking 
machine sanitation and premilking hygiene on the Flemish dairy farms compared to the farms 
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included in the other studies (Jayarao and Wolfgang, 2003). Although there is no regulatory 
limit on the amount of coliforms that can be present in raw milk, the Grade “A” Pasteurized 
Milk Ordinance (Food and Drug Administration, 2009) requires pasteurized milk to have a CC 
≤ 10 cfu/mL. Other research has used ≤50 cfu/mL as the proposed cutoff for “good quality” in 
regard to coliforms in raw milk (Jayarao et al., 2004), which is in agreement with the standards 
for achieving the MQP in Flanders.  
The implementation of CC in a premium system as is the case in Flanders is quite 
exceptional. As shown in Table 3a, this current premium system selects for low BMSCC, BC 
and CC. If CC would not have been taken into account, then BMSCC, BC and CC would have 
been 357 x 103 cells/mL, 21.9 x 103 IBC/mL and 70.8 cfu/mL, respectively, in the farms that 
did not achieve the premium for the whole year. In contrast, farms that would achieve the 
premium in a system without CC, BMSCC, BC and CC would have  216 x 103 cells/mL, 8.07 
x 103 IBC/mL and 18.8 cfu/mL, respectively.   
There are several possible reasons why CC was the main cause of not achieving MQP. 
First, in contrast with BMSCC, CC is only measured twice a month, which makes it more 
difficult to react as a farmer when a high CC is observed. Second, use of geometric means is 
useful to correct for outliers when the data is skewed. Coliform count and BC are positively 
skewed and also the distribution of the geometric means did not normalize the data. Also, the 
geometric mean BMSCC was calculated based on the recordings of the last 3 months, 
whereas this was the last 2 months for BC and CC. Third, in contrast to BC, CC is measured 
after dilution (1:10), making incorrect counts more likely.  
According to Schukken et al. (1990), the annual mean BMSCC should be lower than 250 
x 10³ cells/mL to minimize the chance of passing the penalty limit of 400 x 10³ cells/mL in any 
given bulk tank. Using a threshold of 250 x 10³ cells/mL rather than 350 x 10³ cells/mL in a 
hMQP system, would have most likely selected for a lower BC and CC as well. However, we 
should be cautious to conclude this, since the data only reflect the management during 2009 
from farmers who were familiar with the milk quality system and not aware of the hypothetical 
quality system. Because BMSCC is measured four times a month, it is normally distributed 
and the geometric mean is calculated based on the last 3 months, the authors would prefer 
the hMQP system over the current MQP system. Also, only a small proportion of the variation 
in CC can be explained by manageable practices different from those related to milking and 
equipment hygiene (Piepers et al., 2014), whereas Pantoja et al. (2009) mentioned that every 
10 x 10³ cells/mL increase in BMSCC increased the odds of elevated BC and CC by 2.4 and 
4.3%, respectively.  
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Four variables reflecting milking, herd health and dry cow management were significantly 
associated with achieving MQP during 2009 in Flanders. Obviously, the fact that associations 
were statistically significant in the analyses not necessarily indicates that a causal relation 
exists (Dohoo et al., 1997). Also, when no variation is present in the dataset, it doesn’t mean 
that there is no association between the studied management practices and the outcome 
variable(s). In this study, well-known management practices for good udder health and milk 
quality such as postmilking teat disinfection and changing liners in time were done 
respectively, by more than 90% and less than 10% of the herds, making it difficult to show an 
association. The use of an AMS decreased the likelihood of achieving the MQP the whole 
year. This is in line with the report from The Netherlands indicating that the BC, SCC and 
freezing point may be altered by the introduction of AMS (Jepsen and Rasmussen, 2000; 
Klungel et al., 1998; 2000; Vorst and Hogeveen, 2000). Also, Hamann and Zecconi (1998) 
concluded that electrical conductivity does not identify mastitic quarters or cows with sufficient 
accuracy, and the current generation of AMS does not sort milk according to the appearance 
of the foremilk (Rasmussen et al., 2002), making poor milk quality in the bulk tank more likely. 
The finding that herds where dry cows were fed with minerals were more likely to achieve the 
MQP was in line with the results of Piepers et al. (2014), who used the same dataset as ours 
and demonstrated that providing a mineral/vitamin mix to dry cows was negatively associated 
with BC. The latter could be a reflection of a relationship between MQP and BC. 
Supplementing minerals during dry period could be helpful in curing existing IMI causing 
subclinical mastitis. The use of minerals could also be a confounder and could simply be a 
reflection of the farmers’ attitude towards the importance of appropriate dry cow feeding. 
Achieving MQP was also associated with premilking teat disinfection which was not that 
unexpected as Elmoslemany et al. (2009) reported that the risk of having high BC increased 
by 5.3 for each unit increase in the teat-end cleanliness before the milking unit was attached. 
Our finding corresponds well to the numerous studies that showed a strong teat microbial load 
reducing effect of premilking teat disinfection (e.g. Galton et al., 1986; Magnusson et al., 2006; 
Gibson et al., 2008) and on reducing aerobic mesophilic bacteria (Oliveira et al., 2011) and 
BC (Piepers et al., 2014).  
According to Dohoo and Leslie (1991), SCC is mainly determined by IMI and is therefore 
an excellent proxy to measure prevalence and even incidence of IMI whether clinical signs of 
mastitis are present or not. This probably explains the fact that herds with a high  estimated 
incidence of clinical mastitis (>3% cases per month) were less likely to achieve the MQP. 
However, some studies suggested that low BMSCC was associated with high IRCM (Elbers 
et al., 1998; Beaudeau et al., 2002; Green et al., 2004) whereas other work did not reveal any 
relationship (Barkema et al., 1998; Beaudeau et al., 1998). Also, herds having a higher 
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prevalence/incidence of (clinical) mastitis are using more antimicrobials (Stevens et al., 2016) 
resulting in a higher chance of detecting residues in the bulk tank. Actually, violation against 
antimicrobial residues in the bulk tank was more often observed (0.46%)  in herds with a high 
estimated incidence of clinical mastitis (> 3%) (n = 7) compared to herds with a low estimated 
incidence of clinical mastitis (≤ 3%) (n = 5) (0.36%). However, we should be careful in 
interpreting the incidence data since the majority of participating farmers admitted not to keep 
disease records, hence the use of the term “estimated” incidence.  
 
Conclusions 
Only half of the herds achieved their milk quality premium in all 12 months in 2009, 
suggesting that there is still room for opitmization of the profitability on dairy herds in Flanders 
by improving the udder health and milk quality. If the BMSCC threshold would have been 250 
x 10³ rather than 350 x 10³ cells/mL in a hypothetical system, this would have further reduced 
to 23.5%. The main reason for not achieving the milk quality premiums in the current system 
was CC, whereas this would have been BMSCC in the hMQP system. The latter implies that 
in the current system achieving the milk quality premium is most probably more determined 
by factors related to milking and equipment hygiene and milk storage conditions than by 
factors related to either herd health, transition, feeding and housing management. Still, 
application of premilking teat disinfection, providing a mineral/vitamin mix to the dry cows 
received minerals, and reducing the incidence of clinical mastitis might be helpful in achieving 
the milk quality premium.  
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Abstract 
The aim of this study was to assess the concentration of penicillin G in mammary tissue 
and secretion of dry heifers following systemic administration of penethamate hydriodide. Six 
dairy heifers in late gestation received a single intramuscular injection of 10 g penethamate 
hydriodide and were sacrificed 24, 48 or 144 hours after treatment. Penicillin G concentrations 
were measured in mammary tissue and secretion samples using high performance liquid 
chromatography. Penicillin G was detected in the udder of two animals euthanized at 24 hours 
(mammary tissue and secretion) and at 48 hours post treatment (mammary secretion only) 
after administration at concentrations still close to or above MIC90 values reported for the 
pathogens associated with heifer mastitis. Antibiotic concentration shortly after administration 
will have been substantially higher indicating a potential for systemic treatment with 
penethamate hydriodide to control prepartum intramammary infections in heifers without the 
disadvantages of local therapy such as teat contamination or risk of trauma for the 
administrator.  
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Introduction 
For many years there have been reports that a large proportion of dairy heifers calve with 
infected quarters (Fox, 2009). This condition has been referred to as heifer mastitis and 
studies have shown a wide variation in prevalence, from 74.6 to 29.0% (Trinidad et al., 1990, 
Oliver and Mitchell, 1983) and from 55.0 to 12.3% (Roberson et al., 1994, Parker et al., 2007) 
of quarters being reported as culture positive before and at calving, respectively. A number of 
pathogens have been isolated but studies have shown that infections are predominantly due 
to Gram-positive pathogens, specifically coagulase-negative staphylococci (CNS), 
Staphylococcus aureus, and environmental streptococci (Fox, 2009).  
Heifer mastitis can have a negative impact on future productive life (De Vliegher et al., 
2004, 2005a, 2005b), the effect depending on factors such as virulence of the pathogens 
involved and time of onset of the intramammary infection (IMI) (Piepers et al., 2009). The cost 
of heifer mastitis in early lactation on an average Dutch/Flemish dairy farm has recently been 
estimated to vary from €4 to €82 per heifer with an average of €31 (Huijps et al., 2009). 
To address this issue, antibiotic treatments have been used empirically before calving. 
Various studies have shown that the use of dry or lactating cow intramammary products prior 
to calving in heifers can be beneficial in reducing levels of mastitis pathogens isolated post 
partum and in increasing milk yield during lactation (Nickerson, 2009). Systemic rather than 
local antibiotic treatment presents the advantages of decreased risk of teat contamination, 
more convenient and safer to administer, and four quarters being treated with a single 
administration. 
Penethamate hydriodide is a prodrug which releases penicillin G on hydrolysis. It easily 
crosses the blood–milk barrier and concentrates in udder tissues and milk after intramuscular 
(IM) administration to lactating cows (Ziv, 1980) The in-vitro spectrum of activity is mainly 
within the Gram-positive class of bacteria e.g. Staphylococcus spp., Streptococcus spp., 
Clostridium spp., Bacillus spp. A recent study on a herd struggling with Staphylococcus aureus 
infections showed that IM treatment of heifers at parturition with penethamate hydriodide 
prevented IMI during the first week post partum and resulted in a significant increase in milk 
yield (Kreiger et al., 2007). Another study on a 350 cow dairy herd having problems with S. 
aureus infections showed a significant reduction in the number of IMI after introduction of a 
regimen to inject heifers 2 months prior to calving with penethamate hydriodide intramuscularly 
(Moroni et al., 2002). A prerequisite for the successful use of this treatment in heifers and cows 
before calving is widespread distribution of the drug in the dry udder. 
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The aim of this study was to assess the concentration of penicillin G in mammary tissue 
and secretion of heifers in the third trimester of pregnancy following a single IM injection of 
penethamate hydriodide.  
Materials and Methods 
Animals 
The study group consisted of 6 clinically healthy primiparous dairy heifers (4 Montbeliarde 
and 2 cross-breds Montbeliarde x Charolais) in their 8th to 9th month of gestation, weighing 
from 540 to 630 kg (average 600 kg) and aged between 2.5 and 3.5 years (average 2.6 years). 
Animals had received no treatment with veterinary drugs for at least 2 weeks prior to the 
beginning of a 7 day acclimatization period. 
Drug administration 
After the acclimatization period each of the 6 animals was treated by deep IM injection 
with one vial of the reconstituted test item containing 7.72 g penethamate hydriodide 
(Mammyzine®, Mamyzin®, STOP M®, Boehringer Ingelheim Vetmedica). This equated to 
doses ranging from 12.3 to 14.3 mg/kg. All animals were treated, once only, on the same day. 
No adverse reactions were noted. 
Tissue and secretion samples 
Animals were slaughtered randomly in groups of two at approximately 24, 48 and 144 
hours post treatment. On the day of slaughter 100-120 g pieces of mammary tissue were 
removed from each quarter and individually minced before being placed in plastic bottles. 
Mammary secretions were obtained manually by pressing the mammary tissue of each quarter 
and collecting the liquid in plastic bottles. All the prepared samples were frozen within 2 to 3 
hours, and stored at a temperature below -75°C until their analysis. 
Penicillin G assay 
The determination of penicillin G in mammary tissue and secretion was carried out using 
reverse phase high performance liquid chromatography (HPLC) based on Tarbin et al. (1995). 
Samples weighing 5 g of either mammary tissue (homogenised with 10mL water) or secretion 
(diluted with 10mL saturated dibasic sodium phosphate) were acidified with 0.17M sulphuric 
acid and protein precipitated by adding 5% sodium tungstate solution. The resulting mixture 
was sonicated, shaken for 30 min (horizontal shaker) and the aqueous layer recovered 
following centrifugation (12°C, 10 minutes, 2,800 g). A second extraction step followed, the 
second aqueous layer was combined with the first, and a 20% solution of sodium chloride 
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added. Mammary secretion extracts were adjusted to pH 8 using concentrated sodium 
hydroxide. Extracts obtained were then deposited on an SPE C18 cartridge (Waters, Milford, 
MA, USA) previously washed with methanol, water and a 2% sodium chloride solution. The 
cartridge was then washed with 2% sodium chloride solution followed by water, and dried. The 
cartridge was eluted with a mixture of acetonitrile, water and phosphate buffer. A derivatization 
mixture (1,2,4-triazol dissolved in water with 0.02 M mercury chloride, pH adjusted to 9.0) was 
added to the eluted sample and the mixture was placed in a water bath at 65°C for 2 hours. 
After cooling at room temperature and centrifugation (5 min, 2,800 g), 150 µL of the 
supernatant was injected in the HPLC system (Waters, Milford, MA, USA). The analyses were 
performed at 325 nm with a Spherisorb ODS2 column 250 mm x 4,6 mm (Waters, Milford, MA, 
USA) attached to an appropriate guard column filled with the same material. The analyses 
were carried out at room temperature. The mobile phase consisted of acetonitrile/0.1 M 
phosphate buffer containing 0.0157 M sodium thiosulfate (25/75, v/v). The retention time for 
penicillin G was ca. 12 min using an isocratic elution at 1 mL/min. 
Calibration curves for penicillin G concentration in mammary tissue/secretion were linear 
between 50 and 1000 µg/kg (r > 0.99). The limit of quantification (LOQ) was set to 50 µg/kg 
for the two matrices and the limit of detection (LOD) was 18 µg/kg and 20 µg/kg for mammary 
tissue and mammary secretion, respectively. Penicillin G remained stable in extract for 24 
hours (mammary secretion) or 48 hours (mammary tissue) at ambient temperature, and for 29 
days (mammary tissue) or 90 days (mammary secretion) below -75°C, i.e. for storage periods 
longer than those used in the study. 
Results  
Mammary tissue 
Penicillin G was detected at quantifiable levels in mammary tissue from the 8 quarters of 
the 2 animals sacrificed at 24 hours after treatment (ranging from 90.69 to 151.16 µg/kg) 
(Table 1). No major differences were seen between front and rear quarters. Penicillin G was 
not detected in mammary tissue from any of the quarters of the 4 animals euthanized at 2 and 
6 days post treatment. 
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Mammary secretions 
Quantifiable concentrations of penicillin G were detected in mammary secretion from all 
quarters of the 2 animals sacrificed on the first day after treatment (ranging from 74.53 to 
291.31 µg/kg) (Table 1). Penicillin G concentrations were either similar to the ones observed 
in mammary tissue (animal 2, average 111.2 and 111.9 µg/kg in secretion and tissue, 
respectively), or approximately twice the concentrations in mammary tissue (animal 4, 
average 266.2 and 119.5 µg/kg in secretion and tissue, respectively). In animals euthanized 
on the second day after treatment, quantifiable concentrations of penicillin G were present in 
mammary secretions from the 4 quarters of animal 3, and from the rear quarters of animal 5. 
In animals sacrificed on the sixth day after treatment quantifiable concentrations of penicillin 
G were not detected in secretion samples from 7 of the 8 quarters. Penicillin G was detected 
at a low level in mammary secretion from the remaining quarter at a value close to the LOQ 
of 50 μg/kg.  
 
 
Table 1. Penicillin G concentrations (µg/kg) in mammary tissue and secretion of - end-term dairy heifers 
following administration of penethamate hydriodide. 
Time of sacrifice after 
administration 
Animal number 
(month gestation) 
Quarter 
position1 
Mammary 
tissue 
Mammary 
secretion 
1 day (24 ± 0.5 hours) 
 
 
 
 
2 (8th) 
RL 96.49 74.53 
RR 109.47 98.67 
FL 139.18 119.18 
FR 102.61 152.42 
4 (9th) 
RL 151.16 291.31 
RR 90.69 290.32 
FL 133.32 256.78 
FR 102.98 226.52 
2 days (48 ± 0.5 hours) 
 
3 (9th) 
RL < LOD2 77.39 
RR < LOD 63.81 
FL < LOD 81.76 
FR < LOD 69.25 
5 (9th) 
RL < LOD 66.31 
RR < LOD 73.97 
FL < LOD < LOQ3 
FR < LOD < LOQ 
6 days (144 ± 0.5 hours) 
1 (9th) 
RL < LOD < LOQ 
RR < LOD < LOQ 
FL < LOD < LOQ 
FR < LOD < LOQ 
6 (9th) 
RL < LOD 74.62 
RR < LOD < LOQ 
FL < LOD < LOQ 
FR < LOD < LOQ 
 1RL: rear left, RR: rear right, FL: front left, FR: front right, 2Level of detection (for tissue and secretion= 
18 and 20 µg/kg, respectively), 3Level of quantification (level of quantification = 50 µg/kg).  
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Discussion 
Penicillin G reached tissues from all quarters of the udder of non-lactating heifers in high 
concentrations. Assuming the density of milk secretion and mammary tissues is higher than 
that of milk and colostrum, it appears that antibiotic concentrations present in the udder 24 
hours after administration of penethamate hydriodide were near or above the MIC90 of 
penicillin for S. aureus (0.125->100 μg/ml) and Streptococci (0.07-2 μg/ml) as summarised by 
Erskine et al. (2004) and CNS (e.g. Gentilini et al., 2002, 4.4 μg/ml) i.e. the target pathogens 
commonly associated with heifer mastitis. Previous work shows that after a single IM injection 
of penethamate hydriodide in lactating cows the mean maximum penicillin G concentration is 
reached after 3.76 hours in plasma and after 5.91 hours in milk. With a mean half life of 4.27 
hours (plasma) and 4.00 hours (milk) the maximum concentrations are at least 5 times those 
recorded at 24 hours post administration (Friton et al., 2003). This supports the view that in 
the current study penicillin G concentrations well above the MIC90 for the more common 
mastitis pathogens associated with heifer mastitis will have been reached.  
Previous studies have shown that IM administration of penethamate hydriodide for 3 days 
can be efficacious in the treatment of clinical and subclinical mastitis in lactating cows (Salat 
et al., 2008; Serieys et al., 2005). Additionally, in another study where heifers were treated 
intramuscularly with penethamate hydriodide on one occasion 7 days prior to calving, 
periparturient mastitis incidence was 22% in treated heifers versus 46% in non-treated control 
heifers (Bryan and Friton, 2004).  
Conclusions 
We conclude that systemic use of penethamate hydriodide prior to calving can result in 
levels of penicillin G in mammary tissue and secretion substantially higher than the MIC90 of 
pathogens associated with heifer mastitis. These findings support the view that penethamate 
hydriodide administered via the IM route to heifers prior to calving could be an appropriate, 
although temporary, therapeutic choice while preventive measures are being implemented by 
the herd manager/farmer. Systemic treatment of end-term heifers that have never been 
constrained before has obvious advantages over local therapy using lactating or dry cow 
products. However, this therapeutic approach needs to be verified under field conditions to 
quantify the short and long term effects on udder health (somatic cell counts and clinical 
mastitis cases), and milk production.  
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Abstract 
Prepartum intramammary treatment with antimicrobials of end-term dairy heifers has 
frequently been proposed as a practice to reduce the prevalence of intramammary infections 
(IMI) at calving. From a safety standpoint for both animal and administrator, systemic 
treatment is to be preferred. A clinical trial was conducted on heifers from 10 commercial, well-
managed dairy farms with low prevalence of heifer mastitis. The aim was to assess both the 
short and long-term effects of a systemic prepartum therapy with penethamate hydriodide on 
udder health and milk production. Because it was hypothesized that some herds would benefit 
more from this treatment than others, specific herd-level information was collected prior to the 
start of the actual trial in order to screen for and/or explain potential herd-specific treatment 
effects. Further, the effect of treatment on antimicrobial susceptibility of Staphylococcal 
isolates was monitored. End-term heifers were either treated systemically (during three 
consecutive days) two weeks prior to expected calving date with penethamate hydriodide 
(n=76) or remained untreated (n=73). Systemic prepartum treatment of end-term heifers with 
penethamate hydriodide resulted in fewer IMI in early lactation. However, all 6 cases of CM in 
early lactation occurred in the treatment group [Streptococcus uberis (n = 1), Corynebacterium 
bovis (n = 1), Staphylococcus aureus (n = 1); one sample was contaminated and two samples 
remained culture negative]. No long-term treatment effects (4 to 120 DIM) on milk production, 
udder health or culling hazard during later lactation were detected although treated heifers 
belonging to herds classified as having low yielding heifers out-produced the control heifers. 
Moreover, penicillin susceptibility of Staphylococci isolated from milk samples of either treated 
or control heifers did not differ. Herds with a low prevalence of heifer mastitis are not likely to 
benefit from prepartum systemic antimicrobial treatment of the end-term heifers.  
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Introduction 
Generally, bred heifers are assumed to have no issues with udder health and for that 
reason their mammary glands and secretions are often not checked until calving (Nickerson, 
2009). However, a large proportion of dairy heifers calve with infected quarters (Fox, 2009). 
Studies have shown a wide variation in prevalence, from 29.0 to 74.6% (Oliver and Mitchell, 
1983; Trinidad et al., 1990a) and from 12.3 to 55.0% (Roberson et al., 1994; Parker et al., 
2007) of quarters being reported as culture positive before and at calving, respectively. A 
number of different pathogens have been isolated but studies have shown that infections are 
predominantly caused by Gram-positive bacteria, specifically CNS, Staphylococcus aureus, 
and environmental streptococci (Fox, 2009). Heifer mastitis can have a negative impact on 
future productive life (De Vliegher et al., 2004, 2005a,b), the impact depending on factors such 
as virulence of the pathogens involved and time of onset of the IMI during gestation (Piepers 
et al., 2009). The cost of subclinical heifer mastitis in early lactation alone on an average 
Dutch/Flemish dairy farm has been estimated to vary from €4 to €82 per heifer with an average 
of €31 (Huijps et al., 2009).  
The use of prepartum antimicrobial treatment of end-term heifers in the control of heifer 
mastitis has been studied using short acting intramammary preparations, administered 
between 6 and 21d prior to calving. (Oliver et al., 1992, Oliver et al., 2004; Middleton et al., 
2005; Borm et al., 2006; Roy et al., 2007) and long acting intramammary preparations, 
administered between 0 and 270 d prior to calving (Trinidad et al., 1990b; Owens et al., 1991, 
1994, 2001; Sampimon et al., 2009). The majority of those studies showed positive effects on 
the short-term, as seen by higher cure rates of IMI detected before calving and/or a lower 
prevalence of IMI at calving in treated heifers compared with untreated controls (Nickerson, 
2009). One could argue it makes more sense from an economical point of view to study the 
treatment effects on the longer term rather than on the short term. Trinidad et al. (1990b) 
studied milk production during the first two months of lactation and showed that S. aureus-
infected heifers that had received prepartum dry cow therapy (penicillin and 
dihydrostreptomycin) produced an average of 2.5 kg more milk per day than S. aureus-
infected herd mates that did not receive treatment. Oliver et al. (2004) showed that prepartum 
intramammary treatment using short acting preparations (penicillin-novobiocin and pirlimycin 
hydrochloride) was effective in reducing the percentage of infected heifers and quarters during 
the first 30 days in milk (DIM) whereas Sampimon et al. (2009) reported positive long-term 
effects of dry cow antimicrobial (cloxacillin) treatment 8 to 10 wk before the expected calving 
date on the incidence of CM, test-day SCC, and test-day milk yield (MY) in first lactation. The 
study of Oliver et al. (2004) is contrasted with the findings of Middleton et al. (2005) who 
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observed that intramammary treatment using short acting preparations (pirlimycin 
hydrochloride) did not necessarily reduce SCC or result in higher milk production during the 
first lactation although a higher overall cure rate at calving was noted. 
Borm et al. (2006) concluded, based on the results of milk production, that prepartum 
treatment of end-term heifers with short acting intramammary preparations (cephapirin) was 
not uniformly efficacious across herds but potential herd-level factors explaining the findings 
were not studied further. Bryan and Taylor (2009) also reported a strong herd effect in their 
study demonstrating that systemic treatment with a single large dose of intramuscular penicillin 
within 12h after calving was successful in significantly reducing the incidence of CM in heifers 
within the first 7 DIM. Given these results, use of prepartum antimicrobial therapy in end-term 
heifers as a universal and economical viable strategy to increase milk production and improve 
udder health in heifers is not warranted. However, as some herds seem to benefit from 
treatment and others do not, it would be useful to understand why this is and what kind of 
factors are associated with that finding, specifically in the light of prudent and substantiated 
use of antimicrobials.  
Systemic antimicrobial treatment of end-term heifers has a number of advantages over 
intramammary treatment: a lower risk of teat contamination, a higher convenience and safety 
to administer, and four quarters being treated with a single administration. Systemic use of 
penethamate hydriodide prior to calving was associated with penicillin G levels in mammary 
tissue and secretion substantially higher than the MIC90 of pathogens associated with heifer 
mastitis (Passchyn et al., 2010). However, the limited number of studies that have looked at 
systemic treatment showed either no effect (Parker et al., 2008 using tylosin) or a positive 
effect and were only conducted on problem herds (Kreiger et al., 2007 using penethamate 
hydriodide).  
Antimicrobials are necessary for decreasing the prevalence and incidence of bacterial 
diseases in animals. Their use in veterinary medicine can have a positive effect on animal 
health, animal well-being and productivity, when used with sound clinical judgment combined 
with sound management practices (Johnston, 1998).  Excessive and/or injudicious use of 
antimicrobials should, however, be avoided at all times. Taking the recent concerns related to 
the emergence of antimicrobial resistance in human and animal pathogens and the possible 
link with the use of antimicrobials in livestock into account, monitoring the development of 
antimicrobial resistance, even on the short term, in treatment trials obviously reflects good 
practice. Antimicrobial resistance of udder pathogens in Belgium (Annual Report 2011, Milk 
Control Centre Flanders, Lier, Belgium) is low and in line with other countries (Erskine, 2006). 
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Given all that information, a clinical trial was conducted on heifers from 10 commercial, 
well-managed dairy farms with low prevalence of heifer mastitis. The aim was to assess both 
the short and long-term effects of a systemic prepartum therapy with penethamate hydriodide 
2 weeks before the expected date of calving on udder health and milk production. Because it 
was hypothesized that some herds would benefit more from this treatment than others, herd-
level information was collected prior to the start of the actual trial in order to screen for and/or 
explain any herd-specific treatment effect. Further, the effect of treatment on susceptibility of 
Staphylococcal isolates from milk was monitored.  
Materials and Methods 
Herds, Heifers and Study Design 
The study was conducted between September 2008 and June 2010 and included 229 heifers 
from 10 commercial, well-managed dairy herds, located in a radius of 20 km around Torhout, 
province of West Flanders, Belgium (Table 1). In total 80 heifers served as monitoring heifers, 
76 were treated and 73 were untreated control heifers. Herd owners were approached by the 
first author and asked whether they were willing to participate. All herds had a good animal 
identification system, participated in the local dairy herd improvement (DHI) program (CRV, 
Oosterzele, Belgium) on a 4 to 6 weekly basis, and kept good records of treatments and 
diseases. Herds already treating end-term heifers with antimicrobials before calving were not 
approached.  
Herd size ranged from 45 to 118 lactating cows with an average milk production of 9220 
kg/cow per lactation, ranging from 8154 to 11,122 kg/cow. The geometric mean of the 
BMSCC) per herd in the 6-months period before the study started was 226,000 cells/mL 
ranging from 74,000 to 326,000 cells/mL. None of the herds reported a heifer mastitis problem, 
and none of the herds was considered to have such a problem when comparing the CM and 
SCC herd data using the thresholds published earlier [herd suffering from heifer mastitis if > 
15% of heifers have CM around calving and/or if > 15% of all heifers have a first test-day SCC 
(measured between 10 and 35 DIM) > 150,000 cells/mL, De Vliegher et al., 2012]. All lactating 
cows and heifers were housed in free-stalls with cubicles and in all herds sawdust was used 
as bedding material.  
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Before the actual trial was started, herds were first monitored by sampling the first eight heifers 
per herd that calved (80 heifers in total) in order to construct a number of binomial herd-level 
predictor variables (Table 2 – see further). Milk samples were taken between 0 and 3 DIM for 
SCC measurement (composite milk) and bacteriological culture (quarter milk) as mentioned 
below. Monitoring of a herd ended after the 8th heifer had calved. Thereafter, the actual clinical 
trial started for this herd, comprising approximately an additional 16 heifers of which half were 
treated prior to calving and halve served as untreated controls.  Heifers were alternately 
assigned by the author based on their expected calving date; every other heifer that was 
expected to calve was treated with penethamate. No placebo was used in the untreated 
control group. In total, 160 heifers, belonging to 10 herds (16 per herd), were aimed  to be 
included in the actual treatment trial based on a sample size calculated using an expected 
difference in the proportion of infected animals in early lactation of 20% between the untreated 
and treated group (level of confidence 95%, power 80%; Winepiscope 2.0).  
Treatment Regime 
As mentioned, approximately eight end-term heifers per herd were treated systemically 
approximately 14 days (median 13.8d; interquartile range 10d to 16d) prior to the expected 
calving date, whereas another eight heifers per herd served as untreated controls. Heifers 
were only included if they were clinically healthy at the time of potential treatment, had not 
received any antimicrobial treatment in the last 4w prior to treatment and were excluded from 
the study if they calved within three days after treatment. Treatment consisted of daily IM 
injections of penethamate hydriodide (Mamyzin®/Stop M®, Boehringer Ingelheim GmbH, 
Ingelheim, Germany) for three consecutive days at a dose of 10 g/animal on the first day, 
followed by 5 g/animal on the second and third day (1µg of penethamate hydriodide provides 
1 IU of penicillin G), in accordance with the approved commercial product label for France. 
Mamyzin® is registered in Belgium for treatment of clinical and subclinical mastitis in lactating 
cows, meaning that treatment of end-term heifers with Mamyzin® constitutes extra-label use. 
Extra-label use is allowed in Belgium under specific conditions and with implications for the 
withholding time of both meat and milk. All treatments were administered by the farmer.  
Data and Sampling 
All heifers were sampled by the first author once between 0 to 3 DIM (further referred as early 
lactation) for bacteriological culture (5 mL; duplicate quarter milk samples) and determination 
of milk SCC (30 mL; composite sample: samples of different quarters were combined using 
equal volumes), and were checked for signs of CM at that time. All milk samples were collected 
after disinfection of the teats and after the first streams of milk were discarded. Milk samples 
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were immediately stored at 4°C and then transported under cooled conditions to the laboratory 
(Milk Control Centre Flanders, Lier, Belgium). 
Data on the occurrence of CM, culling and the reason for culling during the first 120 DIM were 
recorded by the farmer. Milk recording data (test-day milk production and composite SCC) of 
all heifers were collected with an interval of 4 to 6 weeks until 120 DIM.  
Laboratory Analyses 
Bacteriological Culture. Bacteriological culture was done as described previously (Piepers 
et al., 2007). Briefly, 0.01mL of milk was plated on a blood-esculin agar (Oxoid, 
Erembodegem, Belgium; 1 plate per cow) and on MacConkey’s agar (Oxoid; 1 plate per cow). 
All plates were incubated aerobically for 36 ± 12 h at 37 ± 1°C. A quarter was considered 
culture-positive when growth of ≥ 1 colony was detected. Samples yielding 3 or more different 
bacterial species were considered to be contaminated. Bacteria were identified by colony 
morphology and Gram-staining. For Gram-positive cocci, catalase tests were used to 
differentiate between catalase-positive staphylococci and catalase-negative cocci. Colony 
morphology, hemolysis patterns, and DNase testing were used to distinguish Staph. aureus 
from CNS. Streptococci were subdivided into esculin-positive streptococci (Streptococcus 
uberis) and esculin-negative streptococci (Streptococcus agalactiae and Streptococcus 
dysgalactiae). Differentiation between Streptococcus uberis and other streptococci was done 
using bile aesculine agar and NaCl 6.5%. The Christie, Atkins, Munch-Petersen (CAMP) test 
was used to differentiate Strep. agalactiae from Strep. dysgalactiae. Coliforms including 
Escherichia coli, Klebsiella spp., and Enterobacter spp. were differentiated from each other 
and from other Gram-negative bacteria based on the appearance on MacConkey’s agar, KOH-
testing, Triple Sugar Iron reactions, indol production and motility. Staphylococcus aureus, 
esculin-positive streptococci, Strep. agalactiae, Strep. dysgalactiae and coliforms were 
considered as major pathogens. Coagulase-negative staphylococci and Corynebacterium 
bovis were considered as minor pathogens. 
Penicillin Resistance. All Staphylococci were tested by the Etest method (AB BIODISK, 
Solna, Sweden), a stable-gradient agar diffusion technique that produces quantitative MIC 
results over a 15 log2 dilution range (Brown and Brown, 1991). Isolates were defined as 
“susceptible” to penicillin G when the MIC was ≤ 0.125 mg/L and as “resistant” to penicillin G 
when the MIC was > 0.125 mg/L, respectively (EUCAST, 2011). 
Somatic Cell Count. Milk SCC was quantified by electronic counting using a Fossomatic 5000 
(Foss Electric, Hillerød, Denmark) at the Milk Control Centre Flanders (Lier, Belgium). 
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Antimicrobial Residues. Before delivering milk (2-4 DIM), farmers tested all treated heifers 
as required by the Dairy Quality Assurance scheme with a Delvo-test (Angelidis et al., 1999). 
No residues were detected in any of the samples. 
Definition of Subclinical and Clinical Mastitis 
A quarter was considered subclinically infected in early lactation (0 - 3 DIM) when, in the 
absence of clinical symptoms, the same udder pathogen was isolated from both duplicate milk 
samples (Borm et al., 2006). A quarter was considered as non-infected when no pathogens 
were isolated from both duplicate milk samples. When only in one sample from both duplicate 
milk samples an udder pathogen was isolated or when one or both milk samples were 
contaminated the data were considered missing. 
Clinical mastitis was recorded by the first author and/or the farmer and was defined as the 
presence of visual signs such as clots in the milk, with or without redness, swelling of the 
udder quarter, or systemic signs. The interval between cases of CM in the same quarter had 
to be ≥ 14d to be included in the analysis as a new CM case (Barkema et al., 1998). All CM 
were treated by the farmer according to the farms’ treatment protocol. 
Herd-Level Predictor Variables  
As aforementioned, a number of binomial herd-level predictor variables were constructed 
using the data gathered from the monitoring heifers (n = 80) prior to the start of the actual 
clinical trial (Table 2). These variables were used to screen for potential herd-dependent 
treatment effects. The distribution of these herd-level predictor variables over the different 
herds is visualized in Table 3. Hygiene scores ranging from 1 (clean) to 5 (dirty) were assigned 
for four body areas: tail head, thigh, udder, and hind limbs (Hughes, 2001). Heifers with an 
average cleanliness score ≤ 2.0 (median value of all herd averages) were considered as 
“clean” and heifers with a cleanliness score > 2.0 were considered as “unclean”. 
Statistical Analyses 
Prior to statistical analysis, observations were explored and checked for unlikely values. No 
data were excluded for this reason. Milk SCC was transformed to the natural logarithmic scale 
(LnSCC) to normalize the data. Significance level was set at P < 0.05. 
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  In general, 8 different outcome variables were used. Outcomes in early lactation (0-3 DIM) 
were: likelihood of IMI due to any pathogen, due to major pathogens only or due to CNS only, 
and prevalence of CM. Outcomes in late lactation (4-120 DIM) were: LnSCC at test-day, MY 
at test-day, incidence of CM and culling. For 5 of the 8 different outcome variables (likelihood 
of IMI in early lactation due to any pathogen, major pathogens only, or CNS only; LnSCC and 
MY at test-day) separate models were fitted using a common approach including the following 
predictor variables: treatment (yes versus no), one of the 8 binomial herd-level predictor 
variables (Table 2), and the interaction between treatment and the included herd-level 
predictor variable. Each of the 8 binomial herd-level predictor variables (Table 2) was added 
to each model, then again removed and replaced by the next one which eventually resulted in 
8 separate models per outcome variable. The models were reduced if the interaction term was 
not significant (P > 0.05). The association between treatment (yes versus no) and the 
likelihood of IMI at the quarter level with either any pathogen, major pathogens only or CNS 
only in early lactation as the different outcome variables was analyzed by means of logistic 
mixed regression models using 1st order marginal quasi-likelihood algorithms (MLwiN 2.16 - 
Centre for Multilevel Modeling, Bristol, UK). In each model, heifer and herd were included as 
random effects to correct for clustering of quarters within heifers and heifers within herds. The 
association between treatment (yes versus no) and MY and SCC at test-day during the first 
120 DIM, respectively, were analyzed using mixed models (SAS version 9.1.3 - SAS Institute 
Inc., Cary, NC, USA) with test-day MY (kg) and LnSCC as outcome variables. Herd and heifer 
were included as random effects to correct for clustering of heifers within herds and repeated 
measurements within heifers. An autoregressive (1) covariance structure was included to 
model the repeated measurements within heifers. Because of the repeated measurements, 
DIM (continuous) at test-day and the quadratic effect of DIM were included in the models 
besides the aforementioned predictor variables.   
The association between treatment (yes versus no) and prevalence of CM in early lactation (0 
- 3 DIM), incidence of CM in later lactation (4 - 120 DIM), and culling in later lactation, 
respectively, were examined using contingency tables and χ2 analysis. Correction for 
clustering of heifers within herds was not feasible because of limited number of events. For 
the same reason, herd predictors and their interaction with treatment were not tested.  
To compare antimicrobial susceptibility of staphylococcal isolates cultured from milk collected 
in early lactation (subclinical samples) from treated and control heifers, survival curves of both 
groups was plotted using a Kaplan-Meier survival analysis (SPSS version 19.0., SPSS Inc., 
Chicago, IL), with the MIC values defined as the time-to-event (Sampimon et al., 2011). When 
isolates were killed below the lowest test concentration or were still growing at the highest test  
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concentration, observations were coded as left of right censored, respectively. The Logrank 
test was used to test for significant differences in survival between the two groups of isolates 
(P < 0.05).  
Results 
Descriptive Results 
In total, 149 heifers (596 quarters) of which 76 treated heifers (304 quarters) and 73 control 
heifers (292 quarters) were included in the clinical trial. The target of 80 heifers in each group 
was not met since herd sizes were sometimes not sufficient to reach the required number of 
heifers within the specified time frame. 
Overall, in early lactation 347 quarters were non-infected, 34 had an IMI with a major 
pathogen, and 94 with CNS (Table 4). Samples from 37 quarters were contaminated and for 
84 quarters assignment of an IMI status was impossible (all data encoded as missing values). 
In total, 128 quarters had an IMI with a major pathogen or with CNS (Table 4). In addition, six 
heifers suffered from a CM at calving (4%). All (n = 12) of the Staphylococcus aureus isolates 
and 73% (n = 143) of the CNS isolates originating from milk samples taken in early lactation 
during the treatment trial were susceptible to penicillin. 
The overall average SCC at first test-day was 290,221 cells/mL (SD = 725,521) and 
decreased to 122,000 cells/mL (SD = 338,819) at the fourth test-day. Average milk production 
started at 27.0 kg/day (SD = 5.9) at first test-day, then rose to 30.2 kg/day (SD = 5.6), to finally 
end at 27.7 kg (SD = 5.3) at the fourth test-day. Thirteen heifers developed a case of CM 
during their first 120 DIM, whereas seven heifers were culled during that period of which one 
because of mastitis issues.  
 
Treatment Effects  
In all herds, quarters from penethamate-treated heifers were significantly less likely to 
have an IMI in early lactation with any pathogen (P = 0.023). A trend towards fewer IMI with 
CNS was also noticed (P = 0.053) (Table 4). The likelihood of IMI with major pathogens did 
not differ between treated and non-treated heifers (P = 0.17). None of the herd-level predictors 
or interactions with treatment was significant, indicating the treatment effects were not 
modified by any of the studied herd-level predictor variables. 
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All 6 cases of CM in early lactation occurred in the treatment group. Strep. uberis (n = 1), 
Corynebacterium bovis (n = 1), S. aureus (n = 1) were isolated;  one sample was contaminated 
and two samples remained culture negative.  
Seventy one percent (n = 60) and 74% (n = 83) of all Staphylococcus isolates recovered 
from milk samples from the control and treated heifers in early lactation, respectively, were 
susceptible to penicillin (P > 0.05) (Figure 3). 
 
 
Figure 3. Kaplan-Meier graph of the proportion of Staphylococcal spp. isolates surviving with increasing 
concentrations of penicillin, cultured from samples taken at calving from control (---) and treated (___) 
heifers (P = 0.81). 
 
Treatment did not influence LnSCC at test-day during the first 120 DIM (P = 0.85) (Figure 
1, Table 5). None of the herd-level predictor variables or interaction terms was significant and 
therefore omitted from the final models. 
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Figure 1. Average LnSCC in heifers systemically treated prepartum with penethamate hydriodide and 
control heifers during 120 DIM (P = 0.85). 
 
Treatment did not influence test-day MY during the first 120 DIM (P = 0.87, Table 5). None 
of the herd-level predictor variables was significant, although one interaction term was (MY 
heifers x Treatment; P = 0.02). Penethamate-treated heifers from herds classified as having 
low yielding heifers out-produced untreated animals (+2.2 kg milk/day, P = 0.07) whereas in 
herds classified as having high yielding heifers, milk production was 1.5 kg milk per day lower 
in treated heifers compared with the controls (P = 0.14) (Figure 2). Also, treatment tended to 
be associated with a higher test-day MY in farms with a high average herd SCC than on farms 
with a low average herd SCC (Average Herd SCC x Treatment; P = 0.08). 
Five (6.8%) control heifers developed a case of CM between 4 to 120 DIM, whereas 8 
(10.5%) treated heifers suffered from a case of CM (uncorrected χ²= 0.21; P = 0.63) (Table 
5).  
In the control group, only one heifer was culled (because of mastitis), whereas in the 
treatment group, 6 heifers were culled, but none of them because of mastitis issues: three 
heifers were culled because of trauma, two were culled because of non-functional quarters 
and one because of claw disorders (Table 5).  
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Discussion 
Prevalence of IMI with any pathogen was 25.3% at the quarter level in the control group, 
which was within the range of 12 to over 57% stated by De Vliegher et al. (2012) reviewing a 
number of different studies. The majority of IMI were with CNS, substantiating the finding of 
most other studies, whereas IMI with major pathogens were in the minority. The sole fact that 
CNS infections are abundantly present in milk samples from heifers at calving should not be 
interpreted as if a heifer mastitis problem exists as their impact on future performances is 
limited or even absent (Compton et al., 2007; Piepers et al., 2010; Piepers et al., 2013).  
From a practical standpoint, the administration of antimicrobials to end-term heifers by 
systemic route is to be preferred over intramammary infusion (Nickerson, 2009). However, it 
has been questioned whether subcutaneous or intramuscular injection of drugs can actually 
cure IMI in bred heifers as insufficient concentrations of the antimicrobial might reach the 
mammary gland (Nickerson, 2009). This is most probably the first field trial that demonstrates 
the mammary gland has been reached by penethamate hydriodide as the systemic prepartum 
treatment was associated with significantly less IMI with both CNS and any pathogen in early 
lactation. This substantiates our previous work showing that substantially higher levels of 
penicillin G than the MIC90 of pathogens associated with heifer mastitis were reached in udder 
tissue and mammary secretions from heifers systemically treated with penethamate 
hydriodide prior to calving (Passchyn et al., 2010). Still, our findings were in contrast with those 
reported by Parker et al. (2008) who found that systemic treatment of end-term heifers with 
tylosin 27 days prior to calving, did not reduce the prevalence of IMI postcalving. All other 
studies on prepartum use of antimicrobials in the prevention of heifer mastitis that showed a 
significant decrease in IMI after treatment were performed using either short acting (Oliver et 
al., 1992; Oliver et al., 2004; Middleton et al., 2005; Borm et al., 2006; Roy et al., 2007) or long 
acting intramammary preparations (Trinidad et al., 1990b; Owens et al.,1991; Owens et al., 
1994; Sampimon et al., 2009).  
Surprisingly, all 6 cases of CM in early lactation occurred in the treatment group. Several 
of those CM might have been caused by gram-negative bacteria. In those cases, no effect of 
a penethamate treatment would have been anticipated. Iatrogenic infections by treatment as 
observed by Deluyker et al. (2005) could be excluded as no local treatment was applied in this 
study. Because not all CM cases are a function of pre-partum IMI and no antimicrobial 
residues were detected in the milk which means that penethamate hydriodide was not active 
at therapeutic levels in the mammary gland at calving, the higher incidence of CM in the 
treatment group could also be the result of chance. However, one could speculate that 
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treatment with penethamate has disturbed the micro-flora in the udder (Oikonomou et al., 
2012), making the quarters of treated animals more susceptible to environmental bacteria 
although this needs further study. 
From an economical point of view, positive long-term treatment effects are needed to 
support prepartum treatment of end-term heifers. Apart from one specific effect, no overall 
positive long-term effects (4 to 120 DIM) were detected during our trial. The latter observation 
is in contrast to the results reported by several other research groups (Trinidad et al.,1990b; 
Owens et al.,1991; Owens et al., 1994; Oliver et al.,2003; Sampimon et al. 2009) applying 
long acting intramammary preparations, but agrees with the findings of Borm et al. (2006) 
using a short acting intramammary preparation. As intramammary treatment with short acting 
preparations and systemic injection(s) have only a short period of curative or preventative 
action, those findings are probably not that surprising; long acting intramammary preparations, 
on the other hand, are expected to result in high drug concentration in the mammary tissue 
during several weeks.  
Also, the herds included in the studies that reported a positive effect of prepartum 
treatment on MY had a high prevalence of major pathogen IMI and had a history of heifer 
mastitis problems (Kreiger et al., 2007; Bryan and Taylor, 2009; Sampimon et al., 2009). Some 
trials were conducted on research farms (Oliver et al., 1992; Owens et al., 1994; Oliver et al., 
2004) or on farms having (suggested) heifer mastitis problems (Kreiger et al., 2007; Bryan and 
Taylor, 2009; Sampimon et al., 2009). The fact that none of the herds included in our study 
actually suffered from a heifer mastitis issue most probably explains why no overall beneficial 
long-term treatment effects (4 to 120 DIM) were detected. Our findings also reinforce that the 
sole fact of a high proportion of heifers/quarters infected with CNS in early lactation should not 
be a worry. In that respect, analysis of the data from the non-treated heifers only in recent 
study substantiated (Piepers et al., accepted) a previously described positive association 
between CNS IMI and milk yield (Piepers et al., 2010).  
Given the conclusions of previous studies (Borm et al.,2006; Bryan and Taylor, 2009), our 
trial was specifically designed in anticipation of potential herd-specific treatment effects by 
including a monitoring period in the study prior to the onset of the actual treatment trial. This 
novel approach allowed us to detect that treated heifers belonging to herds classified as 
having low yielding heifers out-produced the control heifers. We hypothesized that the positive 
effect of prepartum treatment of heifers 2 weeks before calving could depend on the 
management. It is indeed well established that treatment of subclinical mastitis is more 
effective in well-managed than in poorly-managed herds where cured cows or heifers are more 
likely to become re-infected (Barlow et al., 2009). Assuming that the milk production of heifers 
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in our study reflects management, the latter hypothesis could not be substantiated and our 
data even suggest the opposite; all the more so since treatment tended to be more beneficial 
on high SCC herds than on low SCC herds. Still, none of the other herd-level predictors 
specifically reflecting the farmers’ style of heifer-management such as SCC of fresh heifers 
and hygiene of the heifers modified the treatment effect in a similar way, leaving the exact 
explanation of the finding unknown. Based on the herd predictor that encoded for the presence 
of major pathogens, the hypothesis put forward by Barlow et al. (2009) could not be 
substantiated either. Still, caution should be taken when jumping to conclusions as the 
prevalence of IMI with major pathogens was small in our study. Although the herd-level 
predictors were selected based on their biological relevance and practical feasibility, studying 
8 of them when only including 10 herds might have resulted in finding a significant association 
by coincidence. 
Given the concerns that antimicrobial overuse in food animal production has the potential 
to increase antimicrobial resistance in human pathogens, alternative strategies to the 
widespread antimicrobial use are needed (FAO/WHO/OIE, 2007; Silbergeld et al., 2008). In 
that respect, prepartum treatment of end-term heifers, at a time heifers are not producing milk, 
would only be defensible if this would prevent additional treatments during lactation, at a time 
milk is being produced as a marketable product and when this would reduce animal welfare 
issues caused by CM. Also, treatment of end-term heifers consists of extra-label use in many 
countries which obviously has implications for the withholding time of both meat and milk. One 
could hypothesize that selection towards resistant commensals (such as CNS) is more likely 
to occur when systemic treatment is being used. In our study, treatment did not increase the 
likelihood of penicillin resistance in staphylococci (of which a majority was CNS) isolated in 
milk samples at calving. However, selection and spread of resistance takes time, making it 
difficult to conclude on this issue. Anyway, without over interpreting the data and in the light of 
antimicrobial resistance, the use of short-acting antimicrobials (intramammary and parenteral 
use) with a narrow spectrum should be preferred in those herds that suffer from a true heifer 
mastitis problem and that are hence likely to profit from treatment.  
Conclusions 
Systemic therapy of end-term heifers with penethamate hydriodide 2 weeks before calving 
resulted in less IMI at the quarter level in early lactation on the one hand but in more cases of 
CM in the first days after calving (0-3 DIM) on the other hand. Overall long-term effects (4 to 
120 DIM) of penethamate treatment on milk production, udder health or culling hazard during 
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later lactation were not detected. Still, using the data from the monitoring period, it was shown 
that penethamate-treated heifers from herds classified as having low yielding heifers out-
produced control heifers. Treatment of end-term heifers was not associated with the 
development of penicillin resistance in staphylococci isolated from milk samples on the short-
term. Prepartum systemic antimicrobial treatment cannot be warranted in herds with low 
prevalence of heifer mastitis. A similar study conducted on commercial farms with a high 
prevalence of heifer mastitis is required to elaborate further the outcomes of this trial. 
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Abstract 
Heifer mastitis is a well-known problem with a number of pathogens being involved. A 
number of generic risk factors associated with the likelihood of IMI in fresh dairy heifers have 
been identified before. Yet there is a need to identify pathogen group specific factors as the 
impact of (groups of) pathogens on udder health and milk yield is different.  The aim of the 
present study was to identify pathogen group specific risk factors for IMI in heifers participating 
in a prepartum antimicrobial treatment trial, allowing us to test the hypothesis that different 
factors are of importance between treated and untreated control heifers as well. Data from a 
clinical trial in which end-term heifers were treated systemically (over 3 consecutive days) 2 
wk before calving with penethamate hydriodide (n = 76) or remained untreated (n = 73), were 
available. A number of potential risk factors at the herd, heifer and quarter level were recorded 
in the first 3 DIM.  
Quarters from untreated heifers supplemented with ≥ 4 mg selenium/day prepartum were 
significantly less likely to be infected with CNS whereas quarters were more likely to be 
infected with CNS when assistance during calving was needed. Udder edema prior to calving 
significantly decreased the odds of IMI with major pathogens. In treated heifers, no factors 
were detected that were associated with the likelihood of CNS IMI, whereas quarters from 
heifers were significantly more likely to be infected with major pathogens when they were 
housed in the calving pen >1 day, and when they had been in contact with the lactating cows 
prior to calving.  
The risk factors for IMI that were identified in treated heifers were different than those in 
untreated heifers, independently from the pathogen group that was considered. It appears that 
prepartum treatment has not only changed the likelihood of infection but also the factors that 
are associated with infection. However, except for treated heifers with an IMI with major 
pathogens, only a small proportion of the variation could be explained in the final models. 
Therefore, other factors than those that were studied are explaining the likelihood of infection.  
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Introduction 
A high proportion of dairy heifers freshen with IMI causing either clinical or subclinical 
mastitis (De Vliegher et al., 2012). A number of pathogens are involved, with CNS being the 
most prevalent in most studies (Fox, 2009). Intramammary infections caused by major 
pathogens in early lactating heifers are associated with elevated SCC in early lactation and 
result in milk production losses, udder health problems, and premature removal during the 
entire first lactation (De Vliegher et al., 2004, 2005a, 2005b; Piepers et al., 2009, 2010), 
stressing the need for effective control measures. On the contrary, CNS IMI in early lactating 
heifers have a less pronounced impact on the heifers’ future performances, making the need 
for prevention of IMI with CNS at least in early lactating heifers not a priority, or even unwanted 
as heifers with CNS IMI at calving produce more and have a lower incidence of CM during 
their first lactation compared with non-infected heifers (Pearson et al., 2013; Piepers et al., 
2010, 2013). 
A number of factors increasing the odds of IMI in fresh dairy heifers have been identified 
(e.g. McDougall et al., 2009). A 10-point program specifically focusing on the prevention and 
control of heifer mastitis was proposed (De Vliegher et al., 2012), but did not discriminate 
between mastitis pathogen types. Still, studying pathogen group specific risk factors for IMI in 
early lactating heifers allows for the development of pathogen specific prevention and control 
programs.  
Farmers are often more eager to treat animals, even when this includes off-label use of 
antimicrobials, than to improve their herd management (McDougall et al., 2009). However, in 
the light of prudent drug use, and even though prepartum treatment of heifers with 
antimicrobials is probably the easiest way to reduce the prevalence of IMI at calving on the 
short term (Nickerson, 2009), preventing herd health problems such as heifer mastitis via non-
antibiotic strategies is preferable over adopting blanket treatment protocols to reduce the risk 
of antibiotic residues in foodstuff (e.g. milk) and the development of antimicrobial resistance 
in pathogens and commensals. This needs to be stressed since the long-term effects of 
prepartum antimicrobial treatment on farms suffering from heifer mastitis still remain uncertain 
(Borm et al., 2006; Sampimon et al., 2009; Passchyn et al., 2013). Logic suggests that 
temporary use of antimicrobials in control of a severe heifer mastitis problem can only be 
applied under strict conditions and when the etiology has been identified through culturing of 
milk samples, and should go along with the implementation of pathogen group specific 
preventive measures at the same time in order to further reduce the risk for new IMI (De 
Vliegher et al., 2012). Still, even when antimicrobial treatment is applied in the weeks before 
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calving, not all IMI will be cured nor prevented and it is currently not known which risk factors 
are associated with IMI in fresh heifers treated prior to calving with antimicrobials. We 
hypothesized that risk factors from treated heifers would be different from the ones in 
untreated heifers.  
Materials and Methods 
Herds and Animals 
A clinical trial was conducted between September 2008 and June 2010 and included 229 
heifers from 10 commercial, well-managed dairy herds, located in a radius of 20 km around 
the city of Torhout, province of West Flanders, Belgium. The trial was designed to assess both 
the short and long-term effects of a systemic prepartum therapy with penethamate hydriodide 
on udder health and milk production (Passchyn et al., 2013). 
Information on herd size, BMSCC, heifer mastitis problems, and housing as well as the 
study design have been reported before (Passchyn et al, 2013). In short, before the actual 
trial was conducted, herds were first monitored by sampling the first eight heifers per herd that 
calved (80 heifers in total).  After the 8th heifer had calved, monitoring of a herd ended and 
the actual clinical trial, comprising approximately an additional 16 heifers of which half were 
treated prior to calving and half served as untreated controls, started for this herd (Table 2).  
Heifers were alternately assigned by the first author based on their expected calving date; 
every other heifer that was expected to calve was treated with penethamate.  
 
Table 2. Descriptive statistics of the number of herds, heifers and quarters included in the different 
analyses.  
Dataset Total number Average1 Median Range 
Untreated heifers     
 Herd 10 … … … 
 Heifer 73 7 8 6-8 
 Quarter 292 29 32 24-32 
Treated heifers     
 Herd 10 … … … 
 Heifer 76 8 8 6-8 
 Quarter 304 30 32 24-32 
1Average number of heifers/quarters per herd 
Composite milk samples were taken between 0 and 3 DIM for SCC measurement when 
no visual signs of CM were observed. Also, quarter milk samples were taken between 0 and 
3 DIM for bacteriological culture both from quarters with and without signs of CM.  
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Sample Collection and Laboratory Analyses 
Samples. All heifers were sampled by the first author once between 0 to 3 DIM (further 
referred to as early lactation) for bacteriological culture (5 mL; duplicate quarter milk samples), 
were checked for signs of CM, and sampled for determination of milk SCC if no signs were 
present (30 mL; samples of different quarters were combined into a composite sample using 
equal volumes). All milk samples were collected after disinfection of the teats and after the 
first streams of milk were discarded. Milk samples were immediately stored at 4°C and then 
transported under cooled conditions to the laboratory (Milk Control Centre Flanders, Lier, 
Belgium). 
Bacteriological Culture. Bacteriological culture was done as previously described 
(Piepers et al., 2007). Briefly, 0.01mL of milk was plated on a blood-esculin agar (Oxoid, 
Erembodegem, Belgium; 1 plate per cow) and on MacConkey’s agar (Oxoid; 1 plate per cow). 
All plates were incubated aerobically for 36 ± 12 h at 37 ± 1°C. A quarter was considered 
culture-positive when growth of ≥ 1 colony was detected. Samples yielding 3 or more different 
bacterial species were considered to be contaminated. Bacteria were identified by colony 
morphology and Gram-staining. For Gram-positive cocci, catalase tests were used to 
differentiate between catalase-positive staphylococci and catalase-negative cocci. Colony 
morphology, hemolysis patterns, and DNase testing were used to distinguish Staph. aureus 
from CNS. Streptococci were subdivided into esculin-positive streptococci (Streptococcus 
uberis) and esculin-negative streptococci (Streptococcus agalactiae and Streptococcus 
dysgalactiae). Differentiation between Streptococcus uberis and other streptococci was done 
using bile aesculine agar and NaCl 6.5%. The Christie, Atkins, Munch-Petersen (CAMP) test 
was used to differentiate Strep. agalactiae from Strep. dysgalactiae. Coliforms including 
Escherichia coli, Klebsiella spp., and Enterobacter spp. were differentiated from each other 
and from other Gram-negative bacteria based on the appearance on MacConkey’s agar, KOH-
testing, Triple Sugar Iron reactions, indol production and motility. Staphylococcus aureus, 
esculin-positive streptococci, Strep. agalactiae, Strep. dysgalactiae and coliforms were 
considered as major pathogens. Coagulase-negative staphylococci and Corynebacterium 
bovis were considered as minor pathogens. 
Penicillin Resistance. All staphylococci were tested by the E-test method (AB BIODISK, 
Solna, Sweden), a stable-gradient agar diffusion technique that produces quantitative MIC 
results over a 15 log2 dilution range (Brown and Brown, 1991). Isolates were defined as 
“susceptible” to penicillin G when the MIC was ≤ 0.125 mg/L and as “resistant” to penicillin G 
when the MIC was > 0.125 mg/L, respectively (EUCAST, 2011). 
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Somatic Cell Count. Milk SCC was quantified by electronic counting using a Fossomatic 
5000 (Foss Electric, Hillerød, Denmark) at the Milk Control Centre Flanders (Lier, Belgium). 
 
Data Collection 
Herd-level Risk Factors. Binomial herd-level variables were constructed per herd using 
the data gathered from the monitoring heifers (n = 80) prior to the start of the actual clinical 
trial and were used as potential herd-level risk factors for IMI (Table 1).  
Heifer-level Risk Factors. A number of potential heifer-level risk factors were recorded at 
the moment of sampling (0-3 DIM) (Table 1). Hygiene scores ranging from 1 (clean) to 5 (dirty) 
were assigned for four body areas: tail head, thigh, udder, and hind limbs (Hughes, 2001). As 
both udder hygiene score and leg hygiene scores are positively associated with IMI in lactating 
cows and as there exists a clear relationship between both hygiene scores (Schreiner and 
Ruegg, 2003), it was decided to combine them, rather than to evaluate them separately. 
Heifers with an average cleanliness score ≤ 2.0 (median value of all heifers) were considered 
as “clean” and heifers with a cleanliness score > 2.0 were considered as “unclean”. Information 
on fly control on pasture and the deworming program for yearling heifers (yes/no) was 
obtained through a face-to-face interview. The applied fly control strategy was considered to 
be effective if heifers had been provided with two Flectron® ear tags (Zoetis, US) just before 
entering pasture or if during pasture season a heifer was treated with a pour-on solution 
registered for fly control in dairy cattle strictly in accordance with the manufacturer’s directions. 
Body condition was scored approximately two wk before calving and at the moment of 
sampling (0-3 DIM) on a 5-point scale divided into quarter point increments (Edmondson et 
al., 1989). Ease of calving was assessed according to the following scale from 1 to 3: 
unassisted = heifer calved without any assistance; easy pull = one person without mechanical 
assistance; hard pull = ≥ 2 persons without mechanical assistance or 1 person with mechanical 
assistance. This variable was recoded for further analyses (0: no assistance/no difficulties; 1: 
assistance required). Udder edema around calving was scored between 0 and 3 DIM: 1 (no 
edema), 2 (slight edema), 3 (moderate edema), 4 (severe edema) or 5 (extremely severe 
edema) (Dentine and McDaniel, 1983). Recoding into a binary variable was applied for further 
analyses (0: no or slight edema; 1: moderate to extremely severe edema).  
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Quarter-level Risk Factors. A number of potential quarter-level risk factors were recorded 
at the moment of sampling (0-3 DIM). The presence/absence of teat end lesions was recorded 
based on a visual scoring system (Neijenhuis et al., 2000) and expressed by the thickness of 
the callosity ring categorized into 5 classes: none (N), slight (A), moderate (B), thick (C), 
extreme (D). Additionally, the ring was classified as smooth (1) or rough (2). 
The scoring system was simplified as proposed by Mein et al. (2001): no ring (N), smooth 
or slightly rough = a raised ring with no roughness or only mild roughness and no keratin 
fronds (1A, 1B, 1C or 2A), rough = a raised roughened ring with isolated fronds of old keratin 
extending 1-3 mm from the orifice (2B or 2C), very rough = a raised ring with rough fronds of 
old keratin extending > 4 mm from the orifice. The rim of the ring is rough and cracked giving 
the teat-end a “flowered” appearance (2D). None of the teats had a rough or very rough teat 
end. Scoring of teat skin condition was performed by means of palpation and visual inspection. 
Teat skin condition was classified as normal (i.e. smooth sheen, soft, healthy skin), dry (i.e. 
scaly, flaky or rough skin but without cracking), damaged (i.e. chapped with cracks) or severely 
damaged (i.e. deep chaps, scabs or open (ulcerative) lesions). The variable was recoded into 
a binary variable for further analyses (0: normal teat skin condition; 1: dry, damaged or 
severely damaged teat skin). None of the teats was severely damaged.  
 
Definition of Intramammary Infection  
A quarter was considered to have an IMI in early lactation (0 - 3 DIM) when the same 
mastitis pathogen was isolated from both duplicate milk samples (Borm et al., 2006). A quarter 
was considered as non-infected when no pathogens were isolated from both duplicate milk 
samples. When only in one sample from both duplicate milk samples a mastitis pathogen was 
isolated or when one or both milk samples were contaminated the data were considered 
missing.  
Clinical mastitis was recorded by the first author and was defined as the presence of visual 
signs such as clots in the milk, with or without redness, swelling of the udder quarter, or 
systemic signs.  
 
Statistical Analyses 
Prior to statistical analysis, observations were explored and checked for unlikely values. 
No data were excluded for this reason. The dataset was divided in two subsets containing the 
data from the treated heifers and the data from the untreated control heifers, respectively. All 
analyses were performed on both subsets of data separately. 
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Logistic mixed regression models using 1st order marginal quasi-likelihood algorithms 
were fit in MLwiN 2.02.03 (Centre for Multilevel Modeling, Bristol, UK). Heifer and herd were 
included as random effects to correct for the clustering of quarters within heifer and heifers 
within herd. Statistical analyses were conducted with quarter as a unit of analysis. 
Univariable associations between the two binary outcome variables (1) IMI with CNS 
versus non-infected at the quarter level (0= non-infected versus 1= infected with CNS), and 
(2) IMI with major pathogens versus non-infected at the quarter level (0= non-infected versus 
1= infected with a major pathogen), respectively, and all independent variables at the herd, 
heifer and quarter level were tested. Statistical significance in this step was assessed at P < 
0.20. Secondly, Pearson and Spearman correlation coefficients were calculated among the 
significant independent variables to check for multicollinearity. If two independent variables 
had a correlation coefficient ≥ 0.6, only the one with the highest statistical significance was 
selected for further analysis. None of the variables had to be omitted because of this reason. 
In the third step, multivariable models were fit with statistical significance in this step set at P 
< 0.05. A variable was considered to act as a confounder if its removal made the regression 
coefficients of the remaining variables undergo a relative change > 25% or in case the 
regression coefficient ranged between -0.4 and 0.4, if an absolute change > 0.1 was observed 
(Noordhuizen et al., 2001). Finally, all first-order interactions among the remaining 
independent variable in the multivariable models were tested and removed when non-
significant (Wald’s tests P > 0.05). The fit of the final models was evaluated by the inspection 
of the quarter level standardized residuals plotted against the normal scores and against the 
quarter level predicted values, and by calculation of the deviance chi-square statistic to the 
remaining degrees of freedom (Dohoo et al., 2009). The Hosmer Lemeshow goodness-of-fit 
measure and the sensitivity and specificity of the model were assessed on the fixed effect 
models only (Dohoo et al., 2009) using SAS 9.3 (PROC LOGISTIC, SAS Institute Inc., NC, 
USA). 
The proportion of variation for IMI with CNS and IMI with major pathogens present at the 
herd, heifer and quarter level for both the null and the final models was estimated by assuming 
that the total variance at the quarter level on the logit scale was π²/3 with π = 3.1416 (Dohoo 
et al., 2001). Using this approach, the total variance was estimated as followed:  
 
 Var (Zijk) = var(µHerd(j)) + var(µHeifer(i)) + var (ԑijk) = σ²Herd+σ²Heifer+π²/3  
 
where π²/3 = variance occurring at the quarter level,  
σ²Heifer = variance occurring at the heifer level,  
and σ²Herd = variance occurring at the herd level.                                                                                                                              
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Table 3a. Significant (P ≤ 0.20) unconditional associations at the herd, heifer and quarter level for IMI 
with coagulase-negative staphylococci (CNS) in untreated and treated heifers based on logistic mixed 
regression models (See Table 1 for details on the different independent variables).  
 IMI with CNS 
 Untreated heifers  Treated heifers 
Independent variables N1 %2  P-value  N %1  P-value 
Herd level          
Average heifer milk SCC    0.200     NS 
 >150,000 cells/mL 84 19.0    … …   
 ≤150,000 cells/mL 130 29.2    … …   
CNS screening herd    NS     0.146 
               ≥18.5% … …    94 23.4   
               <18.5% … …    133 13.5   
Heifer level          
Hygiene score of the heifer    NS     0.080 
               clean … …    182 20.3   
               unclean … …    45 6.7   
Deworming program    NS     0.093 
              yes … …    83 25.3   
              no … …    144 13.2   
Ease of calving    0.005     NS 
               assistance 41 48.8    … …   
               no assistance 173 19.6    … …   
Group prepartum    NS     0.085 
               dry cows … …    129 23.2   
               lactating cows … …    30 3.3   
               end term heifers      68 13.2   
Housing prepartum    0.049     NS 
               stable 163 20.9    … …   
               pasture 51 39.2    … …   
Season of calving    NS     0.064 
               January – March … …    71 14.1   
              April – June … …    25 28.0   
              July – September … …    61 24.9   
              October - December … …    70 11.4   
Supplementation with selenium    0.028     NS 
              ≥ 4mg/day 67 13.4    … …   
             < 4mg/day 147 30.6    … …   
Quarter level          
 … …  …  … …  … 
          
1Total number of quarters, 2Percentage of quarters infected with CNS. 
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Results 
Descriptive Results 
In total, 149 heifers (596 quarters), of which 76 treated heifers (304 quarters) and 73 
untreated heifers (292 quarters), were included in the trial (Passchyn et al., 2013). 
Overall, in early lactation 347 quarters were non-infected, 34 quarters (5.7%) were infected 
with a major pathogen [14 (2.3%) in treated heifers and 20 (3.4%) in untreated heifers, 
respectively] and 94 quarters (15.8%) with CNS [40 (6.7%) in treated heifers and 54 (9.1%) in 
untreated heifers, respectively]. Within the major pathogens, Staphylococcus aureus (n = 6), 
Streptococcus uberis (n = 10), Streptococcus dysgalactiae (n = 3), other Streptococci (n = 11) 
and Escherichia coli (n = 4) were isolated.  Milk samples from 37 quarters were contaminated 
and for 84 quarters assignment of an IMI status was not possible, because in only one sample 
from both duplicate samples a mastitis pathogen could be isolated (data encoded as missing 
values). In addition, six quarters from six heifers in the treatment group showed signs of CM 
in early lactation (4%). Streptococcus uberis (n = 1), Corynebacterium bovis (n = 1), 
Staphylococcus aureus (n = 1) were isolated; one sample was contaminated and two samples 
remained culture negative.   
 
Risk Factors for IMI in Untreated Heifers 
Four and two risk factors, respectively, were unconditionally associated (P ≤ 0.20) with IMI 
with CNS and IMI with major pathogens in untreated heifers (Table 3a and 3b).  
The final models revealed that quarters from untreated heifers that were supplemented 
with selenium prepartum (≥ 4 mg/day) were significantly less likely to be infected with CNS 
whereas when assistance during calving was needed, quarters were significantly more likely 
to be infected with CNS (Table 4). Udder edema prior to calving significantly decreased the 
odds of IMI with major pathogens (Table 4).  
Model sensitivity (ability to predict occurrence of IMI) was 49.2% for the model with IMI with 
CNS and 43.5% for the model with IMI with major pathogens. Model specificity (ability to 
predict non-occurrence of IMI) was 84.1% and 90.9%, respectively. The Hosmer-Lemeshow 
test for the final model with IMI with CNS was not statistically significant (P = 0.25). The 
deviance chi-square statistic per degree of freedom was 1.05 for the model based on IMI with 
CNS and 0.95 for the model based on IMI with major pathogens, indicating a good model fit. 
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Risk Factors for IMI in Treated Heifers 
Five and four risk factors, respectively, were unconditionally associated (P ≤ 0.20) with IMI 
with CNS and IMI with major pathogens in treated heifers (Table 3a and 3b).  
For IMI with CNS, no risk factors were detected (Table 4). In the final model for IMI with 
major pathogens, two risk factors were significant: quarters were significantly more likely to 
be infected with major pathogens if a heifer was housed in the calving pen for more than one 
day, and if a heifer had been in contact with the lactating cows prior to calving (Table 4).  
 
 
Table 3b. Significant (P ≤ 0.20) unconditional associations at the herd, heifer and quarter level for IMI 
with major pathogens in untreated and treated heifers based on logistic mixed regression models (See 
Table 1 for details on the different independent variables). 
 IMI with major pathogens 
 Untreated heifers  Treated heifers 
Independent variables N1 %2  P-value  N %1  P-value 
Herd level          
Average herd milk SCC    NS     0.083 
 <200,000 cells/mL … …    133 9.8   
 ≥200,000 cells/mL … …    68 1.5   
Heifer level          
Calving pen time    NS     0.006 
 ≤ one day … …    120 3.3   
 > one day … …    81 12.3   
Contact with lactating cows 
prior to calving 
   NS     0.105 
 yes … …    44 16.0   
 no … …    155 4.5   
Udder edema prior to calving    0.019     NS 
 yes 91 4.4    … …   
 no 89 18.0    … …   
Fertilization method    0.029     NS 
 artificial insemination 154 7.8    … …   
 bull 26 30.1    … …   
Group prepartum    NS     0.116 
 dry cows … …    102 2.9   
 lactating cows … …    36 19.4   
 end term heifers … …    63 6.3   
Quarter level          
 … …  …  … …  … 
1Total number of quarters, 2Percentage of quarters infected with major pathogens. 
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For the final model with IMI with major pathogens, model sensitivity (ability to predict 
occurrence of IMI) and specificity (ability to predict non-occurrence of IMI) were 64.5 and 
86.8%, respectively. The Hosmer-Lemeshow test was not statistically significant (P = 0.93). 
The deviance chi-square statistic per degree of freedom was 0.99, indicating a good model fit. 
 
Table 5a. Variance components at the herd, heifer and quarter level of the null models and the final 
multivariable models for IMI with coagulase-negative staphylococci (CNS) in untreated heifers and 
treated heifers. 
 Data hierarchy IMI with CNS 
 
 Untreated heifers  Treated heifers 
 
 Var.Est.1 ± SE² %  Var.Est.1 ± SE² % 
Null models      
 Herd 0 0  0 0 
 Heifer 1.036 ± 0.467 23.9  1.486 ± 0.614 31.1 
 Quarter 3.2893 76.1  3.2893 68.9 
 Total Variance 4.387 100.0  4.776 100.0 
Final multivariable models      
 Herd 0 0  0 0 
 Heifer 0.722 ± 0.437 18.0  1.486 ± 0.614 31.1 
 Quarter 3.2893 82.0  3.2893 68.9 
 Total Variance 4.308 100.0  4.776 100.0 
1Variance estimate, 2Standard error, 3π²/3 = variance occurring at the quarter level (Dohoo et al., 2001). 
 
Variance Components 
 The variance components for the different models are presented in Table 5a and 5b. 
For the null model of CNS IMI in treated and untreated heifers, 31.1% and 23.9% of the 
variation resided at the heifer level, respectively. For IMI with major pathogens in treated and 
untreated heifers this was 54.3% and 41.9%. No variation resided at the herd level in the 
models with CNS IMI as outcome, whereas some variation resided at this level in the models 
with IMI with major pathogens as outcome variable. 
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Table 5b. Variance components at the herd, heifer and quarter level of the null models and the final 
multivariable models for IMI with major pathogens in untreated heifers and treated heifers. 
 Data hierarchy IMI with major pathogens 
  Untreated heifers  Treated heifers 
  Var.Est.1 ± SE² %  Var.Est.1 ± SE² % 
Null models      
 Herd 0 0  0.245 ± 0.776 3.2 
 Heifer 2.369 ± 1.049 41.9  4.201 ± 1.762 54.3 
 Quarter 3.2893 58.1  3.2893 42.5 
 Total Variance 5.761 100.0  7.736 100.0 
Final multivariable models      
 Herd 0.211 ± 0.545 4.0  1.671 ± 1.216 30.4 
 Heifer 1.719 ± 1.050 33.0  0.537 ± 0.914 9.8 
 Quarter 3.2893 63.0  3.2893 59.8 
 Total Variance 5.216 100.0  5.498 100.0 
1Variance estimate, 2Standard error, 3π²/3 = variance occurring at the quarter level (Dohoo et al., 2001). 
Discussion 
To our knowledge, this is the first study investigating pathogen group specific risk factors 
for IMI in both treated and untreated heifers participating in a prepartum antimicrobial 
treatment trial. Treated and untreated heifers were part of the same management when 
housed at the same farm, allowing us to compare risk factors in play besides determining the 
variance components.   
When looking at the unconditional associations, as well as at the final models, the risk 
factors for IMI that were identified in treated heifers were different than those in untreated 
heifers, independently from the pathogen group that was considered. It looks as if prepartum 
treatment has not only changed the likelihood of infection (Passchyn et al., 2013) but also the 
factors that are associated with infection. This suggests that in herds where prepartum 
treatment is implemented, prevention should focus on other aspects than in herds where no 
such programs are in place, although this needs to be substantiated in future research.  
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As no other studies have reported on risk factors for IMI in heifers that were treated with 
antimicrobials before calving, we limit ourselves to comparing the factors associated with the 
IMI likelihood found in the untreated control heifers with those reported in the scientific 
literature. The fact that moderate to excessive edema prior to calving was negatively 
associated with the likelihood of IMI with major pathogens in untreated control heifers was 
unexpected and was in contrast with previous findings (Slettbakk et al., 1995; Waage et al., 
2001; Compton et al., 2007). Actually, we have also reported before that udder edema prior 
to calving was positively associated with the likelihood of IMI in heifers, with contagious major 
pathogens to be more specific but not with the likelihood of IMI with environmental major 
pathogens (Piepers et al., 2011). Because of the limited number of IMI with major pathogens 
(n = 20) in the current study, stratification into environmental and contagious major pathogens 
was not possible.  
Selenium supplementation (≥ 4mg/day) was negatively associated with the likelihood of 
CNS IMI in control heifers, somewhat contrasting with the findings of a previous study (Piepers 
et al., 2011) in which no association could be found between Se supplementation before 
calving and the likelihood of CNS IMI. Since CNS is a large group consisting of different 
species together with the fact that species seem to behave differently (Supré et al., 2011; 
Piessens et al., 2012) and since the CNS isolates from the current study were not identified to 
the species level, we could not further elaborate this finding. Still, it can be anticipated that 
different species were involved explaining the contradictions between studies. Anyway, it 
underlines the need to study risk factors for CNS species-specific IMI but this needs large 
studies and datasets (e.g. Reyher et al., 2011), also larger than the one that is presented in 
this article.  
Observational studies have suggested that dystocia is associated with a higher risk of CM 
in heifers within a month of calving compared with eutocia (Oltenacu and Ekesbo, 1994; 
Barnouin and Chassagne, 2001; Svensson et al., 2006). Our study confirms these findings as 
quarters belonging to heifers undergoing dystocia were more likely to have CNS IMI than 
quarters from heifers where no assistance was required during calving. Still, the majority of 
cases of IMI in our study were not associated with clinical signs, as expected because CNS 
are not likely to cause CM (Supré et al., 2011; Hertl et al., 2014), which is a substantial 
difference. Svensson et al. (2006) hypothesized that the association between reproductive 
disorders and CM could be due to a common factor affecting both disease complexes. Based 
on the conclusions of Proudfoot et al. (2009) showing that cows with dystocia had reduced 
DMI and water intake 24h before calving, a more pronounced negative energy balance in 
heifers that needed assistance followed by decreased weakened immunity, could possibly 
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explain this finding. Still, it does not explain why this factor was not associated with IMI with 
major pathogens.  
Quarters from treated heifers staying in the calving pen for more than one day were more 
likely to be infected with major pathogens. As almost 50% of the farms in Flanders use their 
calving pen for both sick and periparturient cows (De Vliegher et al., 2004), we hypothesize a 
prolonged stay in a more infectious environment explains this finding. In our study as well, 8 
out of 10 farmers used their calving pen for both sick and periparturient cows. 
Except in the model for IMI with major pathogens in treated heifers, all variation in the 
likelihood of IMI with both CNS and major pathogens occurred at the heifer and quarter level 
and none at the herd level. This coincides with our previous findings studying early lactation 
SCC in heifers (De Vliegher et al., 2004). Approximately 97% of the variance in that outcome 
variable occurred at the heifer level, with very small variance estimates at the herd level. At 
that time we suggested that focusing on heifers rather than on the herds seems to be 
necessary when dealing with heifer mastitis on the short term, and this seems to be the case 
also when studying IMI. However, as the variation residing at the herd level for IMI with major 
pathogens was higher in the treated heifers compared to the untreated, we speculate that 
some herds benefit more from treatment than others. It is indeed well established that 
treatment of mastitis is more effective in well-managed than in poorly-managed herds where 
cured cows or heifers are more likely to become re-infected (Barlow et al., 2009).  
The heifer-level variation for both IMI with CNS and IMI with major pathogens was more 
pronounced in treated heifers than in untreated heifers. Although we are considering two 
different datasets making comparison difficult or even unwanted, we hypothesize that some 
heifers benefit more from treatment than others, especially heifers with an IMI with major 
pathogens. This hypothesis is supported by two other studies in which both the average cure 
rate (Borm et al., 2006) and the number of infected quarters (Sampimon et al., 2009 and 
Passchyn et al., 2013) of prepartum treated heifers differed between both herds and heifers 
within herds. Still, the lack of data on cure rates in our study makes it difficult to further 
substantiate this hypothesis.  
The fact that most of the variation in IMI with CNS resided at the quarter level and in IMI 
with major pathogens at the heifer level, can probably be explained by the fact that quarters 
are more likely to be infected with CNS than with a major pathogen. In this study 15.8 % of 
the quarters were infected with CNS and 5.7% with a major pathogen, prevalences that are in 
line with those from literature (Fox, 2009; De Vliegher et al., 2012). The fact that when cows 
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have an IMI with CNS, often more than one quarter per cow is infected with CNS has been 
described before (Piepers et al., 2007).  
Except for treated heifers with an IMI with major pathogens, only a small proportion of the 
variation in the outcome variables was explained in the final multivariable models. This 
indicates that different factors than those we have studied are explaining the likelihood of 
infection (e.g. anatomy of the teat, genetic background of heifer, young stock management). 
The same finding (De Vliegher et al., 2004) actually urged us to study the genetic background 
of heifer mastitis and by focusing on the CXCR1 gene, we recently described a susceptibility 
in heifers that was different for CNS compared with major pathogens (Verbeke et al., 2012). 
In treated heifers, avoiding contact with lactating cows prior to calving and keeping the fresh 
heifers in the calving pen only for a short period of time (< 1 day) seems to be important 
measures to reduce the (re)infection risk. In general and at the same time, additional unstudied 
risk factors on the herd level must be further explored (e.g. barn design, feeding, etc.).  
Conclusions 
Quarters from untreated heifers supplemented with ≥ 4 mg selenium/day prepartum were 
significantly less likely to be infected with CNS whereas quarters were more likely to be 
infected with CNS when assistance during calving was needed. Udder edema prior to calving 
was negatively associated with the likelihood of IMI with major pathogens. In treated heifers 
no factors were detected that were associated with the likelihood of CNS IMI, whereas 
quarters from heifers were significantly more likely to be infected with major pathogens when 
it was housed in the calving pen >1 day, and when it had been in contact with the lactating 
cows prior to calving. Strikingly, all identified risk factors for IMI in treated heifers, also in the 
univariable analyses, were different than those in untreated heifers, indicating that prepartum 
systemic antimicrobial treatment not only change the likelihood of infection but also the factors 
that are associated with infection. Factors other than those we have studied are explaining the 
likelihood of infection as only a small proportion of the variation was explained in the final 
models, except for the one describing the likelihood of major pathogen IMI in treated heifers. 
More and different risk factors at the quarter (e.g. anatomy of the teat), heifer (e.g. genetics, 
immunity), and at the herd level (e.g. barn design, nutrition) should be included in future 
research. 
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Introduction 
The general aim of this thesis was to study (new) challenges related to udder health and 
milk quality (e.g. prudent use of antimicrobials, milk quality and safety, animal welfare, 
emerging pathogens, volatile milk prices, pressure to grow) that dairy farmers and their 
veterinarians are currently facing or will be facing in the (near) future. We believe the results 
from this thesis indeed give better insights in which bottlenecks need to be first unblocked and 
might, in turn, offer opportunities for both the farmer and his veterinarian by implementing fixes 
for them through veterinary herd health management (VHHM) programs (Figure 5) . We came 
to a number of conclusions of which the most important are: 
 Only one-third of the Flemish dairy herds were actually able to combine a low 
BMSCC with a low estimated incidence of clinical mastitis (EICM) in 2009; part of 
the variation in the occurence of CM and in the BMSCC was explained by 
differences in (udder health) management practices (Chapter 3.1).  
 Mycoplasma bovis is also threatening udder health on Flemish dairy farms as the 
herd-level prevalence of Mycoplasma bovis in bulk milk was estimated to be at least 
1,5% (Chapter 3.2); this is worrying, especially so because an increasing herd size 
is a determining factor.  
 The variation in BC and CC in unpasteurized bulk milk in Flemish dairy herds is 
related to different factors than the ones related to milking, herd health and dry cow 
management (Chapter 4.1).  
 Only 52.9% of the dairy herds achieved their MQP in all 12 months in 2009; the 
main reason for not achieving the MQP was an elevated CC (Chapter 4.2).  
 Systemic use of penethamate hydriodide in heifers prior to calving results in levels 
of penicillin G in mammary tissue and secretion substantially higher than the MIC90 
of pathogens associated with heifer mastitis (Chapter 5.1).  
 When looking at short- and long-term effects, herds with a low prevalence of heifer 
mastitis are not likely to benefit from prepartum systemic antimicrobial treatment of 
end-term heifers (Chapter 5.2).  
 Finally, pathogen group-specific risk factors for intramammary infection in heifers 
participating in a prepartum antimicrobial treatment trial were different between 
treated heifers and untreated control heifers (Chapter 5.3), suggesting that 
prepartum treatment not only changes the likelihood of infection, but also the factors 
that are associated with infection.  
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First, some insights are discussed on how udder health and milk quality on the Flemish 
dairy herds can be further improved in order to better respond to the public concerns and the 
volatile and often low milk prices and which bottlenecks need to be first unblocked in order to 
do so. Second, the profitability of a better udder health and milk quality on an average dairy 
farm will be simulated. Next, some aspects on the emergence of antimicrobial resistance and 
the possible indirect effects of antimicrobial treatment are discussed. To end this thesis, some 
challenges and opportunities for the herd health advisor are pinpointed.  
 
Udder Health  
 
Situation in Flanders 
 
Despite the fact that much research and effort has been dedicated to mastitis prevention 
and control, it remains a persistent problem and the most expensive disease of dairy cows 
(Schepers and Dijkhuizen, 1991), also in Flanders, Belgium. Since the disease has two very 
distinctive presentations (subclinical and clinical) that are both of importance, we opted to 
combine them in our definition of herds having a “good udder health” (in Chapter 3.1). Actually, 
a weak correlation was found between EICM and BMSCC, stressing the importance of 
combining both parameters to precisely picture, monitor and evaluate udder health on dairy 
farms: herds with a low BMSCC might well be suffering from CM and vice versa. Surprisingly, 
only one-third of the herds combined a low BMSCC (< 250,000 cells/mL) with a low EICM (< 
3%). The thresholds we used to define the different strata were yet not at all that strict. 
Lowering the threshold to 200,000 cells/mL for BMSCC and < 2% for EICM which are arguably 
better thresholds from an economical point of view, would have resulted in only 8.3% of the 
herds in our study achieving the status of having a good udder health. These findings are 
worrying and indicate that there is still a lot of room for improvement and lots of opportunities 
for both producers and their advisors.  
The first standard mastitis control program comprised 5 points as mentioned before: 
appropriate treatment of CM, culling of chronically infected cows, postmilking teat disinfection, 
correct maintenance and use of the milking equipment, and application of blanket dry cow 
therapy (Neave et al., 1969). Surprisingly, we had to conclude that these and other well-known 
and effective measures are not always implemented on Flemish dairy farms. For example, still 
9% of the herds is not applying postmilking teat disinfection, and 55% of the herds is not 
keeping their cows standing after milking in headlocks, although possible. On 55% of the herds 
the calving pen was also used as a sick pen and 27% of the herds is not providing dry cow 
minerals to their dry cows. One of the most striking findings was that 90% of the herds was not 
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replacing the teat liners on time. These findings probably explain why only a minority of Flemish 
dairy herds has a good udder health. Herd health advisors need to be aware of the fact that 
technical knowledge alone is not enough to be successful. To be succesful, knowledge should 
be used and thus should the farmer be motivated to comply with some basic udder health 
concepts. Dutch research has clearly demonstrated that veterinarians are perceived by 
farmers as an important and highly respected information source with regard to udder health, 
but that they often lack the skills to sufficiently motivate the farmer to take action (Jansen et 
al., 2008; Lam et al., 2011). An upgrade of the veterinarian’s communication and motivation 
skills could thus further strengthen their position as herd health consultants, and boost the 
transfer of (their) knowledge to the field. 
We acknowledge our work was not designed to accurately determine the actual incidence 
rate of clinical mastitis (IRCM). Data were collected through an online questionare (with a 
response rate of 24%) which is not the best manner to get information on disease occurrence. 
Still, only 33% of the responding farmers indicated they kept records of all cases of CM. This 
is minimal and disappointing. Also, we realise BMSCC is only a proxy of the herd-level 
prevalence of cows with subclinical mastitis as only those cows of which the milk is delivered 
contribute to the BMSCC (Lievaart et al., 2007). The average EICM was 3.9% per month or 
46.8% EICM per year, which is considered to be very high. The latter information triggered our 
research group to estimate the IRCM more precisely in a follow-up study specifically designed 
to do so (Verbeke et al., 2014).  Eventually an IRCM of 26% was reported which is lower than 
the numbers included in this thesis (46.8%). Nevertheless, based on the results of Verbeke et 
al. (2014), still 78,000 first cases of CM per year occur which is immense if you consider the 
associated economic losses, the impact on animal welfare and the related use of antimicrobials 
with the latter two being growing public concerns. Using a calculated cost of CM of € 210 per 
case (Huijps et al., 2008), CM alone results in an overall cost for the Flemish dairy industry of 
more than € 16,380,000 per year.  
In the study of Verbeke et al. (2014), farms were randomly selected and 79 % of the 
targeted producers agreed to participate and record all CM cases, but nothing was mentioned 
on whether farmers already had good record keeping in place before the trial started.  
Interestingly, Peeler et al. (2000) reported that farmers that kept records of CM reported a 
significantly higher level of mastitis compared to those not keeping records which is in contrast 
with the findings of our study and the one of Verbeke et al. (2014). In the latter study, a financial 
incentive of €3 was paid per collected sample of CM. Since a CM case has a calculated cost 
of €210 (Huijps et al., 2008) and €3 is not a lot of money, this incentive did probably not help 
to collect and record every single case, most probably still resulting in an underestimation of 
the true IRCM. Also, farmers were contacted every 2 months by phone, the herd veterinarian 
was actively involved and 2 visits were done by the first author during the trial. These contacts 
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might  have biased the results, because extra attention was paid to udder health on those 
farms, making it more likely that farmers improved their (udder health) management during the 
study resulting in a lower incidence of CM. According to Barkema et al. (1999) and based on 
personal experiences, farmers with good udder health management have better record-
keeping systems and pay more attention to individual cows. Since in our study a majority of 
farmers did not keep good records of CM, we probably selected for ”underperforming 
managers”, expressed by a higher EICM or we can say that only a minority of farmers in 
Flanders is keeping good records of CM. This is a bit striking as the larger herd size of the 
participating farmers in our questionnaire compared with the average Flemish herd size and 
the need to have internet access, made us believe we selected more progressive farmers. 
Altogether, it is likely that the true IRCM in Flanders is somewhere in-between the values 
obtained by Verbeke et al. (2014) and our results. Also, in both studies no difference was made 
between a first case of mastitis and a recurrent case. This difference would however be very 
helpful in interpreting the CM data and clarifying the etiology of infection. Cows with histories 
of previous cases of CM are less likely to respond to therapy (Pinzon-Sanchez et al., 2010). 
Before initiating mastitis treatments, producers should consider this effect and enroll a culling 
strategy on their farm for those cows suffering from recurrent cases.  
 
Record-keeping of clinical and subclinical mastitis 
A first bottleneck that needs to be unblocked is the substandard record keeping of clinical 
and subclinical mastitis in Flanders (Figure 5). Based on the results obtained via our 
questionnaire and personal experiences, it is clear that only a minority of the farmers is 
recording CM cases on their farm. This is quite surprising since mastitis is known to be the 
most costly disease and record keeping of antimicrobial treatments is mandatory by the 
Belgian Dairy Quality Assurance Program (IKM). Also, on 33% of the farms, treatment 
decisions were ‘sometimes to never’ based on bacteriological cultures. In more than 40% of 
the Flemish dairy herds, culturing of CM cases is actually never performed. As a consequence, 
only 40% of the farms is evaluating the CM treatments “often”. In times that prudent use of 
antimicrobial drugs has become a priority, this finding is astonishing. Milk recording data (i.e. 
test-day milk production and composite milk SCC) is collected at an interval of 4 to 6 weeks in 
approximately 40% of the Flemish herds (personal communication, Benny Declerck, CRV). 
Detection of cows with sublinical mastitis is, as a consequence, complicated in the majority of 
the herds in Flanders in which BMSCC has to be used as a proxy for the prevalence of cows 
with subclinical mastitis. We should also be aware of the fact that non-saleable milk (e.g. milk 
from treated cows, milk from cows with a high cell count) remains an unknown component in 
that respect (Lievaart et al., 2007). The lack of good record keeping of clinical and subclinical 
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mastitis and the lack of regular diagnostics make it very difficult for the herd health advisor to 
identify the true cause of disease, to identify associated risk factors, to monitor treatment 
outcomes and to evaluate management changes on the farm. The results in Chapter 5.3, for 
example, clearly demonstrate that the most effective measures to prevent IMI in early lactating 
heifers also depend on the (subgroup of) pathogens that (is) are involved. 
 
Treatment of clinical mastitis 
Since herds having a higher prevalence/incidence of (clinical) mastitis are using more 
antimicrobials (Stevens et al., 2016), they are all at a higher risk of delivering milk containing 
antimicrobial residues (Ruegg and Tabone, 2000). In our questionnaire, the average duration 
of treatment of any CM case was around 3 to 4 days. The average withdrawal time of all 
registered intramammary antimicrobials in 2015 in Belgium was 5 days. Taken into account 
the average duration of treatment and withdrawal time, the practical consequences on a 100-
cow herd is that there is a risk of delivering milk with residues almost every day of the year, if 
the IRCM is higher than 3% per month. In our study 53.2% of the herds had a EICM higher 
than 3%. Logically, this results in extra stress for the producers, since penalties for residues 
are high and because of the extra labour that is assocated with it (e.g. collecting wasted milk, 
treatment, …).  Labour is more and more limiting on modern dairy farms, also in Flanders, and 
will thus most probably affect the financial result of the herd. We should, however, mention that 
in Belgium every delivery of milk is tested for the presence of residues and only 0.03% of all 
deliveries were found positive in 2014 (Annual Report, MCC Vlaanderen, 2014). Nevertheless, 
in the light of prudent use of antimicrobials, farms need to focus more on prevention of CM. 
This is a great opportunity for herd health advisors such as the herd veterinarian. The demand 
for formulating standard operating procedures (SOP) will also increase in the near future since 
labour will be more limiting as herd size increases. 
In that respect it is surprising that actually 74.4% of the producers we consulted is not 
using a treatment protocol for CM (Chapter 3.1, unpublished data). There was also a large 
variation in duration of treatment (from 1 to >5 days) (Figure 1) and in the way antimicrobials 
were administered (intramammary, parenterally or both) (Figure 2). On 46% of the farms 
treatment of CM was always done by the farmer, on 42% of the farms this was always done 
by the veterinarian, and on 12% of the herds this was only done by a veterinarian in specific 
cases (e.g. very severe mastitis cases). The lack of SOP is alarming since antimicrobial 
overuse and underdosing in food animal production has the potential to further increase the 
prevalence of acquired antimicrobial resistance, eventually threathening human health. The 
latter issue stresses the importance of avoiding residues in milk and striving for a targeted and 
more prudent use of antimicrobials in the dairy industry. The variation in treatment regimes of 
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CM on Flemish dairy farms is surprising. Producers seem to treat CM cases empirically as 
almost every possible treatment strategy is applied. On 66% of the herds, the off-label use of 
so-called “self-prepared udder infusions” with antimicrobials is actually still a regular treatment 
for CM. Also, when culturing of CM cases was performed, in almost 85% of the herds, 
antimicrobial susceptibility testing was not considered. Veterinarians should try to implement 
evidence-based treatment protocols on their clients’ farms. This, combined with good record 
keeping and susceptibility testing, should help to justify the use of antimicrobials on dairy herds 
and to reveal possible risk factors for IMI. In Belgium, veterinarians make a profit by delivering 
drugs to their clients, including antimicrobials. This conflict of interest potentially threatens their 
business model, yet should not prohibit vets of playing a key role in treatment decisions of 
dairy farmers as they are considered as one of the most positive references among dairy 
advisors and their advice is seen as trustworthy (Swinkels et al., 2015). 
 
 
Figure 1. Distribution of Flemish dairy farms (n = 242) treating mild clinical mastitis cases in 2009 
stratified by the duration of treatment. Only a minority of the herds treated mild clinical mastitis cases 
less than 2 days or more than 5 days. Nevertheless, the treatment duration of mild clinical mastitis cases 
strongly varied between and even within herds (Unpublished results from Chapter 3.1).  
The strong variation in treatment decisions between and within farms (Figures 1 and 2) 
suggest that farmers feel insecure and/or have different opinions on how to treat mastitis 
(Chapter 3.1) which corresponds well with the findings of Jansen and Lam (2012). In our 
questionnaire 72.5% of the farmers gave the highest priority to bacteriological cure of the 
treated quarter rather than delivering the milk as soon as possible after treatment. Swinkels et 
al. (2015) also reported that none of the farmers in their study expressed concern about the 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1day 2days 3days 4days 5days >5days
H
e
rd
s 
(%
)
Never Rarely Sometimes Often Always
General Discussion 
207 
 
increased costs of extended treatment due to more wasted milk and higher antibiotic use. 
Given the large variation in treatment duration and the route of administration within herds in 
our study, it seems farmers (and their veterinarians) feel not confident (enough) with the 
guidelines given by the pharmaceutical companies. The latter typically try to bring mastitis 
products with a short treatment duration and with short withdrawal periods to the market, 
typically as a marketing strategy which, however, does not seem to based on the actual needs 
of the farmers. The resulting lack of confidence might pave the way for inappropriate use of 
antimicrobials such as extended treatments, overdosing and empirical treatments (e.g. so-
called ‘self-prepared udder infusions’). Pharmaceutical companies should be aware of these 
discrepancies and should not only focus on short treatment duration with short withdrawal 
periods. Also, differences between the results obtained in the registration studies and those 
observed in the field might be at least partly explained by the fact that most of the challenge 
models do not include recently calved cows, do not necessarily utilize bacterial strains that are 
as virulent as some of the wild types, and are generally not administered when other possible 
immune stressors (such as metabolic disorders or heat) are present (Erskine et al., 2003). 
Although difficult to solve, we advise pharmaceutical companies to consider also those issues.  
  
 
Figure 2. Distribution of Flemish dairy farms treating mild clinical mastitis cases in 2009  stratified by 
the route of administration. Only a minority of farms treated the mild clinical mastitis cases only 
systemically though the decision to treat mild clinical mastitis cases only intramammary or combinated 
with a parenteral treatment appeared to strongly vary between and even within herds (Unpublished 
results from Chapter 3.1). 
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Reproduction and culling management  
Fertility is perceived by farmers as the most important topic included in VHHM programs 
(Derks et al., 2014) whereas advice on udder health is mostly given only when problems arise 
(Derks et al., 2014). Our findings (Chapter 3.1) suggest that the probability to have good udder 
health is highest in herds that monitor other aspects of cows’ health besides udder health. This 
is not that surprising as cows with optimal reproductive performances have shorter calving 
intervals and are most probably again dried off earlier, increasing their chance to cure of 
existing IMI, in this way reducing their impact on the BMSCC and the risk of CM (Van den 
Borne et al. 2011). Also, farmers that join VHHM programs probably have better records on 
the estimated calving date, leading to a smaller variation in dry period length between cows, 
which consequently makes the total dry period easier to manage. Another explanation might 
be found in the fact that a better fertility at the herd-level offers the farmer opportunities for a 
more targeted culling policy of chronically infected cows, improving general udder health. Also, 
veterinarians might have advised farmers to get rid of sick or problematic cows where farmers 
would have otherwise decided differently, as was recently shown by Derks et al. (2014). 
Following VHHM programs are a great opportunity for farmers to improve udder health and 
milk quality parameters on their herd. 
 
Milk Quality 
 
Premium system 
 
Payment schemes are an important incentive in controlling all bulk milk quality parameters 
(Veerkamp et al., 1998). Premium policies motivate farmers to produce high quality milk 
without providing a potential disruption to the milk supply. However, in Chapter 4.2 we revealed 
that only 52.9% of the herds achieved their milk quality premium for the whole year in 2009. 
This was very surprising since the tresholds for the legal standards and for achieving the 
premium are close together. But since the premiums in Flanders only represent 3% of the milk 
price, farmers are probably not stimulated enough to improve the udder health status and milk 
quality of their herd. On the other hand, Valeeva et al. (2007) showed that non-monetary 
factors relating to the internal esteem, such as job satisfaction, were equally motivating as 
factors affecting farm economic performance. However, these authors also suggested that 
farmers are expected to be more motivated by a price decrease for milk with a greater BMSCC, 
than by a price increase for milk with a lower BMSCC. A three-stage payment system could 
possibly help Flemish farmers to improve milk quality: a base price could be paid for herds with 
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a BMSCC between 200,000 and 300,000 cell/mL. A penalty could be given to herds with a 
BMSCC higher than 300,000 cells/mL and a premium could be given to farms achieving low 
BMSCC (< 200,000 cells/mL). This strategy could also be used for the other milk quality 
parameters.  
Interestingly, CC was the main reason for not achieving the milk quality premiums in 
Flanders. In our opinion, milk buyers should rethink the implementation of CC in their premium 
system. The use of CC results in a lot of frustration for a number of reasons (Chapter 4.2). 
Additionaly, only a small proportion of the variation of CC could be explained by manageable 
practices different from those related to milking and equipment hygiene (Chapter 4.1). We 
hypothesize that milk quality will improve when the BMSCC threshold is lowered and CC is 
excluded from the premium system. Herds with a low BMSCC are more likely to also have low 
CC, yet managing BMSCC is easier than managing CC on a daily base. If milk buyers still 
want to keep CC in the premium system, then first of all, more monthly measurements of CC 
are necessary. Besides that, more research has to be done on risk factors explaining the 
variation in CC, making it feasible in the future for farmers and advisors to implement a 
worthwhile strategy to keep CC values low . 
We propose to change the payment system into a 3-scale system. Since CC has an added 
value for the milk buyers, we still prefer to measure this but to exclude the CC out of the MQP 
system. Instead, lowering the BMSCC threshold in a new premium system would probably also 
select for herds having a low CC. On the other hand, there is still room for improvement in the 
number of herds that achieve the premium in the current system.This latter challenge is an 
opportunity for farmers to improve the financial result on their farms in times with volatile milk 
prices. 
 
Automated milking systems 
 
Automatic milking is one step in a series of steps that can be taken to automate dairy 
production. Because of high labor costs, automatic milking is becoming more common, 
especially in Northwestern Europe (de Koning, 2010). The results from Chapters 3.1 and 4.1, 
along with the results of other studies (reviewed by Hovinen and Pyörälä, 2011) and personal 
experiences however stress the clear need for a pro-active mastitis prevention and control and 
milk quality plan on farms that shift from conventional to automatic milking.  
Although automatic milking has some undeniable advantages over conventional milking 
(Edmondson, 2012), manufacturers of AMS and AMS farmers should be (made) more aware 
of some limitations inherent to automatic milking nowadays. An often poor cleaning of the teats 
before milking and an inferior detection of subclinical and clinical mastitis are some of the major 
challenges of automatic milking. Indeed, different studies have shown that teat cleaning in 
AMS is less effective than manual cleaning (Knappstein et al., 2004; Bade et al., 2008). 
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Equiping the automatic cleaning devices with sensors that can distinguish dirty from clean teats 
before cleaning, that check whether or not a teat is in the cleaning device during teat 
preparation or that evaluate the effectiviness of the cleaning procedure before the teat cups 
are attached would be very helpful in narrowing the gap in udder health and milk quality 
between automatic and conventional milking farms. A Finnish research group attributed the 
increase in BMSCC of herds equipped with an AMS to reduced separation of mastitic milk 
(Hovinen et al., 2009). Indeed, current AMS are yet not able to precisely distinguish abnormal 
milk from normal milk and to automatically separate abnormal milk, despite the fact that the 
European Union Legislation [Regulation (EC) No 853/2004] states that milk for human 
consumption has to be originate from animals free from signs of CM. In fact, in none of the 
numerous studies that have been performed, the ISO/FDIS 20966 (ISO, 2007) limit of 80% 
sensitivity with 99% specificity to detect clinical mastitis were met (Rutten et al., 2013).  
As aforementioned, labor reduction and more flexible labor time appear to be the most 
important reasons for shifting from conventional to automatic milking (Matthijs, 2004). Personal 
experience learns that AMS farmers typically have more confidence in sensor technology than 
other farmers and will thus most probably not compensate for the inferior detection of CM 
cases by the AMS by a visual control. Manufacturers of AMS should thus aim to further improve 
the detection technologies for clinical and subclinical mastitis. In the meantime, they should 
take into account the fact that the reliability of alerts affects the motivation of the farmer to react 
(Steeneveld et al., 2010).  
The strategic choice to shift from conventional to automatic milking needs to go hand in 
hand with an adapted daily management as it is clear that along with the shift, other factors 
including cow movement and activity, feeding systems, transmission routes, and detection 
methods for disease are changing as well,  offering ample opportunity for those advising the 
farmer. Worthwhile to mention is that herds with a good udder health before the introduction 
of an AMS are more likely to have a good udder health after the change. The latter might offer 
opportunities for pro-active and knowledgeable vets as they are best placed to work-out a 
farmer-tailored mastitis eradication program prior to the shift including the detection of high 
SCC cows, screening for (contagious) major pathogens, and appropriate decision-making for 
each individual cow and to further monitor the udder health and milk quality after the shift. 
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Better udder health and milk quality increases profitability 
Huijps et al. (2008) calculated the economic loss of a CM case to be € 210 on average, 
varying from € 164 to € 235 depending on the month of lactation when it occurrs. The economic 
losses caused by subclinical mastitis per cow present on a farm, with an average production 
of 8,500 kg/cow, are depending on the BMSCC (Huijps et al., 2008). For example, the losses 
per infected cow were €72 for a BMSCC between 100,000 cells/mL and 250,000 cells/mL and 
€94 for a BMSCC between 250,000 cells/mL and 400,000 cells/mL. As shown in Chapter 3.1, 
only 52.9% of the herds in our studies achieved their milk quality premium for the whole year 
in 2009. In Flanders, milk processors pay incentives from €1 to up €1.25 per 100 L of milk. It 
is likely that veterinarians are not always aware whether premiums have been achieved on 
their clients’ farms. Even when premiums account for only 3% of the milk price in Flanders, 
they have a certain impact on the financial result of the farm. So, monitoring achievement of 
MQP is an opportunity for herd health advisors striving for better milk quality on their client’s 
farm.  
We simulated the possible losses and gains in € per cow per year in different udder health 
situations and whether the milk quality premium has been achieved for a whole year (green) 
or not (red) in a straightforward manner (Figure 3). Calculations were based on a hypothetical 
100-cow herd, with an annual milk production of 8,500 kg per cow, and economic losses of 
mastitis were based on the abovementioned estimations proposed by Huijps et al. (2008).  
By looking at Figure 3, one could calculate the gains or losses between herds of the same size 
with different udder health statuses. For example, if a producer with a 100-cow herd is milking 
an annual milk production of 850,000 kg of milk, has a BMSCC between 100,000 cells/mL and 
200,000 cells/mL, an IRCM of 1,5% per month, and achieved the milk quality premium the 
whole year, he/she wil gain €360. In a worst case scenario (same herd does not achieve any 
premium, has a BMSCC between 250,000 cells/mL and 400,000 cells/mL and an IRCM of 5% 
per month), the herd will lose €22,000 during that exact same year. This difference is a 
distinctive percentage of the total amount of what could be gained by the total year production. 
For example, when assuming a milk price of €30 per 100 L, the latter difference determines 
8.5% of the total income that could be gained through milk production on that farm. With 
decreasing milk prices, this percentage will further increase, making it even more profitable to 
focus on the udder health and milk quality on dairy farms. As shown in Chapter 4.2, herds with 
EICM > 3% per month and herds with an AMS are less likely to achieve their MQP the whole 
year. In the same chapter, we reported that herds which achieved the MQP the whole year, 
had a lower BMSCC, so hypothetically herds with a high BMSCC will probably more likely not 
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achieve MQP the whole year either. Also, herds with an AMS are more likely to have higher 
BC and CC values (Chapter 4.1) and to have a high BMSCC combined with a low CM (Chapter 
3.1). The latter calculations clearly highlight the financial interest of striving for a better udder 
health and milk quality. Since veterinarians are seen by many farmers as the most important 
advisor on udder health (Jansen et al., 2010), veterinarians should grab this opportunity by 
integrating their recommendations and advice to improve udder health within the framework of 
VHHM.  
 
Figure 3. Losses and gains in € per cow per year under different udder health situations (average 
BMSCC and average monthly CM % per year) and stratified by achieving the milk quality premium for 
a whole year (green) or not (red). Simulations are based on a hypothetical 100-cow herd, with an annual 
milk production per cow of 8500 kg.   
 
Our study on achieving premiums (Chapter 4.2) showed that a surprisingly low percentage 
of farmers achieved the premium the whole year. This leads to lost revenues in those herds. It 
would be interesting to calculate the exact impact of achieving milk quality premiums on the 
financial result of the farm, taking into account the cost of implementing management changes 
with a known impact (e.g. supplementation with dry minerals, application of premilking teat 
disinfection, lowering the incidence of CM and milking with an AMS). On the other hand, 
specific risk factor studies are warranted on AMS herds, since those herds are more likely to 
struggle with milk quality udder health issues compared to conventional milking systems. 
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Antimicrobial resistance and indirect effects after prepartum antimicrobial 
treatment of heifers 
 
In Flanders, only a small proportion of the dairy producers (3.2%) is treating heifers prior 
to calving with antimicrobials (Chapter 3.1). In Chapter 5.1, we showed that systemic use of 
penethamate hydriodide before calving resulted in penicillin G levels in mammary tissue and 
secretion substantially higher than the MIC90 of pathogens associated with heifer mastitis. 
Treatment did not increase the likelihood of penicillin resistance in staphylococci (of which a 
majority was CNS) isolated from milk samples at calving (Chapter 5.2). However, selection for 
and spread of antimicrobial resistance takes time, making it difficult to conclude on this issue 
based on our data. But, when comparing the proportion of resistant staphylococci in the 
monitoring heifers to those from the control and treated heifers, an indirect treatment effect 
was suggested in the control heifers (unpublished data, Figure 4). Before the actual treatment 
trial started, herds were first monitored by sampling the first 8 heifers (the so-called monitoring 
heifers) per herd that calved. Staphylococci isolated in the monitoring period were less likely 
(13.7%) to be resistant to penicillin compared to the staphylococci isolated from the control 
(28.6%) and treated (25.6%) heifers. Strikingly, a similar finding was seen when comparing the 
proportion of infected quarters with any pathogens in the monitoring group (29.7%), with the 
prevalence of IMI found in the control (25.4%) and treated (17.9%) group, suggesting an 
indirect treatment effect present in the control heifers. We are very cautious in drawing 
conclusion based on these data, yet the findings are at least surprising and suggestive of 
indirect and unexpected effects that need more study. Still, we specifically avoided the 
statistical comparison between the data originating from the monitoring heifers and the treated 
and control heifers because a seasonal effect could not be excluded as data from the 
monitoring heifers were collected prior to those of the heifers included in the treatment trial.  
 
Anyway, without over-interpreting the data and in the light of antimicrobial resistance, the 
use of short-acting antimicrobials (intramammary and parenteral use) with a narrow spectrum 
should be preferred in those herds that suffer from a true heifer mastitis problem [herd suffering 
from heifer mastitis if > 15% of heifers have CM around calving and/or if > 15% of all heifers 
have a first test-day SCC (measured between 10 and 35 DIM) > 150,000 cells/mL, De Vliegher 
et al., 2012] and that are hence likely to profit from treatment. In that respect, prepartum 
treatment of end-term heifers, when heifers are not producing milk, would only be defensible 
if it would prevent additional treatments during lactation. At that time, milk is being produced 
as a marketable product and treatment would reduce welfare issues and the chance of finding 
residues caused by CM and the required treatment. 
Chapter 6 
214 
 
  In our prepartum treatment trial with penethamate hydriodide (Chapter 5.2), all 6 cases 
of CM in early lactation occurred in the treatment group. This might be due to chance because 
of the small numbers. Still, one could speculate that antimicrobial treatment disturbed the 
microflora in the udder (Oikonomou et al., 2012), making quarters of treated animals more 
susceptible to new IMI. In that respect, it is worthwile to mention the negative association 
between pre-existing CNS IMI and the incidence of CM cases throughout first lactation 
(Matthews et al., 1991; Lam et al., 1997; Piepers et al., 2010). Those findings support our 
abovementioned hypothesis: certain protective bacteria, such as CNS part of the milk 
microbiome, could be killed using penethamate hydriodide, or whatever antimicrobial 
treatment, making quarters less resistant.  
 
Figure 4. Percentage of isolated Staphylocci resistant to penicillin (blue) in the monitoring quarters    
(13.7%), the treated quarters (25.6%), and the untreated quarters (28.6%), and percentage of IMI with 
any pathogen (red) in the monitoring quarters (29.7%), the treated quarters (17.9%), and the untreated 
quarters (25.4%)(unpublished results from Chapter 5.2), with 95% confidence intervals.  
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When looking at the unconditional associations, as well as at the final models, the risk 
factors for IMI that were identified in treated heifers were others than those in untreated heifers, 
independently from the pathogen group that was considered (Chapter 5.3). It looks as if 
prepartum treatment not only changed the likelihood of infection (Chapter 5.1) but also the 
factors associated with infection. This suggests that in herds where prepartum treatment is 
implemented, prevention should focus on other aspects than in herds where no such programs 
are in place, although this needs to be substantiated in future research. The latter reasoning 
might also apply to blanket dry cow therapy, a mastitis control measure that has been advised 
for more than 40 years (Neave et al., 1969). However, given the recent concerns related to 
emergence of antimicrobial resistance and the preventive use of antimicrobials, selective 
rather than blanket dry cow therapy is more warranted. Risk factor studies that have been 
performed during the last decades mainly enrolled herds where blanket dry cow therapy was 
applied, making it likely that those factors will change on future herds where no or selective 
dry cow therapy is used. So, further risk factors studies on those herds will be necessary 
making a reduced use of antimicrobials possible. 
 
Since farmers are often more eager to treat animals than to improve their herd (health) 
management (McDougall et al., 2009), herd health advisors need to be cautious in advising 
antimicrobial treatments, even when this would be the least expensive measure. Society 
expects decisions that are not (only) driven by economic aspects, but by human health 
concerns and animal welfare issues. Excessive use of antimicrobials should be avoided at all 
time. Farmers and veterinarians have a joint responsibility to ensure the correct and 
appriopiate use of antimicrobials with respect to the society. 
 
Challenges and opportunities for herd health advisors 
New developments in the dairy industry (i.e. abolishing milk quotas, global pressure to 
reduce antimicrobial usage, low milk prices) put extra demands on the udder health advisor. 
This thesis demonstrates that ample opportunities exist for veterinarians as udder health 
advisors though some challenges still need to be tackled (Figure 5). Nowadays, most 
veterinary practices already offer some kind of VHHM program to their clients, during which 
they monitor the herd health status and provide (preventive and evidence-based) advice 
(Derks et al., 2014). The major objective of VHHM should be to support the farmer in reaching 
his targets of farm performance (Noordhuizen, 2001; Noordhuizen and Wentink, 2001; de Kruif 
and Opsomer, 2004), yet in concordance to the expectations of the society. Several studies 
confirmed that mastitis-related information of veterinarians is generally considered trustworthy 
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and valuable (Raymond et al., 2006; Jansen et al., 2008; Swinkels et al., 2015), yet this is not 
always seen in the performances of the herds. Veterinary herd health programs should thus 
include udder health and milk quality as a specific item, all the more since our data in Chapter 
3.1 have shown that both the udder health and milk quality on the Flemish dairy herds can still 
improve. Still, to be effective and succesfull, the veterinary knowledge needs to be applied. 
Convincing farmers to effectively apply their knowledge into practice is still one of the major 
challenges veterinarians should solve. Veterinary herd health advisors should be aware that 
the farmer’s decision-making and behaviour depends on his mindset which is a combination 
of what he wants, knows, believes and perceives (Lam et al., 2011). 
Motivating farmers to take action is thus not just a matter of sharing technical knowledge 
but requires effective communication skills in order to get a better understanding of the farmer’s 
mindset and the underlying explanations for a certain behaviour (e.g. social pressure). 
Possessing strong communication, motivation and people skills is thus a prerequisite for being 
succesfull as a herd health advisor. 
Figures such as the simulated lost revenues due to a suboptimal udder health and the 
every-day risk for antimicrobial residues in the bulk tank on a 100-cow dairy herd with an EICM 
> 3% might be helpful in motivating the farmer as well. A lack of accurate data might be a 
potential bottleneck in setting-up an evidence-based and farmer-tailored VHHM program as 
only a minority of the Flemish farmers appears to accurately record their CM cases and only 
40% of the farmers participate in a 4- to 6-weekly DHI-program. Explaining what can be learnt 
from those records, why it is important to know which bacteria are causing mastitis on their 
farm and to which antimicrobials the mastitis causing bacteria are resistant might be helpful in 
motivating the farmer to keep records and collect milk samples for bacteriological culturing and 
antimicrobial sensitivity testing in the future. Our data clearly suggest that farmers have 
different opinions on how to treat mastitic cows and need support in their treatment-decisions. 
Still, having an evidence-based treatment protocol is a necessary and useful tool on modern 
dairy herds. Veterinarians are among the herd health advisors undoubtely the best placed to 
formulate such a treatment protocol, and can by doing so clearly distinguish themselves from 
other herd health advisors and increase their credibility. Even so, veterinarians should also 
deliver value for money with those services. Establishing farmer-tailored mastitis screening, 
eradication and monitoring programs on farms that shift from conventional to automatic milking 
prior to startup and beyond seems to be a gap in a growing market that pro-active and 
knowledgeable vets can easily fill in. Besides the regular 4- to 6-weekly monitoring based on 
the available SCC and CM data, a monthly monitoring of the bulk tank milk might be 
recommended in particular on those farms that purchase replacement animals or on the ones 
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that are recovering from an outbreak of Mycoplasma bovis mastitis. Also, next to the 4- to 6-
weekly udder health monitoring, regular fertility checks might further improve udder health as 
do the results from Chapter 3.1 suggest but also increase their income and that of the farmer. 
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In response to achieve a worldwide growing demand for milk and dairy products, Flemish 
dairy farmers have substantially increased the average milk yield per cow as well as the 
average herd size. One of the diseases potentially threatening this growth and the financial 
profit for dairy farmers is mastitis, which can occur in two forms, a clinical and a subclinical 
one. Also, heifer rearing has become more and more a priority on modern dairy farms, 
because of the financial impact and longevity which again stresses the importance of healthy 
heifers at calving. Heifer mastitis can have detrimental effects on the future productive life of 
heifers, showing the importance of cure and prevention of IMI in heifers around calving. 
Besides intensification, quality and safety of dairy products have become a major concern for 
both producers and consumers. Next to the absence of residues, microbiological 
contamination of milk is an important issue in food safety as well. The aims of this thesis were 
to identify some new challenges related to udder health and milk quality that modern dairy 
farmers and their vets are currently facing or will be facing in the near future, and to learn how 
these can be turned into opportunities (Chapter 2).  
  
Udder health 
 
Management practices associated with the IRCM and BMSCC on Flemish dairy farms, 
were studied by conducting a web-based questionnaire (Chapter 3.1). In total, 218 farmers 
completed the online questionnaire that consisted of different questions concerning general 
management, herd health management, milking, calving and dry cow management and 
nutrition. Only one-third of the herds in Flanders had a low BMSCC (< 250,000 cells/mL) and 
a low EICM (<3%). Only a weak association between BMSCC and EICM was present. The 
average EICM was 4% per month, or 48% per year. However, it became clear that less than 
half of the farmers are recording CM cases on their farm, making the data to be cautiously 
interpreted. Several factors were found to be associated with good udder health, so-called 
environmental herds and so-called contagious herds. Veterinary herd health monitoring 
seemed to have added value in the prevention of udder health problems whereas in general 
this study gave us also more insights in how antimicrobials are applied in case of udder health 
issues.  
Mycoplasma bovis is an emerging pathogen that can cause mastitis, with ineffective drugs 
treatments, culling and loss of milk production as major consequences. Early detection of cows 
excreting M. bovis bacteria is warranted, especially in expanding herds and farms that often 
purchase replacement animals. In Chapter 3.2, the prevalence of Mycoplasma bovis was 
estimated on Flemish dairy farms. Three bulk tank milk samples per herd were taken with a 
collection interval of two weeks. In three herds (1.5%) M. bovis was isolated from one of the 
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three consecutive bulk samples. The prevalence of M. bovis in Flanders was concluded to be 
at least 1.5% of the dairy herds. Frequent monitoring in herds at risk should be encouraged in 
order to detect the presence of M. bovis as soon as possible and to implement appropriate 
prevention measures when needed. 
 
Milk quality  
 
Associations between herd management practices and both BC and CC from 254 and 242 
dairy herds in Flanders (Belgium), respectively, were studied (Chapter 4.1). Data were 
analyzed using multivariable, multilevel linear regression analysis, allowing variance 
components’ analyses. Both BC and CC fluctuated throughout the year, although the milk 
quality parameters followed an opposite pattern. Bacterial count values decreased with each 
increase of the cleaning frequency of the cubicles (once a week, once a day, twice a day, 
more than twice a day) between January and March. Herds with a conventional milking parlor 
had substantially lower BC than herds where the cows were milked using an automatic milking 
system. Lower BC were observed when the milking parlor was equipped with an automatic 
cluster removal system, when premilking teat disinfection was applied, when the dry cows 
were supplemented with a mix of minerals and vitamins, and when the teats were prepared 
either first wet and dried or via an automatic milking system. Milking cows with a high-pipeline 
milking parlor set-up or with an AMS was associated with substantially higher CC values. 
Herds where prepartum heifers were often treated with antimicrobials before calving had a 
lower CC than farms where heifers were either not or only rarely treated. Most variation in BC 
and CC resided at the herd level rather than at the observation level, indicating that 
management is important in the control of both BC and CC. Still, only a small proportion of the 
total variance was explained by factors capturing information related to the milking, herd 
health, and dry cow management, which suggests that the bacteriological milk quality and in 
particular CC is primarily driven by other factors than the ones included in this study. 
 
In Chapter 4.2, associations between herd management practices, collected through a 
web-based questionnaire from 242 dairy herds in Flanders (Belgium), and achieving MQP 
were studied. Monthly geometric means for BMSCC, BC and CC were available, as well as 
monthly test results of freezing point, residues and filtration. Data were analyzed using binary 
logistic regression. Only 52.9% (n = 128) of the herds achieved their milk quality premium all 
12 months in 2009. If the BMSCC threshold would have been 250 x 10³ rather than 350 x 10³ 
cells/mL in a hMQP, only 23.5% (n = 57) would have achieved their milk quality premium every 
month of 2009. The main reason for not achieving the milk quality premiums in 2009 in the 
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current system was CC, whereas this would have been BMSCC in the hMQP system. 
Lowering the threshold from 350 x 10³ to 250 x 10³ cells/mL in the latter system, would have 
most likely been accompanied with lower BC and CC values. The final model revealed that 
herds where premilking teat disinfection was applied and where dry cows received a 
vitamin/mineral mix were significantly more likely to achieve the MQP in 2009. On the other 
hand, herds with a high (> 3%) EICM and equipped with an AMS were significantly less likely 
to achieve the MQP. 
 
Heifer management 
 
Prepartum intramammary treatment with antimicrobials of end-term dairy heifers has 
frequently been proposed as a practice to reduce the prevalence of IMI at calving. From a 
safety standpoint for both animal and administrator, systemic treatment is to be preferred. The 
aim of the study in Chapter 5.1 was to assess the concentration of penicillin G in mammary 
tissue and secretion of dry heifers following systemic administration of penethamate 
hydriodide. Six dairy heifers in late gestation received a single intramuscular injection of 10 g 
penethamate hydriodide and were sacrificed 24, 48 or 144 hours after treatment. Penicillin G 
concentrations were measured in mammary tissue and secretion samples using high 
performance liquid chromatography. Penicillin G was detected in the udder of two animals 
euthanized at 24 hours (mammary tissue and secretion) and at 48 hours post treatment 
(mammary secretion only) after administration at concentrations still close to or above MIC90 
values reported for the pathogens associated with heifer mastitis. Antibiotic concentration 
shortly after administration was substantially higher, indicating a potential for systemic 
treatment with penethamate hydriodide to control prepartum intramammary infections in 
heifers without the disadvantages of local therapy. However, this therapeutic approach 
needed to be verified under field conditions to quantify the short and long term effects on udder 
health (i.e. somatic cell counts and clinical mastitis cases), and milk production. 
 
Hence, a clinical trial was conducted on heifers from 10 commercial, well-managed dairy 
farms with low prevalence of heifer mastitis (Chapter 5.2). The aim was to assess both the 
short and long-term effects of a systemic prepartum therapy with penethamate hydriodide on 
udder health and milk production. Because it was hypothesized that some herds would benefit 
more from this treatment than others, specific herd-level information was collected prior to the 
start of the actual trial in order to screen for and/or explain potential herd-specific treatment 
effects. Further, the effect of treatment on antimicrobial susceptibility of Staphylococcal 
isolates was monitored. End-term heifers were either treated systemically (during three 
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consecutive days) two weeks prior to their expected calving date with penethamate hydriodide 
(n = 76) or remained untreated (n = 73). Systemic prepartum treatment of end-term heifers 
with penethamate hydriodide resulted in fewer IMI in early lactation. However, all 6 cases of 
CM in early lactation occurred in the treatment group [Streptococcus uberis (n = 1), 
Corynebacterium bovis (n = 1), Staphylococcus aureus (n = 1); one sample was contaminated 
and two samples remained culture-negative]. No long-term treatment effects (4 to 120 DIM) 
on milk production, udder health or culling hazard during later lactation were detected although 
treated heifers belonging to herds classified as having low yielding heifers out-produced the 
control heifers. Moreover, penicillin susceptibility of Staphylococci isolated from milk samples 
of either treated or control heifers did not differ. Herds with a low prevalence of heifer mastitis 
were not likely to benefit from prepartum systemic antimicrobial treatment of the end-term 
heifers. 
 
A number of generic risk factors associated with the likelihood of IMI in fresh dairy heifers 
were identified before. Yet, there was a need to identify pathogen group specific factors as the 
impact of (groups of) pathogens on udder health and milk yield is different.  The aim of the 
present study was to identify pathogen group-specific risk factors for IMI in heifers participating 
in a prepartum antimicrobial treatment trial, allowing us to test the hypothesis that different 
factors are of importance between treated and untreated control heifers as well (Chapter 5.3). 
Data from a clinical trial in which end-term heifers were treated systemically (over 3 
consecutive days) 2 wk before calving with penethamate hydriodide (n = 76) or remained 
untreated (n = 73), were available (see Chapter 5.2). A number of potential risk factors at the 
herd, heifer and quarter level were recorded in the first 3 DIM. Quarters from untreated heifers 
supplemented with ≥ 4 mg selenium/day prepartum were significantly less likely to be infected 
with CNS whereas quarters were more likely to be infected with CNS when assistance during 
calving was needed. Udder edema prior to calving significantly decreased the odds of IMI with 
major pathogens. In treated heifers, no factors were detected that were associated with the 
likelihood of CNS IMI, whereas quarters from heifers were significantly more likely to be 
infected with major pathogens when they were housed in the calving pen >1 day, and when 
they had been in contact with the lactating cows prior to calving. The risk factors for IMI that 
were identified in treated heifers were different than those in untreated heifers, independently 
from the pathogen group that was considered. It looks as if prepartum treatment not only 
change the likelihood of IMI but also the factors that were associated with IMI. However, 
except for treated heifers with an IMI caused by major pathogens, only a small proportion of 
the variation could be explained in the final models. So, other factors than those that were 
studied are explaining the likelihood of IMI at calving. 
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Om aan de groeiende vraag naar melk en melkproducten te kunnen voldoen, hebben 
Vlaamse melkveehouders hun gemiddelde melkproductie per koe en het aantal koeien per 
bedrijf doen toenemen. Éen van de ziekten die een bedreiging kan vormen voor deze groei 
en voor een hoger financieel inkomen is mastitis of uierontsteking. Deze ziekte kan zich in 
twee vormen presenteren,  nameljk een klinische en een subklinische mastitis. Door de 
financiële impact en het belang van langleefbaarheid - wat het groot belang van gezonde 
vaarzen beklemtoont - wint de opfok van vaarzen meer en meer aan belang op moderne 
melkveebedrijven. Vaarzenmastitis kan ernstige gevolgen hebben voor het toekomstige 
productieve leven. Dit geeft aan hoe belangrijk het voorkomen en genezen van intramammaire 
infecties bij vaarzen rond de kalving is. Naast de intensivering van de melkveehouderij, zijn 
kwaliteit en voedselveiligheid van melkproducten een grote zorg voor zowel producenten als 
consumenten. Niet alleen de afwezigheid van residuen in de melk, maar ook de 
bacteriologische contaminatie van melk is een belangrijk aspect van de voedselveiligheid. Het 
doel van dit doctoraatswerk is om enkele nieuwe uitdagingen, gerelateerd aan uiergezondheid 
en melkkwaliteit, die melkveehouders en hun dierenartsen vandaag en in de toekomst zullen 
tegenkomen, te bestuderen en om te leren hoe daarmee kan worden omgegaan (Hoofdstuk 
2).    
 
Uiergezondheid 
 
De incidentie van klinische mastitis en het tankmelkcelgetal op Vlaamse 
melkveebedrijven, samen met  geassocieerde managementfactoren, werden bestudeerd met 
behulp van een digitale enquête (Hoofdstuk 3.1). Deze online enquête bestond uit 
verschillende onderwerpen zoals algemeen management, diergezondheid, melktechniek, 
afkalf-en droogstandsmanagement en voeding en werd volledig beantwoord door 218 
melkveehouders. Slechts één derde van de Vlaamse melkveebedrijven heeft een laag 
tankmelkcelgetal (< 250.000 cellen/mL) gecombineerd met een lage geschatte incidentie van 
klinische mastitis (< 3%/maand). We konden een zwakke associatie aantonen tussen beide 
uiergezondheidsparameters.  Op basis van deze  studie, was de gemiddelde geschatte 
incidentie van klinische mastitis 4% per maand, of 48% per jaar.  Het werd tevens duidelijk 
dat minder dan de helft van de melkveehouders klinische mastitis gevallen registreert op hun 
bedrijf, wat met zich mee brengt dat men deze data met enige voorzichtigheid moet 
interpreteren.  Verschillende risicofactoren waren geassocieerd met bedrijven met een goede 
uiergezondheid, met zogenaamde “omgevingsgebonden bedrijven” en met zogenaamde 
“koegebonden bedrijven”. Diergeneeskundige bedrijfsbegeleiding leek een positief effect te 
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hebben ter preventie van uiergezondheidsproblemen. Deze studie gaf ons ook meer inzicht 
op welke manier antimicrobiële middelen worden ingezet bij uiergezondheidsproblemen.  
Mycoplasma bovis  is een bacterie die mastitis kan veroorzaken waarbij geen  effectieve 
behandeling mogelijk is. Dit kan leiden tot een sterk melkproductieverlies en een verhoogd 
vervangingspercentage.  Een vroege detectie van koeien die Mycoplasma bovis uitscheiden 
is noodzakelijk, in het bijzonder op groeiende bedrijven  die  vaak dieren aankopen. De 
prevalentie van Mycoplasma bovis op Vlaamse melkveebedrijven werd beschreven in 
hoofdstuk 3.2. Drie tankmelkstalen werden genomen op 201 Vlaamse melkveebedrijven, met 
telkens 2 weken tussentijd. Op drie bedrijven (1.5%) kon Mycoplasma bovis geïsoleerd 
worden uit telkens een van de drie tankmelkstalen. Er werd hieruit besloten dat  de prevalentie 
van Mycoplasma bovis op Vlaamse melkbedrijven 1.5% was. Frequente monitoring van 
risicobedrijven moet worden toegejuicht om op die manier zo snel mogelijk de eventuele 
aanwezigheid van Mycoplasma bovis op te sporen en om tijdig de nodige 
managementmaatregelen te kunnen nemen. 
 
Melkkwaliteit 
 
Mogelijke associaties tussen managementmaatregelen enerzijds en het kiemgetal en het 
coligetal anderzijds werden op respectievelijk 254 en 242 Vlaamse melkveebedrijven 
bestudeerd (Hoofdstuk 4.1). De data werden geanalyseerd door gebruik te maken van een 
multivariabele, multilevel lineaire regressie-analyse, wat analyse van variantiecomponenten 
toelaat. Zowel het kiem- als coligetal fluctueerden tijdens het jaar. Beide parameters volgden  
een tegengesteld patroon. Het kiemgetal daalde bij een stijgende frequentie van het 
schoonmaken van de ligboxen (1x per week, 1x per dag, 2x per dag, meer dan 2x per dag) 
tussen januari en maart. Bedrijven met een conventioneel melksysteem hadden een 
substantieel lager kiemgetal dan bedrijven die melken met een automatisch melksysteem. 
Een lager tankmelkcelgetal werd ook opgemerkt wanneer men beschikt over automatische 
afname, wanneer de spenen voor het melken werden gedesinfecteerd, wanneer 
droogstaande koeien gesupplementeerd werden met mineralen en vitaminen, en wanneer 
spenen eerst nat en daarna droog werden voorbehandeld of wanneer dit automatisch 
gebeurde. Melkinstallaties met een hoogliggende leiding of automatische melksystemen 
waren geassocieerd met een substantieel hoger coligetal. Bedrijven waar regelmatig de 
vaarzen met antibiotica behandeld werden voor vaarzenmastitis voor het kalven, hadden een 
lager coligetal dan bedrijven waar dit maar zelden of niet het geval was. De variatie in kiem-
en coligetal was vooral te vinden op bedrijfsniveau en niet zo zeer op het niveau van de 
meting, wat een indicatie is dat het bedrijfsmanagement belangrijk is voor de controle van 
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zowel kiem-als coligetal. Hoe dan ook kon maar een klein deel van de totale variatie verklaard 
worden door de informatie behaald uit de enquête (melktechniek, diergezondheid, 
droogstandsmanagement,…), wat suggereert dat de bacteriologische melkkwaliteit en in het 
bijzonder het coligetal worden gedomineerd door factoren die niet werden bestudeerd in deze 
studie.  
In  hoofdstuk 4.2 werden  mogelijke associaties tussen managementmaatregelen en het 
behalen van  de kwaliteitspremie bestudeerd door middel van een digitale enquête gehouden 
bij 242 Vlaamse melkveebedrijven. We beschikten zowel over de maandelijkse geometrische 
gemiddelden van het tankmelkcelgetal, kiemgetal en coligetal, als over de resultaten van de 
vriespuntbepaling, de filtratietest en de aanwezigheid van residuen. De data werden 
geanalyseerd door middel van binaire logistische regressie. Slechts 52.9% (n = 128)  van de 
bedrijven behaalde de kwaliteitspremie elke 12 maanden gedurende het jaar 2009.  Wanneer 
de grenswaarde van het tankmelkcelgetal in plaats van 350.000 cellen/mL, op 250.000 
cellen/mL zou gezet worden in een hypothetisch melkkwaliteitspremie-systeem, dan zou maar 
23.5% (n = 57 ) bedrijven de kwaliteitspremie iedere maand behaald hebben. De belangrijkste 
oorzaak in het huidige systeem voor het niet behalen van de melkkwaliteitspremie in 2009 
was het coligetal. In het hypothetisch kwaliteitssysteem zou dit het tankcelgetal geweest zijn. 
De grenswaarde verlagen van 350.000 cellen/mL naar 250.000 cellen/mL, zou 
hoogstwaarschijnlijk tevens gepaard gaan met een verlaging van het kiemgetal en het 
coligetal. Bedrijven die de spenen voor het melken desinfecteren (spray of dipmiddel) en 
bedrijven waar droogstaande koeien een vitaminen-en mineralenmengsel kregen, hadden 
meer kans op het behalen van de kwaliteitspremie gedurende het ganse jaar 2009.  Anderzijds 
hadden bedrijven met een hoog percentage aan – geschatte – klinische mastitis  per maand 
(> 3%) en bedrijven die gebruik maken van een automatisch melksysteem, significant minder 
kans op het behalen van de kwaliteitspremie gedurende het ganse jaar.  
 
Vaarzenmanagement 
 
Intramammaire antibioticumbehandeling van drachtige vaarzen voor de verwachte 
afkalfdatum, is meermaals voorgesteld als maatregel om de prevalentie van IMI’s op moment 
van kalven te verminderen. Vanuit veiligheidsredenen voor zowel het dier als de persoon die 
toedient, valt systemische behandeling te verkiezen. Het doel van de studie in hoofdstuk 5.1 
was om de concentratie van penicilline G in uierweefsel en secretie van droogstaande vaarzen 
te bepalen na een éénmalige injectie met penethamaat hydriodide. Zes hoogdrachtige 
vaarzen kregen een enkele intramusculaire injectie met 10g penethamaat hydriodide en 
werden nadien geëuthanaseerd op respectievelijk 24, 48 en 72 uur na de behandeling. De 
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concentratie van penicilline G werd bepaald in het uierweefsel en het uiersecreet met behulp 
van hoge performantie chromatografie. Penicilline G werd gedetecteerd in het uier bij twee 
dieren geëuthanaseerd op 24u (uierweefsel en secreet) en op 48u (uiersecreet) na toediening, 
in concentraties die dichtbij tot hoger lagen dan de MIC90 waarden die beschreven staan voor 
pathogenen geassocieerd met vaarzen mastitis. De antibioticumconcentraties kort na 
toediening waren substantieel hoger, hetgeen een mogelijkheid biedt aan systemische 
behandeling met penethamaat hydriodide in de controle van IMI’s bij vaarzen, zonder de 
nadelen van een intramammaire therapie. Deze therapeutische benadering moet echter 
verder onderzocht worden onder veldomstandigheden om de korte en lange termijneffecten 
op de uiergezondheid (somatisch celgetal, klinische mastitis) en de melkproductie te 
kwantificeren. 
 
Bijgevolg werd een klinisch veldonderzoek uitgevoerd bij vaarzen op 10 commerciële, 
goed gemanagede melkveebedrijven met een lage prevalentie aan vaarzenmastitis 
(Hoofdstuk 5.2). Het doel van deze studie was om zowel de korte termijn als de lange 
termijneffecten van een systemische prepartum behandeling met penethamaat hydriodide op 
de uiergezondheid en de melkproductie te bestuderen. Omdat de hypothese was dat sommige 
bedrijven meer zouden profiteren dan andere door deze behandeling, werden specifieke 
bedrijfsgegevens verzameld voor de eigenlijke start van het onderzoek met de bedoeling om 
eventuele bedrijfsspecifieke effecten van de behandeling te kunnen verklaren. Daarnaast 
werd ook het effect van behandeling op het ontstaan van antimicrobiële ongevoeligheid bij 
Staphylococcus isolaten gemonitord. Hoogdrachtige vaarzen werden ofwel systemisch 
behandeld (gedurende 3 opeenvolgende dagen) met penethamaat hydriodide 2 weken voor 
de verwachte afkalfdatum (n = 76), of bleven onbehandeld (n = 73). Systemische prepartum 
behandeling van hoogdrachtige vaarzen met penethamaat hydriodide resulteerde in minder 
IMI aan het begin van de lactatie. Alle 6 gevallen van klinische mastitis in de vroege lactatie 
kwamen voor bij de behandelde groep [Streptococcus uberis (n = 1), Corynebacterium bovis 
(n = 1), Staphylococcus aureus (n = 1); een staal was gecontamineerd en twee stalen waren 
negatief op cultuur]. Er werden geen lange termijneffecten (van 4 tot 120 dagen in lactatie) 
gevonden op de melkproductie, de uiergezondheid of de kans op opruimen gedurende het 
verdere verloop van de lactatie. Wel zagen we dat behandelde vaarzen die behoorden tot 
bedrijven die geklassificeerd werden als ‘bedrijven met laagproductieve vaarzen’ meer melk 
gaven dan de controledieren. De gevoeligheid voor penicilline van Staphyloccus isolaten van 
zowel de behandelde vaarzen als de controlevaarzen was niet verschillend. Bedrijven met 
een lage prevalentie van vaarzenmastitis hadden geen voordeel van een systemische 
prepartum behandeling met antibiotica van hoogdrachtige vaarzen.  
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Verschillende risicofactoren die geassocieerd zijn met de kans op IMI bij pasgekalfde 
vaarzen zijn reeds bestudeerd. Aangezien de impact van pathogenen op de uiergezondheid 
en de melkproductie verschillend is, is er een behoefte aan pathogeen specifieke 
risicofactoren te identificeren. Het doel van deze studie was om deze pathogeen specifieke 
risicofactoren voor IMI bij vaarzen te bestuderen tijdens een veldproef met een systemische 
prepartum antibioticumbehandeling (Hoofdstuk 5.3).  Dit liet ons toe om de hypothese te 
testen dat de risicofactoren tussen behandelde en niet-behandelde vaarzen verschillend zijn. 
De data waren beschikbaar uit een veldproef waarbij hoogdrachtige vaarzen ofwel systemisch 
behandeld werden met penethamaat hydriodide (gedurende 3 opeenvolgende dagen), 2 
weken voor de verwachte afkalfdatum ( n = 76 ), of onbehandeld ( n = 73 ) bleven (zie 
Hoofdstuk 5.2). Verschillende potentiële risicofactoren op bedrijfs-, vaars, en kwartierniveau 
werden geregistreerd in de eerste 3 dagen van de lactatie. Kwartieren van onbehandelde 
vaarzen die gesupplementeerd werden met ≥ 4 mg selenium/dag voor het kalven hadden 
significant minder kans om geinfecteerd te zijn met CNS (Coagulase-negatieve 
Staphylococcen). De kwartieren hadden meer kans om geinfecteerd te zijn met CNS wanneer 
assistentie bij het kalven moest verleend worden. Uieroedeem voor de kalving deed de kans 
op een IMI met major pathogenen significant dalen. Bij de behandelde vaarzen werden geen 
risicofactoren geassocieerd met de kans op een IMI met CNS gevonden. Kwartieren van 
behandelde vaarzen hadden significant meer kans op een IMI met major pathogenen wanneer 
ze langer dan 1 dag in de afkalfstal verbleven, en wanneer ze voor het kalven contact hadden 
met lacterende dieren. De risicofactoren voor IMI die we identificeerden bij behandelde 
vaarzen waren verschillend van die van de niet behandelde vaarzen, en dit onafhankelijk van 
de bestudeerde groep pathogenen. Het ziet er naar uit dat de prepartum behandeling niet 
alleen de kans op een IMI veranderde, maar ook de factoren die hiermee geassocieerd waren. 
We konden weliswaar maar een klein deel van de variatie verklaren in ons finaal model, met 
uitzondering voor de behandelde vaarzen met een IMI veroorzaakt door major pathogenen. 
Bijgevolg zullen andere factoren dan die wij bestudeerd hebben, de kans op IMI op moment 
van kalven veel meer beïnvloeden.  
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Dankwoord 
Het is zover. Ik mag beginnen aan mijn laatste hoofdstuk. Het dankwoord. “Waarom doe 
je eigenlijk een doctoraat? “ Het aantal keer dat ik die vraag gehoord heb de laatste 8 (jawel, 
8) jaar is niet meer te tellen. Het antwoord hierop is multifactorieel. Lap, het begint al. Acht 
jaar werken aan dit proefschrift heeft me zeker op een andere manier laten denken. Natuurlijk 
hoop ik ook een bedrage te kunnen leveren aan de kennis over uiergezondheid en 
melkkwaliteit, maar het meer analytisch denken lijkt me toch wel het belangrijkste wat ik heb 
bijgeleerd. Een vleugje statistiek (waarmee je volgens de leek toch alles kunt bewijzen ) zal 
hierbij zeker helpen. Maar een doctoraat maken doe je helemaal niet alleen. Het is echt 
teamwerk en zonder een grote groep mensen zou hiervan weinig in huis zijn gekomen. 
Sommige hebben me enorm geholpen bij het wetenschappelijke gedeelte van deze karwei, 
anderen hebben ervoor gezorgd dat ik de stress kwijt kon, de batterijen terug kon opladen, en 
het leven min of meer zijn verdere gang kon gaan. Ik ben ervan overtuigd dat een goeie 
combinatie van beide soorten steun uiterst belangrijk waren voor mij.  
Ik zal, ietwat tegendraads, starten met de twee mensen te bedanken waardoor ik zonder hen, 
ten eerste er nooit geweest zou zijn, en ten tweede nooit zover als dit geraakt zou zijn. Mama 
en papa, bedankt! Jullie hebben maar 1 zoon, maar de tijd die jullie in mij gestoken hebben 
(en nog altijd doen) is onbetaalbaar. ‘Niet gaan bestaat niet, moeilijk gaan bestaat wel’, hoorde 
ik je, papa, vrij vaak zeggen. Het heeft altijd in mijn achterhoofd blijven spelen. Ik weet niet 
waar die passie voor melkvee vandaan komt, maar ik hoop dat jullie trots zijn op mij, ik ben 
alvast super trots op jullie! 
Terug naar de normale volgorde. Professor De Vliegher, beste Sarne. Bijna tien jaar terug 
vroeg je mij na een doctoraatsverdediging, of dit ook niets voor mij zou zijn. Een tweetal jaar 
ging erover vooraleer we ons eerste project klaar hadden. Eventjes naar Brussel op een 
zonnige dag met ons projectvoorstel. We hebben uiterst lekker gegeten, maar jammer genoeg 
ons project niet binnen gehaald. Opgeven staat echter niet jouw boek, dus vonden we wel een 
oplossing hiervoor en die kwam er dan ook vrij snel. Sarne, hartelijk dank voor je inzet en 
gedrevenheid! Dit dankwoord ben ik aan het schrijven op het vliegtuig richting Chicago. Hoe 
symbolisch! De besprekingen over mijn doctoraat die we hadden, samen met Sofie, 
verschilden waarschijnlijk vooral in tijd en plaats in vergelijking met alle andere Phd studenten. 
Een koffie bij de Starbuck’s in Chicago, avondoverleg op de faculteit, besprekingen in het 
vliegtuig, druk emailverkeer op een zaterdagavond (die dan de zondagmorgen werden verder 
gezet) … het zat er allemaal bij. De periode is te lang om op te sommen wat ik allemaal van 
jou heb geleerd, maar het is zeker een heleboel. Ik wens je verder heel veel succes met alles 
wat je nog zult ondernemen. Mijn steun heb je!  
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Dr. Piepers, beste Sofie. Ik moet jouw evenveel bedanken voor alle hulp bij dit proefschrift. 
Het startte met wat draaitabellen op een donderdagnamiddag en liep uit tot MlWin, SAS en 
SPSS. Ik mag natuurlijk ook niet vergeten de ontelbare keren dat jij mijn schrijfsels hebt 
verbeterd, nieuwe ideeën hebt naar voor gebracht en zeker ook de laatste maanden een erg 
grote hulp geweest bent voor het bereiken van mijn doel. Ik wens je heel veel succes met 
MEX en het M-team. Beiden zijn toch kinderen van jou en Sarne. Ik kijk vol bewondering hoe 
jullie samen een mooie mix kunnen maken van wetenschap, praktijk, communicatie en 
marketing. De kans is dan ook uiterst groot dat onze samenwerking niet stopt bij dit doctoraat. 
We hebben nu al terug wat nieuwe ideeën, dus dat wordt nog leuk.  
Vervolgens wil ik ook de examencommissie bedanken. Allereerst Professor de Kruif. Uw 
lessen waren keer op keer zeer interessant en op de praktijk gericht. Professor Keefe, dear 
Greg, thank you much for your help and novel ideas on the two articles we wrote together. 
Combining being Dean of your faculty with your job as researcher and lecturer, must be one 
big challenge. I appreciate your kindness and your scientific knowledge enormously. Professor 
Lam, beste Theo. Hartelijk dank voor het zeer grondig nalezen van mijn proefschrift. Uw 
opmerkingen waren keer op keer een verbetering voor dit werk. Ik wens u het allerbeste toe 
in uw verdere loopbaan, want dat is een heus curriculum geworden. Ook uw opmerkingen 
tijdens de ‘Dutch Mastitis Research Workers’ meetings, waren voor mij telkens erg 
inspirerend. Professor Opsomer, beste Geert, ook u moet ik erg bedanken. Voor het nalezen 
van dit werk en ook voor alle kennis die u met ons deelde tijdens het laatste jaar op de 
buitenpraktijk (toch al een tijd geleden eigenlijk). Beste Bart, we zijn samen gestart met de 
cursus statistiek te volgen en jij was duidelijk een pak sneller klaar dan ikzelf. Bedankt voor 
de nuttige aanvullingen en in de toekomst werken we zeker en vast nog geregeld samen. Ik 
dank ook Prof. Houf, Dr. Demeulemeester en Ir. Leloup voor het nalezen van mijn thesis en 
het zetelen in de examencommissie. Allen hartelijk dank !  
Bedankt ook aan alle farmaceutische firma’s (Bayer Animal Health, Boehringer Ingelheim, 
Ceva, Hipra, MSD, en Zoetis ) die mijn onderzoek en/of het drukken van deze thesis financieel 
hebben ondersteund. Ik dank ook Boerenbond voor het verspreiden van de enquête en MCC 
Vlaanderen voor het uitvoeren van de bacteriologie.  
Natuurlijk dank ik ook alle mensen van de DI08 en in het bijzonder alle leden (en ex-
leden) van het M-team: Karlien, Anneleen, Kathelijne, Kristine, Marina, Dimitri, Zyncke, 
Ameline, Lars en Els. Mijn bezoeken aan de faculteit waren vaak op latere uren en van korte 
duur. Jullie waren altijd bereid om me te helpen waar nodig. De congressen met jullie naar de 
VS en Nederland, waren altijd aangename belevenissen. Lars, bedankt voor het labo-werk! 
Anneleen, bedankt voor de hulp tijdens de laatste maanden! Ik reken verder op jou en Anthony 
voor het schapen scheren. Steven, dikke merci voor het ‘online’ maken van de enquête! 
Zyncke en Ameline, bedankt voor de praktische regelingen de laatste dagen.  
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Ook de ex-collega’s bij DAP De Toren, Anne-Marie en Evelien, dank ik voor het 
bijspringen bij de staalnames van de vaarzen wanneer het voor mij eens niet lukte. Het gaat 
jullie goed in jullie verdere loopbaan. Dr. Omer Gunst, bedankt dat u een mooie praktijk hebt 
overgelaten, waarin de melkveehouderij een serieuze plaats kende. Dankzij deze klanten is 
mijn passie voor melkvee nog verder kunnen toenemen.  
Ik dank ook alle melkveehouders die meegeholpen hebben aan dit onderzoek. In 
bijzonder, de tien melkveehouders die deelnamen aan de vaarzenproef: Marc, Jos, Dries, 
Marc, Xavier, Wim, Koen, Peter, Koen, en Guido. Dankzij jullie ingesteldheid werd het mogelijk 
om praktijkonderzoek te doen, zeker geen evidentie met de proefstelling die ik voor ogen had. 
Hartelijk dank! 
Gert en Marina, jullie heb ik de laatste maanden wel wat ‘verwaarloosd’. Blijkbaar hebben 
jullie echter veel geduld met me. Dank hiervoor. Nu zijn we helemaal klaar om er nog eens 
extra in te vliegen en Milk@vice verder uit te breiden! Marina, jij bent nu de volgende in de rij 
(hoop ik ). Veel succes en je zult dat super doen. Gert – no pressure - maar een Phd is 
misschien iets voor jou ? Om het met een quote uit ‘Het Eiland’ te zeggen : “Ik ben blij dat 
jullie in mijn team zitten”! 
De studentenjaren liggen al een tijd(je) achter ons. Maar ik zal ze nooit vergeten. Die zes 
jaren in Gent waren fantastisch! Studies combineren met koeien en … de Vlaams 
Diergeneeskundige Kring! Dank aan alle mensen die in het verleden en in de toekomst hier 
hun steentje aan hebben bijgedragen en nog zullen bijdragen! Ons steentje, namelijk het 
Boerderijtje, is spijtig genoeg ter ziele gegaan, maar heette de club vroeger niet WIK (Willen 
is Kunnen)?  
Na de studies kom je zoals zo velen in de praktijk terecht en ‘verwateren’ ongewild 
sommige relaties met oud-studenten een beetje. Maar niet met allen. Tom en Kristof. We 
hebben fantastische tijden beleefd als student : ‘poten gaan kappen’ in Oentjserk, schapen 
verlossen bij nonkel André en tante Nouche in Frankrijk, weken intern op de buitenpraktijk 
waar ik tot mijn grote verbazing nog heb gesupporterd voor een niet nader te noemen 
voetbalploeg in de Champions League.... those were the days! Maar ik ben heel blij dat we 
deze lijn 15 jaar later nog altijd kunnen doortrekken. Ook al hebben we elk van ons onze 
tegenslagen ook al gehad. Tom, bedankt voor je steun! Regelmatig sloten we de feestjes bij 
jou af met wijlen Luc De Vos door de boxen. Over andere – nog meer legendarische - feestjes 
zal ik niet schrijven, maar we zullen er vaak – ik toch – aan herinnerd worden. Kristof, jij bent 
niet te volgen. Letterlijk dan. De weekends en etentjes met Tom en jij, mondden vaak uit in 
gewichtheffen, bankdrukken, handenstand (niet voor mij gelukkig) of een voetbalmatch met 
de ganse bende. Zalig gewoon! An en Liesbeth, ook jullie bedankt ! Het moet niet makkelijk 
zijn, om wanneer Kristof, Tom en ik samenkomen, het gesprek van de eerste minuut tot de 
laatste over koeien te zien lopen. Ja, ja, we vinden altijd wel een aanknopingspunt ! We 
 254 
 
doen nochtans hard ons best  ! Veel succes met DAP Okapi, Tom en An samen met Chanel, 
Mathis en Alizée! Kristof en Liesbeth, veel succes met alles wat jullie ondernemen en jullie 2 
topsporters in wording, Arne en Ward!  
Een speciale vermelding gaat uit naar alle vrienden bij KTG Houtland: in willekeurige 
volgorde met de kans dat ik iemand vergeet (waarvoor nu al mijn excuses): Cé en Elke, Kris 
en Eva, Wouter en Nathalie, Pieter VE, Pieter VS en Wendy, Dieter, Valentijn en Katrien, 
Didier en Joke, Joeri en Julie, Koen en Lies, Kevin en Katrien, Davy en Jill, Bert L, Bert D, 
Peter, Niels, … Tennis is een mooie sport en zeker als de sfeer errond fantastisch is. Voor mij 
een welkome afwisseling in een al te vaak te drukke agenda. Het voordeel van tennis is dat 
je: 1. niet goed hoeft te zijn om te kunnen spelen en 2. je het ook op oudere leeftijd nog altijd 
kunt spelen (althans zo lijkt het) en 3. de derde helft altijd uitloopt . We zitten dus voor 
meerdere jaren goed en hoeven niet direct te verleggen naar biljart, vogelpik of petanque! 
Mooi zo! 
Mijn familie dank ik ook van harte. Alle ‘Passchyntjes’, de ‘De Goe’ s , en de ‘Goolaertsjes’. 
Het zijn er te veel om op te noemen eigenlijk . Jullie aanwezigheid hier doet me echt veel 
deugd! Steven, je bent er niet meer, maar ‘you did something to me’. Thanks mate !  
Jore en Liene, mijn oogappels. Kijk, jullie naam staat in het boekje van papa! Jullie weten 
van niet beter, dat papa altijd ‘bezig is met de koeien’. Ofwel haalde ik de landelijke geur in 
huis, ofwel moest ik weer voor een paar dagen weg om ‘les te volgen’ of ‘les te geven’ ofwel 
zat ik thuis voor mijn computer. Dat zal niet altijd leuk geweest zijn voor jullie, maar je ziet, als 
je maar doorzet, komen er aan zulke dingen ook een einde! Nu zal papa echt wel meer tijd 
voor jullie kunnen maken. Ik kijk er al naar uit om de gewone dingen te doen met jullie, een 
wandeling maken, meegaan naar de volleybal, in de tuin ravotten, eens samen tv kijken,…. 
Vergeet niet dat het niet uitmaakt wat jullie later zullen doen, zolang je maar zorgt dat je de 
beste wil worden in hetgeen je doet! Straks komt er nog een broertje of een zusje (en ik weet 
het al  ) bij, en kunnen jullie elk grote zus zijn!  
Annelies, kijk waar we nu staan! We zijn er eindelijk geraakt. Nooit gedacht, he? Ik zeg 
‘we’ omdat jij voor een groot stuk hieraan hebt bijgedragen. Niet alleen heb jij het geduld om 
tabelletjes en pagina’s goed te zetten in Word (en ik niet ), maar heb jij ontelbaar veel dingen 
thuis gedaan. Het huishouden, de tuin onderhouden, voor de kindjes zorgen en een full-time 
job….Te veel om op te noemen, maar niet te veel om je daarvoor enorm te bedanken! Super 
hard bedankt, schat! Voor alles! We gaan straks uitbreiden  en ik kijk er zo naar uit! Ik zie je 
graag!  
 
Pieter  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
